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Summary 
Recent development of many advanced biomolecular technologies has boosted research in 
the life sciences domain. These new technologies offer great opportunities for the large 
scale study of organisms down to their DNA, genes and gene products. However, the 
analysis and integration of all these new data is seriously hindered by the slow production 
of suitable software infrastructure and the problems will only increase as even more 
technologies are developed at a fast rate. This thesis addresses this problem. 
The ideal software infrastructure enables biologists to easily connect to data and analysis 
tools in other laboratories, for which standardization is helpful. However, a ‘local’ 
infrastructure must also accommodate the specifics of their biotechnologies, the specific 
details of the plant/animal/microbe species studied, and the protocols used to generate and 
process data. Currently, many time-consuming changes in software code are needed to 
assemble and adapt dozens of software infrastructure components by hand to the specifics 
of another experiment. Invaluable software components may be developed elsewhere but 
small and large differences in data and software structure make it hard to fit them together. 
Therefore, research groups often (re)develop all software themselves. The inevitable ‘wheel 
reinventions’ are an unnecessary waste of effort and greatly reduce the lifespan of the 
software. Efficient mechanisms to ease software infrastructure variation are wanted 
(Chapter 1). 
My aim with this thesis is to introduce and validate innovative informatics solutions to 
timely produce, maintain, and evolve the ‘dynamic’ software infrastructures needed. 
Leading principle is to exploit commonalities within a SOFTWARE FAMILY* of bioinformatics 
infrastructures, while dealing with variation in a systematic manner. An example of a 
software family is a set of websites for genetic data and an example of variation is the need 
to support specific mouse or plant species. I propose to use a minimal ‘domain specific’ 
computer language to efficiently describe the various needs of biologists, and a software 
tool to automatically translate such descriptions into variants of working software 
infrastructure (Chapter 2).  
Realization of this strategy is nontrivial and requires a toolbox of methods. A large part of 
this thesis describes an example of such toolbox, called ‘MOLGENIS’ 
(http://www.molgenis.org). This toolbox includes (i) a DOMAIN SPECIFIC LANGUAGE (DSL) to 
describe the common and variable features of infrastructures to handle biological data, (ii) a 
‘stock’ of (semi-finished) reusable assets with common functionalities such as data storage, 
access, and visualization, and (iii) a suite of GENERATORS to automatically translate DSL 
                                                          
* See glossary, page 8. 
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descriptions into the specific software codes needed to tailor and glue these components 
together (see also cover and Chapter 3). 
The following case-studies helped to fine-tune and evaluate strategy, methods, and toolbox:  
1. Chapter 4 describes the challenges of a molecular genetics group establishing a 
MICROARRAY laboratory. We generated a software infrastructure to support the 
preparation of measurement materials, treatment of biomaterials, and production of 
raw experimental data in their ‘wet’ lab. 
2. Chapter 5 describes the challenges of a bioinformatics group analyzing many 
GENETICAL GENOMICS experiments for their collaborators. We generated a software 
infrastructure to import heterogeneous data from collaborators, manage in-process 
data, and share processed results in their ‘dry’ lab. 
3. Chapter 6 describes the challenges of a clinical trial coordination center involved in 
the analysis of CLINICAL STUDIES. We generated a software infrastructure to preserve and 
(re)distribute databases produced in various clinical studies and to allow biomedical 
researchers to extract and integrate cross-study data. 
4. Chapter 7 describes the challenges of a bioinformatics group that needed processing 
tools for METABOLIC genetical genomics data. We generated a software infrastructure 
with reusable processing modules that can be used in alternative workflows for large-
scale analysis. 
The results of these case studies are very promising. Using the proposed strategy, one can 
generate and improve the necessary infrastructure features up to 40x faster, compared to 
writing software code by hand. This greatly helps to keep up in the fast evolving domain of 
the life sciences. We also learned how to structure software infrastructures such that they 
can be easily extended. Newly generated reusable assets, and data processed with them, can 
be integrated more easily by other laboratories because their standardized production 
process. Of course, domain specific languages (DSLs) and generators are not the best 
solution for every problem, so I also evaluated when to use other variation mechanisms.  
How to optimally use the work presented in this thesis? A public repository to share DSL 
models, or modules thereof, can greatly help groups to benefit much longer from each 
other’s software developments notwithstanding variation in research aims. They can 
oversee few changes in a DSL file much better than they can oversee many related changes 
scattered throughout software code. ‘Fundamental’ informatic research can provide the 
foundation for additional DSLs to further ease evolution of (biological) software and data 
integration. Integration of MOLGENIS with complementary ‘processing’ toolboxes 
promises a future with even more benefits for the development of ‘dynamics software 
infrastructures for the life sciences’ (Chapter 8). 
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Samenvatting 
Het onderzoek in de levenswetenschappen is de laatste jaren in een stroomversnelling 
gekomen door de ontwikkeling van geavanceerde biomoleculaire meettechnieken. Deze 
technieken maken het mogelijk allerlei eigenschappen van een organisme te bestuderen tot 
op het niveau van het DNA, de genen en hun genproducten. Helaas blijft de ontwikkeling 
van software infrastructuren om deze nieuwe stroom van data te verwerken en integreren 
achter terwijl de uitdagingen de komende tijd zeker niet minder worden met de komst van 
bijvoorbeeld verbeterde machines om DNA af te lezen. 
De ideale software infrastructuur stelt biologen in staat om eenvoudig data en rekentools uit 
te wisselen met collega’s, en hierbij helpt standaardisering enorm. Een ‘lokale’ 
infrastructuur moet echter ook passende ondersteuning bieden voor de ter plaatse gebruikte 
biomoleculaire technieken, de specifieke aspecten van de plant/dier/bacteriesoort die men 
bestudeert en de protocollen die men gebruikt om data te genereren en te verwerken. Het 
vergt nu vaak nog veel handwerk om de programmacode van alle infrastructuuronderdelen 
aan te passen aan een specifiek experiment. Daarnaast blijkt het vaak lastig waardevolle 
software componenten van elders in te passen, bijvoorbeeld omdat verschillende 
programmeertalen zijn gebruikt of omdat componenten anders zijn gestructureerd. 
Onderzoeksgroepen (her)ontwikkelen daarom vaak hun eigen software en vinden zo als het 
ware het wiel opnieuw uit. Dit is zonde van tijd en geld en verkort de levensduur van de 
software enorm. Er zijn efficiënte mechanismen nodig om zulke software infrastructuren 
van onderzoeksgroep tot onderzoeksgroep te variëren.  (Hoofdstuk 1).  
In dit proefschrift ben ik op zoek gegaan naar een krachtige strategie om tijdig de 
benodigde ‘dynamische’ software infrastructuren te bouwen, onderhouden en vooral, tot 
volledige bloei te laten komen. Mijn uitgangpunt hierbij was om de overeenkomsten tussen 
infrastructuren van dezelfde ‘software familie’ (zeg: diverse websites voor biologische 
data) zoveel mogelijk te benutten terwijl de verschillen tussen de infrastructuren (zeg: een 
muis of een plant-experiment) systematisch aan te pakken (zie ook voorkant omslag). Ik 
stel voor om een ‘minimale’ computer taal te gebruiken om efficiënt de verschillen in 
infrastructuur-wensen te beschrijven, en een geautomatiseerde gereedschapskist om zulke 
beschrijvingen snel te vertalen in werkende programmacode (Hoofdstuk 2). 
Realisatie van deze strategie is niet eenvoudig en vereist een gereedschapskist aan 
methoden. Een belangrijk deel van dit proefschrift beschrijft een uitgewerkt voorbeeld van 
zo’n gereedschapskist, genaamd MOLGENIS (http://www.molgenis.org). Deze kist bevat 
(i) een domein specifieke taal om algemene en specifieke kenmerken van gewenste 
biologische data-infrastructuren te beschrijven, (ii) een voorraad met (halffabrikaat) 
bouwstenen voor gemeenschappelijke functies zoals data opslag, toegang, en presentatie, en 
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(iii) een stel generatoren om die beschrijvingen automatisch om te zetten in 
programmacode die de bouwstenen aanpast en assembleert (Hoofdstuk 3). 
Casestudies hebben geholpen strategie, methoden en gereedschapskist aan te scherpen: 
1. Hoofdstuk 4 beschrijft de problematiek van een moleculaire genetica groep die een 
laboratorium voor ‘microarray’ experimenten wilde inrichten. We genereerden een 
software infrastructuur om de voorbereidingen en metingen van ruwe en bewerkte 
biologische materialen in hun ‘natte lab’ te volgen. 
2. Hoofdstuk 5 beschrijft de problematiek van een bioinformatica groep die verschillende 
‘genetical genomics’ experimenten analyseert voor biologische partners. We 
genereerden een software infrastructuur voor de import van ruwe data, beheer van 
tussenresultaten, en het delen van resultaten in hun ‘droge lab’. 
3. Hoofdstuk 6 beschrijft de problematiek van een centrum voor de coördinatie en analyse 
van medische studies. We genereerden een software infrastructuur voor de centrale 
opslag en verspreiding van data over verschillende studies en om onderzoekers in staat 
te stellen studiedata te doorzoeken, integreren en downloaden via een centrale website. 
4. Hoofdstuk 7 beschrijft de problematiek van een bioinformatica groep bij de statistische 
analyse van (metabolische) genetical genomics data. We genereerden een software 
infrastructuur met herbruikbare rekenmodules zodat die in verschillende paden kunnen 
worden aaneengeknoopt voor grootschalige analyses. 
De resultaten behaald in deze vier cases zijn veelbelovend. Door middel van de 
voorgestelde strategie kan men tot 40x sneller alle benodigde functies en verbeteringen 
realiseren met bijna de efficiëntie van‘massa productie’. Zo wordt het gemakkelijker om bij 
te blijven in het zich snel ontwikkelende onderzoeksveld van de levenswetenschappen. 
Daarnaast geven deze casussen inzicht hoe zulke infrastructuren het best in te richten zodat 
uitbreidingen nog eenvoudiger worden. Verder zijn nieuw gegenereerde bouwstenen door 
hun standaard productieproces beter uitwisselbaar zodat andere laboratoria ze eenvoudiger 
kunnen inpassen. Uiteraard zijn domein specifieke talen (DSLs) en generatoren niet de 
oplossing voor alle problemen. Ik heb daarom ook gekeken wanneer de het gebruik van 
DSLs loont en wanneer men beter een andere strategie kan gebruiken. 
Het is nu zaak om deze strategie maximaal te benutten. Een openbare ‘catalogus’ voor het 
delen van infrastructuur modellen (in de DSL), of onderdelen daarvoor, kan zorgen dat 
onderzoeksgroepen langer van elkaars ontwikkelingen blijven profiteren. Zij kunnen 
verschillen in één DSL document veel gemakkelijker overzien dan een heleboel verschillen 
verspreid in programmacode. ‘Fundamenteel’ informatica onderzoek kan de basis bieden 
voor meer DSLs om de evolutie van (biologische) software en integratie van data verder te 
vereenvoudigen. Integratie van MOLGENIS met complementaire gereedschapskisten voor 
bijvoorbeeld data analyse stromen (ontwikkeld in andere bioinformatica groepen) belooft 
een toekomst met nog veel meer mogelijkheden voor de ontwikkeling van ‘dynamische 
software infrastructuren voor de levenswetenschappen’ (Hoofdstuk 8). 
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1.1 Problem statement 
The advent of various biomolecular technologies has boosted biological and medical 
research. Figure 1 illustrates the heterogeneous types and large amounts of biomolecular 
data and the complex protocols needed to produce and analyze these new data (see section 
1.3 for a glossary of terms): 
 
Multiple plants (Fig 1a) or mice (Fig 1b) are crossed with smart breeding 
strategies to produce hundreds of genetically different offspring. Each individual 
of these offspring is fingerprinted with molecular marker technologies (AFLP in 
Fig 1a, SNPs in Fig 1b) to generate 10,000-100,000 pieces of information about 
their genetic make-up (genotypes). Each individual is also profiled using gene 
expression technologies (Qiagen-Operon microarrays in Fig 1a) or mass 
spectrometry technologies (LC-MS in Fig 1b) to get 100,000 pieces of 
information about which of the 20,000-30,000 genes are ‘switched on’ (gene 
expression), or which genes result in protein and metabolite molecules (visible as 
mass peaks). All technical steps in the complex data production process have to 
be well documented, e.g. and what batch of DNA microarray chips was used, 
what temperature for hybridization, in order to be able to track and trace data and, 
if needed, re-do and re-interpret certain analyses. The (pre-)processing of gene 
expression (Fig 1a) or mass spectrometry (Fig 1b) data will require several days 
at a computing cluster of 100s state-of-the-art PCs, and will generate output that 
exceeds input in size and complexity. Although different in origin, both types of 
data may end up in a similar type of analysis to uncover the genetic determinants 
of plant/animal features and to reconstruct biological networks (QTL, correlation 
and network analysis in Fig 1).  
 
Storing, managing, processing, cross-linking and interpreting these data won’t work 
anymore using only a paper lab journal, some rewritable CD’s, a stack of Excel files and a 
copy-and-paste into analysis software, and there is little debate about the need for software 
infrastructures to archive, analyze and integration of all these data. Timely production of 
such infrastructures has become a major bottleneck. 
chapter 1 
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Figure 1a | A high-throughput molecular biology protocol. 10+ lines of the A. thaliana plant are 
inbred and genotypically profiled using biomolecular markers. The expression of thousands of 
genes is measured for 100+ individuals of these inbred lines, using two-color microarrays that may 
use 10.000+ of probes (that hybridize with the gene products). The expression data is preprocessed 
on the computer to reduce systematic errors. Finally, the QTL likelihood along the genome is 





































Figure 1b | Another variant of a molecular biology protocol. The process shown has much in 
common with the process described in Figure 1a. However, important differences have to be 
accounted for, e.g. difference in species (strains of mouse instead of lines of A. thaliana), genotyping 
device (SNP arrays instead of biochemical markers), and omic level measured (metabolite abundance
instead of gene expression). This requires another variant of software infrastructure in order to
accomodate those differences.  
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Figure 1 also illustrates why development of such software infrastructures is non-trivial 
and time-intensive:  
 
Software developers have to make a large effort to master the complex biological 
terminology and biotechnological processes before they can start helping the 
biologists. Once they understand the terminology, they can start to tailor and 
assemble many software components for storing, finding, updating, calculating 
and user interfacing each data type.  They have to face the large scale of data: 
standard components may not work and all steps need to be automated. For 
example, copy-and-pasting thousands of ‘probe annotations’ one-by-one into the 
tool used for network analysis is not an option. A new or improved biomolecular 
method (SNP instead of AFLP in Fig 1) has different input/output signatures that 
require changes in the software infrastructure parts that support other steps. New 
and invaluable software components may be developed elsewhere outside the 
control of the infrastructure owners (e.g. a revolutionary tool for QTL calculation 
or network reconstruction). These heterogeneous software components are often 
implemented on a different technical platform (Oracle, Windows, Linux, using 
Java, Perl, C++, etc). making it hard to make them fit in the infrastructure 
software. Although experiments may follow roughly a common protocol – in Fig 
1: generate offspring, fingerprint and profile offspring, pre-process data, map 
QTLs and reconstruct networks – there are also important differences requiring 
many variants of software infrastructure. Moreover, it is unpredictable today 
what new (combinations of) molecular and statistical technology will be around 
tomorrow. Still, researchers want to have the new or modified infrastructure 
variant with a short time-to-market to keep ahead in the competitive world of 
science. 
 
This thesis aims to introduce and validate innovative informatics solutions to address 
these challenges. The result, I hope, is that bioinformaticists will have a new strategy 
to timely produce, maintain and evolve software infrastructures that suit biologists’ 
needs.  
1.2 Thesis road map 
Figure 2 provides a road map to the four parts of this thesis. The current chapter provides 
an introduction into the research problem (previous section), a short outline of each chapter 
(this section) and a glossary of terms (next section). Chapters 2-3 describe methods to 
tackle the research problem and review related work. Chapters 4-7 describe detailed cases 
covering different (parts of) software infrastructures for (systems) biology. Chapter 8 
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discusses the contributions of this thesis and outlines future work. Below a short outline of 
each chapter is given. 
Methods 
Chapters 2-3 describe methods to tackle the research problem and review related work. 
We conceptualize and implement an informatic strategy to alleviate the problems described 
above and describe how to implement this strategy in practice. 
 
Problem analysis and approach | In Chapter 2 we further analyze the problems described 
above. Biologists need software infrastructures that easily connect to work that is done in 
other laboratories, for which (numerous) standardization initiatives have been helpful. 
However, the infrastructure must also accommodate the specifics of their biological system, 
but appropriate mechanisms to support variation have been lacking.  
Chapter 1: Introduction




Problem analysis and approach 
Beyond standardization: dynamic 




Generative development in action 
How to generate dynamic software 







Infrastructure for the wet-lab 
Molecular Genetics Information System 
(MOLGENIS): alternatives in developing 
local experimental genomics databases. 
 
Chapter 5 
Infrastructure for dry-lab 
MGG: A customizable software 
infrastructure for genetical genomics  
 
Chapter 6 
Infrastructure for clinical trials 




Reusable assets for processing 
MetaNetwork: a computational protocol 
for the genetic study of metabolic 
networks. 
Chapter 8: Discussion and Future work
Evolution of a biological software family, dealing with commonalities and variation, how to 
bring many more benefits to biology. 
Figure 2 | Road map of this thesis.  
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In this thesis I argue that a strategy that goes ‘beyond standardization’ using a 
minimal computer language (to describe what biologists need), and a software tool 
called a generator (to automate software implementation), can be used to quickly 
produce customized software infrastructures that ‘systems biologists really want to 
have’. We review six recent example initiatives, one of which is presented in this thesis, 
that give a glance into a future with many more benefits. 
 
Generative development in action | In Chapter 3 we report on the use, working and 
implementation of a generator to quickly produce ‘Molecular Genetics Information 
Systems’. The MOLGENIS generator is an example of a ‘domain specific’ tool to generate 
ready to use software infrastructures for biology, including user interfaces for biologists and 
programmatic interface for bioinformaticians. We show a concrete ‘domain specific 
language’ to describe how for example a microarray experiment is to be organized in terms 
of data and their relationships, and how simple “text file” generators automagically 
generate all parts of database, application logic and user interfaces. Only parts specific to 
research supported by a software variant need to be generated, on top of reusable assets that 
have mechanisms to easy variation. We found a 48 fold reduction of effort in comparison 
with hand-writing software.  
Cases 
Chapters 4-7 describe case studies covering various (parts) of working software 
infrastructures for systems biology. For each case we describe what functionality is needed 
by biologists/bioinformaticists and how we implemented a suitable software infrastructure 
to accommodate these needs.  
 
Infrastructure for the wet lab | In Chapter 4 we report on the case of a molecular 
genetics group establishing a microarray laboratory. They required infrastructure to support 
the work in their ‘wet’ lab, i.e. preparation of measurement materials, treatment of 
biomaterials, and production of raw experimental data. We evaluated twenty existing 
microarray databases (Table 4.1) and then decided to build a new system. Five typical 
requirements were identified and alternative solutions evaluted for: (i) evolution ability to 
keep up with the fast developing genomics field; (ii) a data model to deal with local 
diversity; (iii) storage of data files in the system; (iv) easy exchange with other software; 
and (v) low maintenance costs. This resulted in the first generated MOLGENIS-variant and 
since then supported over 90 projects.  
 
Infrastructure for the dry lab | In Chapter 5 we report on the case of a bioinformatics 
group analyzing many genetical genomics experiments for their collaborators. They 
required infrastructure to support the work in their ‘dry’ lab, i.e. import of heterogeneous 
data from their collaborators, management of in-process data, and sharing of processed 
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results. A central infrastructure would ease sharing of resources (data, processing 
algorithms, visualization tools) within and across organisms and collaborators. The 
diversity of the data made this challenging: transcript, protein, metabolite, and genotype 
data were provided from hundreds of genetically different individuals from human, mouse, 
A. thaliana, and C. elegans (remember Figure 1). The MOLGENIS generator tool was 
evolved to provide variation mechanisms for data (such as ‘inheritance’) and processing 
centered interfaces (such as data access from the R statistical language). This resulted in a 
second MOLGENIS variant ‘for genetical genomics’ (MGG) that can be customized by 
individual research groups to suit their needs.  
 
Infrastructure for clinical trials | In Chapter 6 we report on the case of a clinical trial 
coordination center involved in the analysis of many clinical studies. They required 
infrastructure to preserve and (re)distribute databases that were produced in different 
clinical studies and that allow biomedical researchers to extract (cross-study) data. We 
explain our design decisions, describe a generic and flexible data model, and give 
mechanisms to preserve and extract data in a custom, reproducible and labor extensive 
fashion. Such a uniform system eases the reuse of methods by data administrators and 
provides clinical researchers with a uniform (web-based) user interface to quickly extract 
custom datasets that suit their analysis needs. The detailed descriptions also constitute a 
foundation for local system developers to base their own  projects upon. 
  
Reusable assets for processing | In Chapter 7 we report on the case of a bioinformatics 
group that needed to process (metabolite) genetical genomics data. They required 
infrastructure to (i) map metabolite quantitative trait loci (mQTLs, regions on the genome 
containing genes) that supposedly underlie variation in metabolite abundance in genetically 
different individuals, (ii) predict potential associations between metabolites using 
correlations of mQTL profiles, rather than of abundance profiles, (iii) asses statistical 
significance using simulation and permutation procedures, and (iv) provide visual and 
textual report on predicted metabolic networks. We developed a package of reusable 
processing modules that can be used in alternative combinations because of the use of 
standardized (intermediate) data structures that allows the modules to ‘talk to each other’. 
In addition, this package can also talk to MOLGENIS for genetical genomics, described in 
Chapter 5. We describe in detail how these programmatic modules work and how they can 
be used.  
Discussion and future work 
In Chapter 8 we evaluate and discuss our findings on use of novel ‘generative’ strategies 
for the production, maintenance, and evolution of biological software infrastructures. We 
first discuss the benefits for bioinformaticists involved in the development of local software 
infrastructures for particular experiments, based on the experiences with the MOLGENIS 
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generator tool developed in this thesis. Next, we discuss the benefits of generative methods 
for the public software infrastructures, for example to ease the integration of biological data 
and processing tools that are provided by numerous distributed and heterogeneous web 
resources. Finally, we discuss how even more can be gained if emerging ’generative 
bioinformatics’ tools would join hands and define future informatics projects to support 
these initiatives, to allow future bioinformaticists to generate even more comprehensive 
software infrastructures for the management, processing and integration of systems biology 
data. 
1.3 Glossary of terms 
The research presented in this thesis integrates knowledge and methods from the fields of 
biology, medical sciences, bioinformatics, (information) management and software 
engineering. Below, we provide glossaries of terms. We thank many anonymous sources 
for this information. We apologize if we use these terms in a too loosely manner; we did it 
to improve readability for a broad public. References to the glossary are indicated in the 
main text with BOLD SMALL CAPS. Interested readers can find also a list of hyperlinks to 
software infrastructures for biology (or parts thereof) and software engineering tools in the 
appendix. References to this online information are indicated by THIN ITALIC SMALL CAPS.  
Molecular biology terms.  
Below a short glossary is provided to introduce the reader into molecular biology:  
CENTRAL DOGMA OF MOLECULAR BIOLOGY 
DNA is the blueprint of life. DNA can be ‘read’ using a process called 
transcription resulting in the production of messenger RNA (MRNA). In most 
species mRNA is then processed to splice out non-revelant parts and then 
moved from the nucleus (where DNA lives) to the cytoplasm (outer part of 
the cell). mRNA is than translated into PROTEINS molecules by cell 
components called ribosomes. 
DNA (DEOXYRIBONUCLEIC ACID), POLYMORPHISM, SNP 
Deoxyribonucleic acid (DNA) is a molecule encodes 
hereditary information and that is mostly found inside the 
nucleus (core) of cells. DNA consists of very long strands 
of chemical  bases (also called nucleic acids).  Typically 
105-108 adenine, guanine, cytosine or thymine (AGCT) 
molecules are chained together by sugars and phosphate 
groups to form a very large molecule. Two DNA strands 
are paired together into a double helix such that each 
base (nucleotide) on one strain is paired to a specific 
partner on the other strand (basepairs A-T or G-C). The 




















or regulatory elements influencing GENE EXPRESSION. By convention, one end of the DNA 
strand is called 5’ (five prime) and the other end 3’ (three prime). The specific nucleotide 
sequence varies between individuals of one population (polymorphism), for example, 
there are positions where a single nucleotide is different (single nucleotide polymorphism, 
SNP). In cells, continuous strings of DNA are organized in structures called 
chromosomes. Sexually reproducing species have pairs of chromosomes (i.e. are 
diploid), e.g. Human has 23 pairs of chromosomes, and Arabidopsis thaliana has 5 pairs 
of chromosomes. Asexually reproducing species have one set of chromosomes instead of 
pairs.  
GENES, ALLELES, GENE EXPRESSION AND GENOMICS 
Genes are discrete units on the DNA that code for proteins. This involves specific 
sequences to switch on a process called gene expression which transcribes the DNA into 
MRNA and then translates it into PROTEINS (see below) The complete set of genes as 
scattered over all chromosomes is called the genome. Due to POLYMORPHISMS, genes may 
have different variants (alleles) over individuals, which may lead to variation in function 
and regulation of genes, and as a consequence to different TRAITS (or disease). The study 
of an organism’s entire genome is called genomics, with functional genomics mainly 
concerned with the dynamics of gene expression, the function of the proteins produced 
and protein-protein interaction while structural genomics studies the structure of these 
proteins (typically before function is known). 
MRNA, TRANSCRIPT AND TRANSCRIPTOMICS 
Messenger RNA (mRNA, Messenger Ribonucleic Acid or transcripts) molecules are 
copies of a part of DNA. The enzyme RNA polymerase uses the non-coding strand of 
the DNA sequence as template for the RNA copy and using base pairing 
complementary to ensure the correct copying, i.e. G-C, A-U (n mRNA T is replaced by U). 
An mRNA may be protein-encoding which means it can be translated into a protein. The 
transcription of mRNA is known as GENE EXPRESSION and the study of gene expression is 
also called transcriptomics. 
PROTEINS,  PROTEOMICS AND PROTEIN-PROTEIN INTERACTION 
Proteins are long chains of molecules consisting of up to 20 different amino acids and 
include enzymes to catalyze chemical processes; structural components that shape 
cells; hormones for signaling; antibodies to bind (intruding) molecules; and transport 
molecules. Proteins fold into unique 3-dimensional structures and typically have active 
sites that participate in chemical reactions and protein-protein interactions. The total set 
of proteins in a cell is known as the proteome and the study of proteins is also called 
proteomics. 
METABOLITES AND METABOLOMICS 
Metabolites are small molecules that are starting, intermediate or end products of 
metabolism (often catalyzed by enzymatic PROTEINS). So-called primary metabolites are 
involved in growth, development and reproduction and are necessary for survival. So-
called secondary metabolites are involved in less important functions such as 
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pigmentation or antibiotics. Metabolism is the sum of all chemical reactions that take place 
in every cell of living organisms such as synthesizing cellular material or breaking down 
complex molecules releasing energy. Metabolism is a complex web of interconnected 
reactions and its study is called metabolomics.  
GENOTYPE 
Genotype is the result of measurement (GENETIC PROFILING, see below) on how an 
individual differs from other individuals regarding its DNA sequence and variant of ALLELE. 
PHENOTYPE, TRAIT 
A phenotype is any observable trait of an organism such as flowering time (known as 
classical phenotype), but also GENE EXPRESSION or METABOLITE ABUNDANCE (known as 
molecular phenotypes). 
MODEL ORGANISMS 
Some species are extensively studied to understand particular 
phenomena. The expectation is that discoveries made in an 
organism model will give insight in the workings of other organisms. 
For example, mouse is a model for humans. Other well studied 
model organisms are budding yeast (Saccharomyces cerevisiae), 
roundworm (Caenorhabditis elegans), fruit fly (Drosophila 
melanogaster) and the plant mouse ear cress (Arabidopsis thaliana). 
SYSTEMS BIOLOGY 
Many components of biological systems, and their interactions, have been successfully 
identified by studying parts of systems in isolation, such as GENES, TRANSCRIPTS, and 
PROTEINS. However, static diagrams of genes/proteins and their connections are not 
sufficient to fully understand a biological system. Comprehensive and quantitative data on 
concentrations and dynamics are needed to make clear how and why cells function the 
way they do. Increasingly integrative experiments are being designed that combine 
evidence from multiple ‘ome’-levels (genome, proteome, metabolome), as well as 
phenotypic data on normal and disease processes, for many model organisms or even 
humans (clinical data). These systems biology studies promise the comprehensive 
information needed to understand how whole systems function See for example (Joyce 




Below a short glossary is provided to introduce the reader into the many technologies that have 
been developed to measure the biomolecular entities as described above. 
MICROARRAYS, PROBES 
A microarray is a device that has thousands measurement probes 
(spots), each with a DNA sequence complementary to the MRNA 
sequences that are expressed. When the mRNA is available it binds 
to the probes, thus allowing measurement of GENE EXPRESSION, i.e., 
how much is a gene ‘switched on’. There are many microarray 
platforms available that measure one sample (single channel), to 
estimate the absolute value of gene expression, or two samples (dual-channel) to 
compare the ratio of gene expression (using two color labels: Cy5/red and Cy3/green). 
Common platforms are Affymetrixtm, Agilenttm, Qiagen-Operontm, and Illuminatm. 
MASS SPECTROMETRY (MS), PEAKS 
A mass spectrometer measures the abundance of molecules (or 
compounds), i.e., how much of a PROTEIN or METABOLITE molecule is 
available. A sample is prepared by removing unwanted compounds for 
example using a separation method like LIQUED CHROMATOGRAPHY 
(then it is then called LC/MS). Next, a mass spectrometry machine 
ionizes the compounds and measures traveling time in an 
electro/magnetic field. The traveling time of molecules in the machine is a function of both 
mass m (resisting acceleration) and charge z (speeding up acceleration). The result is a 
spectrum of peaks, where each peak position represents a certain mass-over-charge 
ratio (mass of the molecule divided by its charge, m/z) and each peak height represents 
the total number of ions counted (intensity). 
LIQUID CHROMATOGRAPHY (LC) 
A liquid chromatography device separates chemicals in a mixture of chemical compounds 
(analyte). This mixture is dissolved using a special solvent (mobile phase) and is then 
passed through solid matter with (solid phase) that has different affinity for different 
compounds. For example, one phase has affinity for organic materials. Depending on this 
affinity each compounds takes longer or shorter to pass through the solid phase, which 
results in separation. For example, first less and later more organic molecules. These 
separated compounds can later be identified using another method such as mass 
spectrometry, MASS SPECTROMETRY (in combination known as LC/MS). 
POLYMERASE CHAIN REACTION (PCR), PRIMERS 
A polymerase chain reaction (PCR) can be used to multiply a fragment (partial 
sequence) of DNA using the enzymatic replication mechanism that normally occurs inside 
organisms. It can be used to generate millions of copies of DNA which can then easily be 
measured. A pair of primers is used to select which part of the DNA should be amplified: 
one primer acts as duplication starting point from one end (5’) and another as duplication 
starting point from the other end (3’). At each duplication cycle the parts between 5’ and 3’ 
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primer are duplicated the most, while the other parts of DNA are less duplicated, resulting 
in an exponential surplus of the desired fragment of DNA.  
GENETIC FINGERPRINTING, AFLP, SNPS 
Genetic fingerprinting is used to find out what gene variants 
ALLELES are present in an individual, i.e. what is the allelic 
combination that defines genetic make-up of each individual in a 
screen. An technology to do genetic fingerprinting uses amplified 
fragment length polymorphism (AFLPtm) that first cuts genomic DNA 
and then uses PCR on PRIMERS that amplify specific POLYMORPHIC 
regions of DNA (called markers). The result of PCR is then applied onto a ‘gel’ which 
results in lanes of visual “bands” for each individual, with the availability of the band 
indicating what variants are available for each marker. Another technology for genetic 
fingerprinting is using SNP microarrays to create a profile of which SNP variant is available 
in each individual. 
GENETICAL GENOMICS, QTLS 
Genetical genomics is a strategy to map genetic determinants that 
underlie variations in transcript, protein or metabolite abundance that 
are observed in genetically different individuals. For transcriptome 
data, this strategy works as follows: genetically profile individuals 
and measure gene expression (preferably genome-wide) in 
genetically different individuals, treat the transcript abundances of 
each gene over all individuals as a quantitative trait, use molecular markers to fingerprint 
the individuals, use quantitative trait locus (QTL) mapping to identify regulators. QTLs 
are region(s) of DNA that are most likely to regulate a particular trait. In case of gene 
expression (eQTL) a QTL is called cis-acting if a QTL is very close to the gene that is 
expressed and may be that the gene regulates itself. Otherwise it is called trans-acting. 
BIOINFORMATICS 
Analysis of the results of molecular experiments requires methods from applied 
mathematics, informatics, statistics, chemistry, artificial intelligence (etc). This thesis mainly 
deals with the informatics, and does not touch the numerous other aspects of 
bioinformatics. In several chapters we shortly mention some statistics therefore we provide 
some minimal terminology here. Typically an hypothesis is tested, e.g. the null hypothesis 
is that gene X is not differentially expressed between sick and healthy tissues, and the 
alternative hypothesis is that there is a difference. A statistic test such as ‘Students t-
test’ estimates the probability that the null hypothesis is not true, e.g. with a significance 
level of 5%. Type 1 error is a false positive, meaning the null hypothesis is rejected while 
actually true. Type 2 error is a false negative, meaning the null hypothesis was not 
rejected while the alternative hypothesis was actually true. Problem with modern high 
throughput experiments is that there are thousands of hypotheses tested (e.g. for each 
gene) and, consequently, also hundreds of false positives (e.g. 5%*20.000) and negatives. 
In Chapter 7 we mention the need for a mechanism to control this false discovery rate.  
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Software engineering and information management terms 
Below a short glossary is provided to introduce the reader into the basics of software engineering 
and information management.  
SOFTWARE INFRASTRUCTURE 
Software infrastructure is the combination of data structures, user interfaces, 
processing tools and supporting elements that together provide functionality to 
support certain (biological research) processes. A large part of the work is software 
‘plumbing’ to make sure that all components are connected together and data and 
events flow between them. Software infrastructures tend to become large and 
complicated programs with many software components written in a PROGRAMMING 
LANGUAGE. Therefore, appropriate SOFTWARE ARCHITECTURE is a key success factor. 
PROGRAMMING LANGUAGE, COMPILATION, SOFTWARE 
A programming language is an artificial language that can be used to write programs 
that control the behavior of a computer. A collection of computer programs that performs 
some task is called software. A computer is a platform that consists of hardware (e.g. 
Intel, PowerPC) and operating system (e.g. Windows, Linux, Apple). Files written in 
programming language have to be translated (compiled) into language of a platform by a 
compiler before they can be executed. Some programs however can run on multiple 
platforms and are therefore called multi-platform or platform independent. Examples of 
general programming languages are C++, Java, Python, and Perl.  
SOFTWARE ARCHITECTURE 
Software architecture is described as the software components, the 
external properties of those components and the relationships among 
them. A software infrastructure is deemed suitable if it enables all the 
necessary features and qualities, e.g. if two functions are not always 
necessary in combination then the components providing this function 
should be uncoupled to allow to independent use. A common architecture 
for data centric applications is a three layer architecture: a front-end 
layer shows a graphical user interface, a back-end layer stores data 
using a DATABASE MANAGEMENT SYSTEM and an intermediate ‘business’ 
layer that contains all application logic.  
DATABASE MANAGEMENT SYSTEM 
A database management system (DBMS) is computer SOFTWARE that helps to manage 
databases, i.e. a structured collection of files containg records of data. Typically, a 
DBMS comes with a specific programming language to query and maintain the data 
(e.g. SQL), i.e. to retrieve selections of records and use transactions to add, update and 
delete records. Many DBMS are ‘relational’ (RDBMS) which means they arrange the data 
into tables with columns as attributes and rows as records. There are also ‘hierarchical’ 
and ‘object-oriented’ dbms’s. 
SOFTWARE FAMILY / SOFTWARE PRODUCT LINES 
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Instead of developing software applications one by one, multiple applications having 
many ‘phenotypic’ similarities can be approached as one software family. Thus, the 
software family-members can exploit their common ‘genetic’ make-up while dealing with 
variations in a systematic manner. To achieve this, domain engineers create REUSABLE 
ASSETS with adequate variation points that allow application engineers to create a 
product line of software systems more efficiently than when developing each product 
variant in isolation. (Note: although the terms software family and software product line 
are often used interchangeably there is an important difference: software families focus 
on commonalities in building blocks while product lines focuses on commonalities in 
features from an application domain/market perspective. Much insight on product lines, 
domain engineering and product engineering comes from non-software product industry). 
MODULE / REUSABLE ASSETS 
To ease the assembly of software, units of functionality are often designed as modules. 
Related modules have a uniform interface so they can be easily assembled and 
(re)used interchangeably. Good modules hide implementation details so that a change 
inside one module does not require changes in other modules (i.e. there is only ’loose’ 
coupling). Often modules are designed to be reused following systematic procedures, 
either as as-is, or with systematic modification/configuration. When modules are tailored 
to a specific domain they are often called reusable assets, e.g. a module to visualize 
regulatory gene networks. When they have a more general purpose they are often called 
components, e.g., a module that shows a calendar dialog on the screen.  
GENERATIVE SOFTWARE DEVELOPMENT 
Generative software development is a SOFTWARE FAMILY approach that focuses on 
automating the mapping from user requirements into working software variants for a 
specific domain. A desired system can be automatically produced using CODE GENERATION 
from a higher level specification in a DOMAIN SPECIFIC LANGUAGE, on top of REUSABLE 
ASSETS. In GENERATIVE SOFTWARE DEVELOPMENT, a model of a complete application is 
described using such a language, and therefore this approach is also known as model 
driven software development. 
DOMAIN-SPECIFIC LANGUAGE (DSL) 
A domain specific language (DSL) is a minimal programming language to describe 
features for a certain domain in a compact and easy way. In contrast to ‘general 
programming languages’ such as Java en Perl, a DSL does not try to cover all behavior of 
a machine but instead tries to make a subset of functionality particularly easy to use 
for development of certain applications. Examples of domain specific languages are R 
(statistics), HTML (layout), and MOLGENIS (biological databases).  
CODE GENERATOR / INTERPRETER 
A code generator translates a DOMAIN SPECIFIC LANGUAGE into a general programming 
language (such as Java), which is then again COMPILED (by Java) into an executable 
PROGRAM. Alternatively, an interpreter can be created that reads the DSL and directly 
executes the desired behavior.  
  
Chapter 2 
Beyond standardization: dynamic 
software infrastructures for systems 
biology 
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Progress in systems biology is seriously hindered by slow production of suitable software 
infrastructures. Biologists need infrastructure that easily connects to work that is done in 
other laboratories, for which standardization is helpful. However, the infrastructure must 
also accommodate the specifics of their biological system, but appropriate mechanisms to 
support variation are currently lacking. We argue that a minimal computer language, and a 
software tool called a generator, can be used to quickly produce customized software 
infrastructures that ‘systems biologists really want to have’. 
About Chapter 2 
The purpose of this chapter is to 
conceptualize the main argument of this 
thesis: biological software developers can 
benefit much from an innovative and 
powerful strategy that enables ‘software 
mass customization’. We explore software 
engineering literature that provides 
methodological ingredients for this 
‘generative’ strategy. Moreover, we review 
six recent bioinformatics initiatives that use 
this kind of strategy that give a glance into 
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Systems biologists seek to interpret large volumes of highly heterogeneous information to 
understand how biological systems function. Investments in software at local, national and 
global levels have contributed significantly to progress in biological data interpretation. 
Numerous standardization initiatives provide conventions on how to encode biological 
information to enable unambiguous transfer and interpretation (Brazma, et al., 2006), and to 
allow software “…to collaborate with each other” (Stein, 2002). Web sites, such as those 
offered by the US National Center for Biotechnology Information (NCBI), the European 
Bioinformatics Institute (EBI) and many organism-specific communities, open-source 
software suites such as BIOCONDUCTOR, and commercial programs, have opened up a large 
pool of software tools for the systems biologist. After two decades of (post-)genomics 
research, one would hope that ‘off-the-shelf’ software components can be quickly tailored 
to specific research and glued together into seamless software infrastructures that satisfy 
everyone. The example below serves to show that, unfortunately, this is not yet true.  
The international COMPLEX TRAIT CONSORTIUM (CTC) aims at sharing data and 
software resources among many systems genetics groups that are researching the mouse as 
a model for human disease (Abiola, et al., 2003). Complex trait researchers use 
recombinant inbred populations, which are immortal, and want to bring all observations on 
these lines together in a central repository, with relevant tools to analyze complex traits 
within and across GENETICAL GENOMICS experiments (Jansen and Nap, 2001). Such a 
repository allows researchers to, for example, find genes that are co-regulated in diverse 
samples such as brain tissue and stem cells (Bystrykh, et al., 2005). The successful analysis 
of these resources requires an appropriate software infrastructure. The consortium has 
developed an infrastructure called GENENETWORK (Chesler, et al., 2005), but while in its 
early stages just a few years ago, they did not envision the pace of data production and 
progress in methodology, and certainly did not expect that groups that were working on 
other organisms such as Arabidopsis thaliana (Alberts, et al., 2005; Keurentjes, et al., 2006) 
and Caenorhabditis elegans (Li, et al., 2006), also using recombinant inbred lines, wanted 
to join and share resources. Many handwritten changes in the software code of the 
infrastructure have been necessary to meet these needs.  This urges a re- thinking of CTC’s 
software development strategy. 
This systems genetics scenario is exemplary for many infrastructure initiatives in 
systems biology. Standardization has opened up a pool of biological and non-biological 
software that can be reused off-the-shelf, for example, for QTL calculations, sequence 
information and gene network reconstruction, and for data storage and user interaction (Fig 
1). Unfortunately, tailoring and integrating these software components into a seamless 
software infrastructure that a systems biologist can use requires many lines of hand-written 




Figure 1 | Software infrastructure for systems biology. A general sketch of software 
infrastructure for a systems genetics experiment is shown (Alberts, et al., 2005; Bystrykh, et al., 
2005; Keurentjes, et al., 2006; Li and Burmeister, 2005). A similar sketch can be made for other 
systems biology experiments, and such sketches will have much in common with that shown 
here (shown in yellow, see also cover), but will also have important variations (shown in grey). 
Advanced reuse and customization techniques can convert much of the grey to yellow (see 
Boxes 1, 2 for how this can be done). The top panel contains the software components that 
provide systems biologists with the interfaces to the software infrastructure. The middle panel 
contains software components to store and manage biomolecular data from various related 
genetical genomics experiments and results obtained from various (pre-)processing steps that 
have been applied to these data. The bottom panel provides software components that are 
applied in various combinations to these data to execute the analysis protocol that is specified by 
the user, for example, to load and preprocess raw data from microarray or mass spectrometry 
experiments, to map genetic determinants (QTL) that underlie variation in transcript, protein or 
metabolite abundance with the aid of molecular markers, to use the correlations between QTL 
profiles for the reconstruction of regulatory, developmental or metabolic networks, and to 
combine this with information from other resources such as the Kyoto Encyclopedia of Genes 
and Genomes (KEGG). Software components that have been written in different languages such 
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finished) software infrastructure would save communities like CTC a lot of work, time and 
money (see the blue line in Fig 2). Still, scripting such reusable assets together into a new 
customized software infrastructure, or modifying an existing infrastructure (for example, 
using CTC’s GeneNetwork for A. thaliana instead of mice), requires many minor and 
sometimes major changes. Such changes make it difficult to evolve software over time and 
to benefit from the efforts of others in software development. Therefore, we must go 
beyond standards as they focus only on commonalities and not on variations. We need a 
minimal computer language that can be used by systems biologists and their 
bioinformaticists to adapt software components to the biological details of their particular 
system, and a software tool, called a generator, that automatically produces a customized 
software infrastructure using reusable assets. This would reduce the number of hand-written 
lines of software code to a level at which one can much more efficiently maintain and 
evolve such software infrastructures (see the green line in Fig. 2). 
We believe that it is timely to move bioinformatics from expensive, almost one-at-a-
Figure 2 | Cost effectiveness of development strategies. Advanced software development 
strategies can reduce the software programming effort by up to 99%  (Clements and Northrop, 
2002; Fogh, et al., 2005; Weiss and Lai, 1999). To show this, we implemented a software 
infrastructure using three different development strategies: hand-written, using reusable assets, or 
using code generation. We mimicked the evolution of the software infrastructure over time by
increasing the number of features such as data tables and columns within tables: at 10 and 18
features a major change in data tables was needed. Compared with a completely hand-written 
software infrastructure, the implementation work was reduced to 20% when using reusable
assets, and to 2% when using code generators (measured in source lines of code, SLOC). The
upfront investment in software generators was reduced to 30% of the total costs for hand writing,
correcting for the fact that a generator SLOC takes around three times the effort of a ‘normal’
SLOC. Generation paid off, even within this small project. The return on investment will rise when
code generators are used to produce more variants of the software infrastructure. 













































Investments in generators and assets
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time, ‘cottage-industry’ towards twenty-first-century engineering practice, from which 
biologists obtain the customized software infrastructure they really want to have. Six recent 
example initiatives go beyond standardization and give a glance into a future with many 
more benefits for the management (CCPN, caCORE and MOLGENIS) and analysis 
(BioMOBY, Taverna and PISE) of data on biological systems (see Table 1 and the Box 2 
Online Showcase). This paper provides guidelines on how to get there. 
2.2 Powers of standardization 
It is important to understand that standardization paves the path for local and collaborative 
software infrastructures, such as CTC’s GeneNetwork.  
Data standards define how (bio)molecular information should be described so that data 
can be exchanged unambiguously and analysed by different researchers (Ravichandran and 
Sriram, 2005). A case in point is the use of tab-delimited and FASTA-formatted sequence 
data by the Human Genome Project. A recent review has charted the maze of data standards 
for systems biology, including transcriptomics, proteomics, metabolomics, protein 
interaction and pathways  (Brazma, et al., 2006). For example, MIAME (Minimum 
Information About a Microarray Experiment) has established rules for microarray 
data (Brazma, et al., 2001). More complex data standards come with supporting software 
implementations to help bioinformaticists to comply with it. This includes a mark-up 
language (ML) to exchange the data in a file, and software toolkits (STK) to easily parse 
and write ML-formatted files, for example, MIAME comes with MicroArray Gene 
Expression (MAGE) supporting software MAGE-ML and MAGE-STK (Spellman, et al., 
2002). 
Software standards define how software should behave so that components can be 
stitched together more easily (Stein, 2002). Bioconductor has established minimal rules on 
data input and output, parameters and control structures, so that software components can 
be combined with relative ease to (pre-)process Affymetrix, cDNA and liquid 
chromatography–mass spectrometry data, and to analyse and plot genomics data 
 (Gentleman, et al., 2004). Other examples are SRS (Etzold, et al., 1996), EMBOSS (Rice, 
et al., 2000) and the BIO* TOOLKITS (BioPerl, BioJava, BioPython and BioRuby), which 
have established similar rules for interoperability to read, analyse, align, store and visualize 
gene and protein information. Financial investments in software standards have been even 
greater outside the biology community, for example, for data management (MYSQL and 
POSTGRESQL), web applications (PHP and APACHE TOMCAT), statistics (THE R 
PROJECT) (Ihaka and Gentleman, 1996), ontology modelling (the W3C SEMANTIC 
WEB) (Wang, et al., 2005), and sharing of services over the web (W3C WEB SERVICES 
ACTIVITY) (Foster, 2005). 
As fields mature, it becomes feasible to put a consensus set of off-the-shelf software 
components together into a seamless software infrastructure that systems biologists can use. 
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An example is provided by the BIOARRAY SOFTWARE ENVIRONMENT (BASE) (Saal, et al., 
2002), a software infrastructure for data management and integrated analysis of microarray 
experiments. Others include the GENERIC MODEL ORGANISM DATABASE (GMOD) to store 
the range of data that is collected on model organisms (Stein, et al., 2002), the UCSC 
GENOME BROWSER to visualize sequence information (Kent, et al., 2002), and 
CYTOSCAPE for visual analysis of molecular interaction networks (Shannon, et al., 2003). 
These software infrastructures, or components thereof, are widely reused as starting 
points (Ameur, et al., 2006; Matthews, et al., 2005; Washietl, et al., 2005) for hand-tailored 
local software infrastructures (Fig 1). 
In a commentary paper, Stein (2002) predicted that all these developments in 
standardization would ultimately create a bioinformatics community in which data and 
software providers and users could easily connect with each other. In a more recent 
commentary paper, Cassman (2005) called for top-down coordination to produce standard 
software infrastructures for systems biology, an important process that should not be left to 
ad-hoc developments. 
2.3 Barriers to further development 
Systems biology is developing rapidly and methodologies to generate and analyze data are 
still being established. This makes it hard to know what standards should look like.  
Data standards must often be extended to serve the needs of a particular community. 
For example, MIAME and MAGE have been extended with details on toxicology and plant 
experiments (MIAME/Tox (Mattes, et al., 2004) and MIAME/Plant (Zimmermann, et al., 
2006)), and with additional elements to include proteomics and metabolomics data 
(SysBIO-OM (Xirasagar, et al., 2004), FUGE-OM (Jones, et al., 2004)). All these new 
dialects of standards force the rewriting of existing software infrastructures, thereby 
limiting the value of the standards  (Fogh, et al., 2005). In other cases, communities have 
even rejected an existing standard, because it was too unwieldy to use in practice, as the 
history of MIAME/MAGE has demonstrated (the MICROARRAY GENE EXPRESSION DATA 
SOCIETY is currently working on a much simpler, tab-delimited standard called MAGE-
TAB (Brazma, et al., 2006)). These lessons show that it is unlikely that there will ever be a 
data standard that accommodates all the systems biology needs of every local laboratory.  
Software standards tend to emerge de facto when the best local efforts become widely 
accepted and reused  (Quackenbush, 2006). However, these standards can interfere with the 
cumbersome, error-prone and expensive hand-written changes at the software code level of 
standard components that, with current software programming approaches, are required to 
accommodate even small differences at the biological level (Table 2, ‘hand written’). 
Transferring a locally running extension to a (new) public release of the standard software 
becomes hard. It might therefore be difficult to keep a mouse and an A. thaliana variant of 
GeneNetwork on parallel tracks. We have witnessed similar problems for users of BASE, 
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whereby laboratories had to continue to use an outdated version of the standard software 
infrastructure because of their local modifications. This means that laboratories get on 
different and possibly isolated tracks and can no longer benefit from each other’s software 
efforts. These lessons show that maintenance and evolution of software infrastructures is 
slow and inefficient using today’s methods.  
In a recent commentary, Quackenbush et al (2006) called for bottom-up, community 
based standards that evolve as systems biology research charts a particular path. We agree 
that bottom-up, instead of top-down, standardization is important to prevent premature 
standards that, in the worst case, can have the effect of stifling innovation. However, we 
also believe that ‘one-size-fits-all’ standards are insufficient to satisfy all the essential, 
possibly contradictory, research needs of each laboratory. Standards focus on 
commonalities, and not on differences. Therefore, ‘better implementations’ of standards, 
however important (Baxter, et al., 2006; Hunt and Thomas, 1999), will not adequately serve 
variation and will therefore not reduce the number of handwritten changes between variants 
of a standard software infrastructure. 
2.4 Towards dynamic biological software 
Until the late nineteenth century, most products were manufactured by hand, just like most 
biological software today, which, although meeting the individual needs of each customer, 
was costly in terms of both time and money. The era of (mechanized) mass production 
made many standard products timely and affordable for everybody, but at the expense of 
variation (‘you can have any colour Ford T as long is it is black’). Only in recent years have 
many manufacturing firms added the capability to tailor a product to customer needs while 
keeping near mass production efficiency (Tseng and Jiao, 2001). 
Recently, ‘software mass customization’ has also become possible using so-called 
‘GENERATIVE SOFTWARE DEVELOPMENT’ (Czarnecki and Eisenecker, 2000) (Box 1). 
‘SOFTWARE PRODUCT LINES’ for customer–supplier contracting (Clements and Northrop, 
2002), diesel engine control units  (Clements and Northrop, 2001), telecommunication 
switches (Weiss and Lai, 1999), navy ship control (Brownsword and Clements, 1996) and 
mobile phones have shown up to 90% reduction in software development effort, and there 
have been strong increases in the customizability and quality of these software products 
(see the SOFTWARE ENGINEERING INSTITUTE web site). Generative software projects that 
are closer to systems biology include the development of customized clinical trial 
databases (Nadkarni, et al., 1998), electrical engineering simulators (Eker, et al., 2003), 
landscape dynamics methods (Fall and Fall, 2001) and medical resonance imaging (MRI) 
software (Jaring, et al., 2004). There are dozens of code-generation projects that are 





Box 1 | How to breed software infrastructures for systems biology 
Generative methods bring together the best designs and experts so that software 
infrastructures can continuously evolve to advance science (see figure). A systematic 
approach to commonality and variation enables better quality, more efficient and more 
flexible implementations than would be possible individually. The impact and value of 
collaborative software infrastructure efforts can be greatly improved when: 
• Similar software infrastructure projects are approached as one ‘software family’ so 
that they can benefit from each other. 
• Common features are implemented as ‘reusable assets’ to reduce re-inventions and 
duplicated work. A modular architecture ensures that it is possible to assemble assets 
into many interesting variants. 
• Variable features are automatically implemented using ‘software generators’ so that 
the need for laborious computer programming is reduced. 
• Biologists can configure software variants themselves using a ‘domain-specific 
language’, without unnecessary implementation details. Such a blueprint specifies the 
types of data that are needed, the methods to analyse that data and the screens to 
view that data. The code generators then automatically implement how the desired 
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A growing number of bioinformatics projects  (Covitz, et al., 2003; Fogh, et al., 2005; 
Garcia, et al., 2005; Garwood, et al., 2004; Goesmann, et al., 2003; Letondal, 2001; Oinn, 
et al., 2004; Sarkans, et al., 2005; Shah, et al., 2004; Swertz, et al., 2004; Tang, et al., 2005; 
Wilkinson and Links, 2002) have already adopted ‘generative’ reuse and customization 
techniques, such as software families, reusable assets, domain-specific languages and 
generators (Table 1).  
 
Table 1 | Bioinformatics initiatives using generative software methods.  
Data oriented projects* 






CCPN (Collaborative Computing 
Project for NMR, Fogh, et al., 2005) 
helps to build an application 
programmers interface (API) for 
biological data to ease integration of 
analysis programs, as developers 
get data exchange, storage and 
















and SQL code 
from a Python 
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CACORE (Cancer Common 
Ontologic Representation 
Environment, Covitz, et al., 2003)  
helps to build reliable programmatic 
access to biological data and 
relationships with public data, such 
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MOLGENIS (Molecular Genetic 
Information System, Swertz, et al., 
2004)  eases development of 
biological databases so research 
groups can store their biological 
data, and related data files, in a web-






















*Other data oriented bioinformatics projects that use some generative methods: Pedro (Garwood, et al., 2004) 
generates data entry forms for XML documents; ArrayExpress (Sarkans, et al., 2005) and BRIDGE (Goesmann, et 
al., 2003) generate some database functions. 
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Table 1 | Continued. Processing oriented projects* 







BIOMOBY (Wilkinson and Links, 2002) 
eases publication of processing services 
in a repository (yellow pages) so 
biologists can find them on the basis of 
the type of data that is in hand. For 
example, many services use FASTA 
files as the input type, which allows 
BioMOBY to find relevant services such 
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TAVERNA (Oinn, et al., 2004) eases the 
implementation of analysis workflows. 
Through an editor, one can point-and-
click on existing processors and then 
link inputs and outputs together, for 
example, to annotate Affymetrix probes 
through EMBL, Medline, SwissProt, GO 




















PISE (Pasteur Institute Software 
Environment, Letondal, 2001) helps to 
build graphical user interfaces for 
processing programs such that 
biologists can run and link these 
programs by clicking on buttons and 
filling in text-boxes. 
http://www.pasteur.fr/recherche/unites/si












formats) in XML 
Interpreter in 
Perl generates 
web pages and 
calls command 
line programs 
*Other processing oriented bioinformatics projects that use some generative methods: Pegasys (Shah, et al., 2004) 
has assets and a workflow tool for HPC sequence analysis; GPipe (Garcia, et al., 2005) and Wildfire (Tang, et al., 
2005) generate EMBOSS workflows. 
 
Below we review these four techniques of software generation, and how six example 
initiatives, CCPN (Fogh, et al., 2005), caCORE (Covitz, et al., 2003), MOLGENIS (Swertz, 
et al., 2004), BioMOBY (Wilkinson and Links, 2002), Taverna/MyGRID (Oinn, et al., 
2004) and PISE (Letondal, 2001), have brought tailor-made software infrastructures to 




There is a large variation in needs between CTC laboratories that, by now, use systems 
genetics to study a range of organisms (such as humans, mice, rats, C. elegans, yeast and A. 
thaliana), and even more between laboratories from different parts of the systems biology 
community. Moreover, systems biology continues to evolve dramatically, which makes 
simple reuse difficult. However, on the software infrastructure level, researchers have 
similar needs in terms of data handling, parameterized execution of ANALYSIS 
WORKFLOWS and visualization (Fig 1). Infrastructure variants that are designed to 
accommodate specific research can be created more efficiently when they are approached 
as one ‘software family’: by the reuse of common features, while managing variation in a 
systematic way (Clements and Northrop, 2001; Weiss and Lai, 1999) (Box 1a). 
The six example initiatives (Table 1) have made common features in software 
infrastructure reusable and demonstrate how family-based software works for related 
applications. For example, common features are used to: search, store, exchange and edit 
biological data (CCPN, caCORE and MOLGENIS); share, and connect to, independently 
developed analysis components (BioMOBY and PISE); link those components together in 
processing workflows (Taverna); and provide a biologist-friendly user interface 
(MOLGENIS and PISE). A family of tailored software infrastructure variants can now be 
generated with much less effort to manage data from studies such as clinical trials and 
human cancer expression studies (Tobias, et al., 2006), or microarray experiments ranging 
from medical to microbial subjects (Kuipers, et al., 2002; Swertz, et al., 2004). They can 
also be specifically generated to run analysis workflows for gene annotation, sequence 
analysis and microarray processing on data ranging from plants (Wilkinson, et al., 2005) to 
human genetic disease (Stevens, et al., 2004). The Online Showcase demonstrates how one 
infrastructure family can have variants for sequencing, microarrays and genetical genomics 
data (Box 2).  
Family-based software development requires some investments, but these pay off as 
soon as the number of family members increases, that is, once more variants of software 
components and software infrastructures have to be produced (Fig 2). 
Reusable assets 
Software families implement common infrastructure features as ‘reusable assets’ that can 
be extended and plugged together in alternative configurations (Lampel and Mintzberg, 
1996; Ulrich, 1995). So, the six examples that are given here can provide each laboratory 
with a suitable software infrastructure variant (Box 1B). However, if some assets look like 
Lego bricks and others like Meccano components (for example, Bioconductor versus 
EMBOSS), then it is still hard to plug them together. Therefore, the most dominant reusable 
asset is the SOFTWARE ARCHITECTURE (Bass, et al., 2003), with rules on how assets should 
fit together within the infrastructure family so that they become MODULAR building blocks 
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(typically based on proven DESIGN PATTERNS) (Buschmann, et al., 1996; Fowler, 2002). 
This vastly reduces the programming effort that is needed to fit existing (standard) assets 
together, or to share newly developed assets with collaborators (Table 2). 
CCPN, caCORE and MOLGENIS have infrastructure assets that can read and write 
data from or to data files, relational databases or web services. These assets can be 
customized with limited programming to handle data as diverse as transcript abundance, 
mass spectra and metabolite networks. BioMOBY, Taverna and PISE have infrastructure 
assets that can access and pipeline processing methods into analysis workflows. These 
assets can be customized with limited programming to normalize data, annotate proteins 
and visualize networks by using off-the-shelf processing methods. Methods that adhere to a 
software standard, such as EMBOSS command-line tools or BioMOBY web services, can 
be reused more easily. Customized assets can actually be exchanged between groups and 
can become reusable assets themselves. 
Domain-specific language 
The working systems biologist wants to apply software tools to increase the understanding 
of biological function without having to ‘tinker under the hood’; how biological features 
translate into software code is too much detail for many researchers. A minimal language to 
list a biologist’s requirements on a more appropriate level of abstraction can be helpful. 
Software engineers call such a language that is tailored to a specific task a DOMAIN-
SPECIFIC LANGUAGE (DSL) (Box 1c) (Batory, et al., 2000; van Deursen and Klint, 1998). 
Biologists and (bio)informaticists can discuss and specify the types of software 
infrastructure or variations to the infrastructure that they need to have in the vocabulary of 
the DSL, and this can be understood by all who are involved as well as by a software tool 
(described below). A single change in such an ‘infrastructure blueprint’ typically leads to 
many detailed changes in the program code of the running software infrastructure (Fig 1). 
CCPN, caCORE and MOLGENIS have a DSL that enables systems biologists and 
bioinformaticists to describe the diverse data types that their infrastructure must support 
(and in the case of MOLGENIS, also how to show them on screen, see the Online 
Showcase). BioMOBY, PISE and Taverna have a DSL to model how the methods and 
analysis protocols should look, that is, the types of data and parameters that should be 
included or excluded in the methods and how methods should be combined into sensible 
processing workflows. CCPN and caCORE use a software DSL called unified modelling 
language (UML) to specify the structure of biological data. UML is unfortunately less 
suited for other things such as user screens, services or analysis workflows. BioMOBY, 
MOLGENIS, PISE and Taverna therefore created their own DSLs, which incidentally are 
all based on the extensible mark-up language (XML, see the Online Showcase). However, 
many biologists will not be used to the relatively precise syntax and grammar of a DSL. 
Instead, a graphical editor can help in writing the specification; caCORE and CCPN advise 
using third-party UML editors and both Taverna and BioMOBY provide their own editors. 
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An impression of what a DSL for a systems genetics infrastructure should model is shown 
in Fig 1. Examples of how these models are described in DSL are shown in the Online 
Showcase (Box 2).  
Software generation  
A DSL file can be generated into a working application manually or automatically by 
INTERPRETERS or CODE GENERATORS (Box 1d). With automatic software generation, 
systems biologists and (bio)informaticians can interactively build the right software 
infrastructure in short cycles of editing the infrastructure model in DSL, running the 
software interpreter or generator, and then observing whether they have the infrastructure 
they require (or need to make further changes). Software generation can save up to 99% of 
the tricky infrastructure programming, thereby saving many weeks at the cost of the one-off 
development of the software generators (Fig 2). 
A generator is a powerful tool if you can apply it many times, whereas the cost of 
describing the variation in DSL (each time), and the cost of creating the generator itself 
(one time), are relatively low. The development of a generator does not have to be difficult 
if one can transform a previously hand-written asset into a ‘generative’ asset. Obviously, in 
cases in which the generators themselves would become complicated, then reusable assets 
or even a more traditional cottage-industry approach is more appropriate (Table 2). To 
illustrate the kind of pragmatism (Hunt and Thomas, 1999) that is needed, the Online 
Showcase provides some guidelines for generative bioinformaticists, gives two examples, 
in which we either used or did not use a generator, and shows how generation can work in 
practice (Box 2). 
2.5 Prospects for the future 
Systems biology can (and should) move from slow and expensive, almost one-at-a-time, 
practice to a much more cost efficient many-of-a-kind practice in which biologists can 
quickly obtain customized software infrastructures that meet their specific needs. What 
must be done to make the most of it? 
A repository to share DSL models, or modules thereof, will help to keep different 
research groups on the same track, because they can oversee the few changes in a single 
DSL file much better than they can oversee many related changes that are spread 
throughout software code. The Online Showcase (Box 2) demonstrates how that could 
work: everyone involved can find, learn, reuse and customize infrastructure variants for 
sequences, microarrays and systems genetics using just one simple DSL. An accompanying 
repository of code generators and reusable assets helps to share and evolve resources at the 
software level. These efforts could result in an infrastructure platform for systems biology, 




Table 2 | Pros and cons of software infrastructure development strategies 
Hand written Reusable assets Generation 
Customization and evolution: ability to keep up with research 
Pro: Groups can have any 
feature they want (given the 
expertise, time and money 
for development). 
Pro: Common features are 
shared and easily integrated. 
Con: Custom assets still 
require much hand-work. 
Pro: Generators build up to 
99% of variable features so 
developers can focus more on 
novel developments. 
Reuse and integration of the best concepts and implementations 
Con: Standard concepts 
have to be implemented by 
hand, and therefore require 
investments from each local 
group. 
Pro: Reusable assets 
become the building blocks 
of each local system.  
Con: Assembly still requires 
some effort. 
Pro: The best (DSL) concepts 
are automatically assembled 
in each system without further 
programming. 
Consistency to ensure maintainability and usability 
Con: Adhering to plans and 
design rules in hand-written 
software is hard; typically, 
some quirks will appear. 
Pro: Reusable assets have a 
predictable modular 
interface.  
Con: Implementations are 
less consistent. 
Pro: The extreme consistency 
of the code that is generated 
makes software easier to 
understand, use, integrate 
and maintain. 
Reliable, efficient and complete software 
Con: Improvements must be 
worked into all software parts 
by hand. Bugs have to be 
fixed one at a time. 
Pro: Common features are 
improved once-and-for-all.  
Con: Variable features are 
still hand-maintained. 
Pro: If a generator is improved 
then all generated features 
also improve. Generators do 
not make human errors. 
Cost effectiveness 
Con: Each feature, in each 
system, has to be defined by 
hand, which requires 
expertise, time and money. 
Pro: Large parts of the 
software can be reused. 
Con: Much work is required 
to produce variants. 
Con: Implementing a 
generator requires effort.  
Pro: Pays off when more 





Box 2 | Generating software infrastructures in practice. 
 
Interested readers can generate their own MOLGENIS software infrastructures, and learn 
that generative software development (Box 1) is some 20-times faster than conventional 
methods. Formed on the basis of the existing infrastructures BioSQL, BASE (Saal, et al., 
2002) and GeneNetwork, an initial set of application models is provided online for 
sequencing, microarrays and systems genetics, all written in the same domain-specific 
language (DSL). These models can therefore be considered as variants or members of the 
same software family. By running the code generator, these models can be automatically 
turned into working software infrastructure variants that are equivalent to their hand-written 







Box 2 | Continued. 
Generation will not always be the most appropriate strategy. The history of generative 




Generate graphical user interfaces | In the Showcase, we needed some 30 user 
interface screens. We took a custom ‘GUI asset’ and rewrote it as a ‘template’. For 
example, the code sentence ‘select * from samples’ that retrieves data became ‘select * 
from $entity.name’ for other entities that were defined in our DSL. This template is only 
50% longer than the original asset, but can be used to produce code for all other graphical 
user interfaces, without human errors (Table 2). We later added an advanced search 
option to the template, which - after re-generation of the software code - was then 
available in all graphical user interfaces. 
 
Don’t generate large data-file import | In the Showcase, we also needed functionality to 
import large data files for <10 different biomolecular data types. The import logic was too 
diverse and was considered too unpredictable for new data types in the future to justify the 
investment in code generators (Table 2). Instead, we simply hand-wrote separate small 
scripts that served the goals well. One DSL term, ‘plug-in’, allowed the hand-written code 
to be incorporated automatically during code generation. 
 
Guidelines for software generation: 
Think ahead, but not too far ahead | Build code generators only for those assets that 
often need to be customized, and in cases in which variations are predictable. Pro-actively 
building generators has proved wasteful because of inaccurate guesses about where 
(biological) needs were heading  (Brownsword and Clements, 1996; Clements and 
Northrop, 2001; Krueger, 2002). 
 
Keep it simple | Generators require thinking on a higher level of abstraction. Use code 
generators only when their abstraction (in DSL and generators) is much less complex than 
the software code that is to be written. Otherwise, hand-writing is more appropriate. 
 
Extensibility | Code generators should produce human-readable software code. Such 
software code is more consistent than hand-written code. This allows parts that cannot, or 
should not, be generated to be quickly added.  
 
Clear separation | Generated and hand-written code must be clearly separated. This 
ensures that the software infrastructure (or variants thereof) can be (re)generated without 
losing the hand-written additions. 
 
Domain specificity | Use code generators that are tailored towards systems 
biology. It is often much more cost effective to build a new generator than to adapt a 
general-purpose code generator to suit biology. 
 
Open world | Build your code generators in such a way that they can reuse software 





Variants from separate software families need to be ‘pluggable’ to allow comprehensive 
infrastructures that, for example, integrate data management (in MOLGENIS) and analysis 
(in Taverna). This is easy between CCPN and caCORE as both use UML. The other 
families will need DSL translators, or even standardization (of some components) into one 
DSL, which will be relatively easy as the DSLs have much in common. This also requires 
some common software standards, such as web services between BioMOBY and Taverna. 
The other families must bridge their incompatible reusable assets in a similar way, which 
could result in a ‘software population’ (Van Ommering, 2002) for systems biology in which 
software infrastructures from all families can work seamlessly together. 
Migration paths from hand-written infrastructures to their dynamic counterparts are 
needed to ensure that researchers who are now stuck in their (hand-written and modified) 
software infrastructure, can join and share resources. The Online Showcase (Box 2) 
demonstrates how that could work: we generated a prototype of the open source BASE 
infrastructure as a MOLGENIS variant. The generated software infrastructure offers a 
similar functionality as current BASE, but is much easier to evolve over time and therefore 
has a longer predicted lifetime. We also generated prototypes for systems genetics and 
sequence information. 
Going beyond standardization with generative software development methods brings 
systems biology one step closer to software mass customization, by which systems 
biologists and bioinformaticists can rapidly and cheaply build the software infrastructure 
that ‘systems biologists really want to have’. 
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Motivation | Systems biology is diverse and evolving quickly, challenging 
bioinformaticists to efficiently develop and adapt the necessary software infrastructures. A 
recent review showed that novel methods for ‘dynamic’ software development can help and 
have been recently applied by a number of bioinformatics projects (e.g. Taverna, 
MOLGENIS, CCPN). A detailed exposé on their development is still left wanted. 
Results | We report how the desired biological properties of a custom ‘molecular genetics 
information system’ (MOLGENIS) can be efficiently described using a ‘domain specific 
language’ such that ‘code generators’ can automatically produce the working software. We 
aim to bring bioinformaticists up and running to use these modern strategies by detailing 
implementation, providing leading principles and comparing hand-written and ‘generative’ 
software development, 
Availability | Readers can generate a custom MOLGENIS using open source tools on 
www.molgenis.org/generator or choose from a catalogue of MOLGENIS variants for 
sequences, microarrays and genetical genomics on www.molgenis.org/variants.  
 
About Chapter 3 
The purpose of this chapter is to move 
from concepts of ‘generative’ development 
in Chapter 2 to concrete methods to 
actually implement this strategy for biology. 
We show that even with simple 
technologies, such as an ‘xml’ based 
domain specific language and ‘text file’ 
generators, one can build tools to 
automatically generate all parts of 
database, application logic and user 
interfaces. We evaluate the potential of 
such tools in increased adaptability and 
reuse of biological software and list 
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3.1 Introduction 
High-throughput technologies have boosted biological and medical research and there is 
little debate on the need for software infrastructures to manage and process the datasets 
produced. However, software developers are struggling with the complexity and diversity 
of biological systems, unpredictable evolution of molecular biotechnologies, and scale of 
experiments. Figure 1 outlines the novel ‘generative’ development strategy that several 
recent bioinformatics projects adopted to speed up custom infrastructure 
development (Swertz and Jansen, 2007), including Taverna for analysis workflows (Oinn, 
et al., 2004), MOLGENIS for biological data management (Swertz, et al., 2004) and CCPN 
for processing tools (Fogh, et al., 2005). The aim of this paper is to bring biologists ‘on 
speaking terms’ and bioinformaticists ‘up and running’ to use these methods.  
In this paper we demonstrate step by step how bioinformaticists can use a domain specific 
language to efficiently describe the biological details of their particular biological system, 













q describe needs of 
alternative experiment 








Figure 1 | Generative development. Many minor and major changes have to be written in 
software code before a ‘standard’ software infrastructure accommodates a particular research. 
Using ‘generative’ methods  (Swertz and Jansen, 2007), a bioinformaticst just needs to describe 
in domain specific language (DSLn) what is needed for his experiment and use generatorso to 
quickly produce a software infrastructurep that accommodates these needs. When needs 
changeq, a bioinformaticists can (re)run the same generator with a different DSL filer to quickly 
produce another variant of software infrastructures (boxes indicate changes). The generator 
systematically deals with variation of software components while commonalities are exploited via 
reusable assets. This vastly reduces time-to-research and enables bioinformaticists to quickly 
evolve a family of software infrastructures, with each variant accommodating a specific research, 
while still on track to reuse the best common features. 
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and use software generation tools to automatically generate a web database tailored to the 
experiments of their biologists, building on reusable components. Next, we detail leading 
principles and implementation materials, and the 48 times efficiency improvement that we 
found, as compared to hand-writing software. Finally, we discuss implementation 
alternatives and future prospects.  
Bioinformaticists can use the ‘MOLGENIS generator’ (www.molgenis.org/tools) to 
generate more variants of this molecular genetics information system. A public catalog of 
‘MOLGENIS variants’ (www.molgenis.org/variants) eases sharing and reuse. It currently 
holds variants that accommodate two-color microarray experiments on microbes (Swertz, et 
al., 2004), genetical genomics and metabolomics on several species (Swertz, Submitted), 
and more. We invite the bioinformatics community to add more variants, and to extend the 
generative toolbox, to quickly generate software infrastructures biologists want to have. 
3.2 Domain specific language 
Figure 2 shows how a MOLGENIS variant can be defined in a single file. The file is 
written in MOLGENIS’ domain specific language (DSL). This enables compact 
specification of what experiment database is needed, i.e. to declare how an experiment is 
organized in terms of data types and their relationships and how these data are to be shown 
on the screen. Figure 2 shows the following features:  
• Three data entities: nExperiment, Sample and Hybridization; the entity Experiment 
has six fields, including ID, Medium and Stress (because it needs to administrate 
microbe experiments). 
• One user interface formo to control Experiments, with a sub menup, consisting of 
two child forms for Samples and Hybridizations. Child forms are automatically linked 
to the parent form based on cross references, e.g. the field ‘Experiment’ of ‘Sample’ 
references to the ‘ID’ of an ‘Experiment’q. 
• Security rules so researchers with role ‘analyst’r have ‘add’ and ‘update’ rights and 
experiments can only be viewed by researchers of the group ‘owning’ the 
experiments.  
• Use of default settings to keep the DSL file short: each field is default of type ‘string’ 
(a variable character string of length 255) unless otherwise specified to e.g. 
’decimal’t; each field has to be set to a value by the researcher unless specified to be 
nillableu; each field can be edited (updated) unless specified to be read onlyv; and 
each entity is viewed one-record-per-screen unless specified as listw.  
One can think of DSLs as little languages that are tailored to efficiently express a particular 
problem, task or area (Bentley, 1986; van Deursen and Klint, 1998). The level of 
abstraction is raised so no lengthy, technical and redundant details on how each feature 
should be implemented in general programming languages have to be given  (Brooks, 1995; 
Greenfield, et al., 2004). Examples of DSLs include R/Splus for statistics, MatLab for 
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mathematics, SQL for databases, HTML for layouting, and now MOLGENIS for biological 
software infrastructures. MOLGENIS domain specific language has biology specific data 
types such as ‘nsequence’ (nucleotide sequence) and provides advanced features such as 
‘extends’, ‘implements’ and ‘abstract’ that eases reuse and variation of data structures (see 
online langage manual at www.molgenis.org).  
In most cases, knowledge of the DSL is all that is needed to produce a custom 
MOLGENIS variant. However, one may want to include hand-programmed components 
into MOLGENIS, for example to add a special ‘screen’ that plots QTL profiles. This 
requires a DSL sentence that points to the ‘plug-in’ (allowing it to be seamlessly integrated) 
as well as hand-programming the plug-in itself. For example, we developed a 
‘RegulatoryNetworkScreen’ that builds on the ‘FormScreen’ asset (see next section), which 
saved us the work of writing the plug-in from scratch. 
 
<molgenis><!-- data structure --> 
   <entity name="Experiment"> 
      <field name="ID" type="autoid"/> 
      <field name="Name" unique="true"/> 
      <field name="Medium"/> 
      <field name="Stress" nillable="true"/> 
      <field name="Log" type="text"  
             nillable="true"/> 
      <field name="VisibileToGroup"  
             type="read_permission"/> 
   </entity> 
   <entity name="Sample"> 
      <field name="Name" unique="true"  
             readonly="true"/> 
      <field name="OD" type="decimal"/> 
      <field name="Experiment" type="xref"  
             xref_field="Experiment.ID"  
             xref_label="Name"/> 
   </entity> 
   <entity name="Hyb"> 
      <field name="SlideID" type="autoid"/> 
      <field name="ArrayID" type="int"/> 
      <field name="Sample" type="xref"        
             xref_field="Sample.Name"/> 
      <field name="Experiment" type="xref" 
             xref_field="Experiment.ID"  
             xref_label="Name"/> 
   </entity> 
<!-- user interface --> 
   <form name="Experiments" entity="Experiment" 
         write_permission="analist"> 
      <menu name="ExperimentMenu"> 
         <form name="Samples" entity="Sample"/>
         <form name="Hybriodizations"  
               entity="Hyb" viewtype="list"/> 
      </menu> 












Figure 2 | One file produces custom 
infrastructure. Detailed software needs 
for an experiment can be described in 
domain specific language (DSL, top). The 
MOLGENIS generator reads DSL and 
automatically produces the custom 
software infrastructure specified (bottom). 
The screenshot includes example data. 
See main text for description of the 
numbers.  












3.3 Reusable assets 
Figure 3 summarizes MOLGENIS’ reusable assets and their variation mechanisms. 
Reusable assets provide building blocks with a modular structure which allows them to be 
assembled in diverse combinations, similar to prefabricated houses that are build from 
modular walls instead of bricks. Some building blocks are semi-finished and need to be 
‘completed’ before use. Below, PEAA refers to ‘patterns for enterprise application 
architecture’, a catalogue of proven solutions for software design problems that we used as 
guideline (Fowler, 2002). Figure 3 shows MOLGENIS having: 
• DataMappers: to hold all common parts needed for reading/writing to database tables 
and return nice success/error messages when finding, counting, adding, updating, or 
removing data. (See PEAA, page 165). The semi-finished DataMappers need to be 
‘completed’, e.g. a programmer needs to ‘extend’ DataMapper to become an 
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- find(filter): List<entity> 
- count(filter): int 
- add(<entity> e) 
- update(<entity> e) 
- remove(<entity> e) 
* findSql(): sqlstring 
* addSql(): sqlstring 

























Experiment Sub Menu 
Figure 3 | Reusable assets 
reduce implementation 
efforts.   
(A) shows finished and semi-
finished components that 
provide reusable features for 
showing screens (FormView 
and MenuView), handling user 
requests (Form- and 
MenuController) and reading 
and writing to the database 
(DataMapper).  
(B) shows components of a 
completed software variant  as 
described in Figure 2. Only the 
‘differences’ needed to be 
added using systematic 
variation mechanisms (dotted 
lines). Inheritance completed 
semi-finished components by 




A modular framework eases 
assembly of a seamless 
application (arrows). These 
systematic steps of completion, 
configuration and assembly can 
be automated in generators 
given the precise description in 
MOLGENIS’ domain specific 
language (see Figure 4). 
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• ScreenViews: to hold all common parts needed to the database as a web page in the 
browser with a data table and edit form with buttons to add, update, remove, show 
previous, next, etc. (See PEAA, page 350). MOLGENIS currently has FormView, 
MenuView, TreeView and PluginView screens to show forms, menus, tree-like data, 
and plug-ins respectively. ScreenViews need to be completed, e.g. FormView becomes 
ExperimentForm adding details on how the fields of experiment are to be shown to the 
user. 
• ScreenControllers: hold all common parts needed to decode a HTTP request sent via 
the users web-browser for one of the views. For example, FormController handles 
requests to update FormView in terms of records to be added, changed, or removed via 
the underlying DataMappers, or to reload the data shown in terms of next/previous 
records. (See PEAA, page 333). 
The reusable assets encapsulate best practices and standard biological or non-biological 
components so they become available ’for free’ to the MOLGENIS community. 
Components are adapted to a common modular structure so they can be reused inside 
MOLGENIS, e.g. the Java DataBase Connectivity (JDBC) library is incorporated for 
talking to databases. Variation to accommodate specific research is implemented 
systematically and can therefore be automated. This does not exclude the use of the 
reusable assets when developing by hand, for example when building plug-ins or when 
creating a processing tool that is currently outside the scope of MOLGENIS generators (see 
next section). 
3.4 Generators 
Figure 4 provides an example of the simple, text based, generators used in MOLGENIS. 
Each generator automatically translates elements inside the MOLGENIS DSL into fully 
working components of a biological database variant. The systematic variation mechanisms 
of the reusable assets, as well as the structured descriptions of the software in the domain 
specific language, allow for an automated translation. The three layers shown in Figure 3 
are generated by one generator for the database (bottom), eight generators for the 
application programming interface (middle), and five generators for the graphical user 
interface (top). An additional generator produces documentation.  
A program termed MolgenisFactory, runs all the generators and can be used online or 
offline (see www.molgenis.org/tools). One can choose to generate MOLGENIS as a simple 
executable using an embedded web server, or as a server application using an external web 
server. Alternatively, one can also choose to generate MOLGENIS as an embedded 
database (HSQL, www.hsqldb.org) or using an external database (MySQL, 
www.mysql.org). In addition, one can choose to generate an R-api (application 
programming interface) and an ‘SOAP’ web services api. This allows bioinformaticists to 
talk to data in MOLGENIS from within their statistical scripts written in the R language 
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(www.r-project.org) or a web service capable tool like Taverna (taverna.sourceforge.net). 
MOLGENIS can be configured to which generators to use, either by a checkbox (online) or 
configuration file ‘molgenis.properties’ (offline). Some may even want to add new or 
extended generators, which requires some programming (see next section).  
3.5 Implementation 
Below we summarize leading principles that guided the implementation process and we 
detail the resulting implementation of MOLGENIS. 
Leading principles 
The first step in implementing a ‘generative software family’ is listing what features should 
be fixed and what features should be variable, a process known as domain analysis 
(Neighbors, 1981). Table 1 summarizes the required features of MOLGENIS experiment 
databases, explains why these features are indeed required, and describes what parts of the 
features are common and variable over experiment databases. To get this picture, we 
compared 20 existing microarray databases next to many requirements interviews, see 
Table 1 in  (Swertz, et al., 2004). Detailed examples on how these features can be used to 
support microarray or genetical genomics experiments can be found in (Swertz, et al., 2004; 
Swertz, In process). 
To make MOLGENIS work, it was essential to limit the scope of the family. If the 
members of our software family would vary too widely then the reusable assets and  
 
 
public class ${Name(entity)}Mapper  
  extends DataMapper<${ Name(entity)}> { 
  public String addSql(${Name(entity)} e) { 
   return String.format( 
     "insert into ${ Name(entity)} ( " 
     +"${csv(entity.Fields, "name($i)")}" 
     +") values (" 
     +"${csv(entity.Fields, "'%s'")}" 
     + ")", 
     ${csv(entity.Fields, 
"e.get${Name(i)}()")} 
     ); 
  } ... 
 
 
public class ExperimentMapper 
   extends DataMapper<Experiment> { 
   public String addSql(Experiment e) { 
      return String.format( 
      "insert into Experiment ( " 
      +"ID,Name,Medium,Stress,Log, 
visibleToGroup" 
      +") values (" 
      +"'%s','%s','%s','%s','%s','%s' 
      +")", 
      e.getID(), e.getName(),  
      e.getMedium(),e.getStress(),  
      e.getLog(),e.getVisibleToGroup() 
      ); 
   } ... 
(A) Generator Template (B) Generated source file generates
Figure 4 | Generators automatically ‘write’ specific software. (A) ‘template’ based generator for 
semi-finished reusable asset ‘DataMapper’ as described in Fig 3. The template is applied to each 
<entity> in DSL generating many completed DataMappers that otherwise need to be written by
hand. (B) shows an example of the generated source files, in this case for <entity 
name="Experiment"> as described in Fig 1. The command $Name(entity) translates to the name of 
the entity (“Experiment”) and command ${csv($entity.Fields, x)} means that command ‘x’ is 
applied to each field of entity and returned as comma separated string (csv).  
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Table 1 | Common and variable features of MOLGENIS experiment databases.  
 
generators would become very complicated and laborious to build (in line with the findings 
of Clements and Northrop, 2001). Therefore we decided that ‘software to manage 
proteomics experiment data’ fits inside the family while a ‘tool to calculate gene networks 
from the collected microarray data’ does not. This may sound strange to a life scientist 
given the obvious biological commonalities amongst raw and processed microarray data 
and obvious differences with proteomics research. However, a proteomics database has 
many informatic features in common with a microarray database (e.g., data management, 
user interface) while a calculation tool has different needs (e.g. running/stopping 
algorithms, graphic visualizations). The latter needs are better solved in another family 
focused on calculation tools. 
The second step is implementation of common and variable parts, which we started 
with a prototype. Here we applied the principle of don’t repeat yourself, DRY (Hunt and 
Thomas, 1999): every piece of design knowledge must have a single, unambiguous, 
authoritative representation. We searched through the prototype software code. If we found 
identical pieces then we put them into the library of reusable assets. E.g., connecting to a 
Feature Common (C) and variable (V) features 
F1. Data 
Store and find lab activities, 
datasets and biomaterials. 
C1. Logic to add, update, remove, find, and count data entities 
in a database; read and write data files. 
V1. Data structures that suits the research, e.g., samples in a 
clinical lab have a “tissue” while microbe samples do not. 
F2. Control 
Manipulate lab entities such 
that it suits the research 
process. 
C2. Logic to select, navigate (first, previous, next, last), find 
(filter), and edit data entities (using the logic of C1). 
V2. Control structures that suit the research, e.g., experiments 
are shown with a menu with subforms for Samples and 
Hybridizations.  
F3. View 
View entities and controls 
interactively (via the 
Internet). 
C3 Presentation of logic that shows F1 and F2 with usable 
layout and formatting. 
V3. Presentation of structure of the specific entity (V1) and 
control structure (V2) of a system variant via the Internet 
(optionally in company style). 
F4. Security 
Ensure that the right people 
get access to the results. 
C4. Manage users, roles and privileges and have authentication 
and authorization in place. 
V4. Set Roles and Privileges to entities and controls, e.g., only 
spotters (role) are allowed to add arrays (privilege). 
F5. Extensibility  
Allow addition of 
components for data 
processing and 
visualizations. 
C5. Have a plug-in mechanism to integrate external programs 
so these programs can benefit from entity and control logic. 
V5. Extend a system variant with logic beyond the family, e.g., 
quantification file validation, complex data aggregation and 
export to files. 
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database and handling of requests from a user (in a web browser) were common activities 
that could be standardized. If we found very similar pieces of software code then we put 
them into a generator. E.g., for each type of data we needed to describe (a) queries to store 
and retrieve the data and (b) a web form to show them on screen, requiring software codes 
which looked very similar (and were typically programmed by “copy-paste”). The 
biological differences that underlie the variations in this similar software were described in 
the domain specific language, e.g., we describe the data structure once, centrally, and let the 
generators do the “copy pasting” in order to adapt the queries and user screens to the data 
(instead of programming them by hand). To further reduce the work we choose sensible 
defaults in the domain specific language, a principle known as convention over 
configuration (Figure 2, s-v).  
In each subsequent step we evolved the MOLGENIS generator, only incorporating 
new functionality when we repeatedly needed it. One should not fall in the pitfall of trying 
to generate everything: there are a lot of situations were you need only ‘one’ variant and 
that therefore do not justify expanding the generator. E.g. a ‘login’ screen is better solved 
by a one-time plug-in. This kind of reactive approach is known to reduce the risk of 
proactively implementing thousands of expensive features that in practice are never 
used (Krueger, 2002). For example, we needed functionality for searching and storing data 
for each step in the microarray experiment so we started with that in the prototype. 
Advanced features like parsing of CSV files was not needed at that point and were ignored. 
During the four years of using MOLGENIS we added numerous functions and 
optimizations, such as filters for the data, viewing data as a ‘tree’, or downloading data as 
CSV files. The generators ensure that ‘old’ MOLGENIS software variants can benefit from 
these improvements: when a MOLGENIS variant is re-generated then these improvements 
are automatically integrated in the newly produced version. 
Implementation details 
The domain specific language was implemented using XML. DSL files can be edited using 
off-the-shelve XML editors. We developed a new language because among the existing 
DSLs there was none with the right focus and abstraction level to fit the domain of 
experiment databases. SQL and UML were the closest but lacked in biological and user 
interface details. We choose XML because it is easy to understand, thanks to the self-
explaining nature of ‘named’ parameters, i.e. <xml name=”value”>. DSL files are read into 
the MOLGENIS generator by a Java class called ‘MolgenisLanguage’ that also checks the 
correctness of the file and adds default settings. Documentation in Javadoc is available at 
www.molgenis.org/doc.  
The reusable assets were implemented using Java (http://java.sun.com) for the variants 
of DataMappers, ScreenControllers, and ScreenViews. The HTML layout for each variant 
of ScreenView is encoded in Freemarker templates (http://freemarker.sourceforge.net/). 
Each MOLGENIS can be generated either as executable (JAR) that uses embedded web 
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server Jetty (http://www.mortbay.org) or as Java web application (WAR) that needs to be 
deployed on a Tomcat application server (http://tomcat.apache.org). Each MOLGENIS can 
be generated to connect either to a MySQL/Innodb database server for large scale 
‘transactional’ data management (http://www.mysql.org) or an embedded HSQLDB 
database (http://www.hsqldb.org). The combination of Jetty and HSQLDB allows for 
prototyping without deployment hassles. The combination of Tomcat and MySQL provides 
superior performance but requires some server configuration (see online installation 
manual). 
The generators were implemented using Java and Freemarker. Each generator consists 
of a directory with two files: a Freemarker template that describes the code to be generated 
(similar to Figure 4a) and a Java ‘Generator’ class that controls the generating process. A 
new generator can be developed as follows: first write some examples of the desired 
programs by hand, were possible using similar patterns (like in Figure 4b) and mark which 
parts are variable between them. Then copy one of these examples into a generator 
template (text file) and replace all variable parts with ‘holes’ that are to be filled by the 
code generator based on parameters from DSL (like in Figure 4a). At each generation, the 
template is then automatically copied and the ‘holes’ filled, based on parameters described 
in the domain specific language, saving the laborious work of doing this by hand. 
Several optimizations were made to accommodate larger data sets (>100MB). First, 
the DataMappers have been enhanced with methods to speed database updates 5-15 times 
up as compared to one-by-one data updates, e.g. addition time of an Affymetrix assay 
(190.000 data entries) was reduced from 100 to 10 seconds. This speedup was made 
possible by using the ‘multi row syntax’ of MySQL and ‘batch’ methods of JDBC; 
MOLGENIS now inserts up to 10.000 data entries in a single command thus vastly 
reducing slow network traffic. Second, efficient ‘data lists’ are being generated to reduce 
memory usage up to four times as compared with Java-standard ArrayLists. As and added 
bonus, these lists add extra finder methods, e.g., one can say 
GeneList.findByName(‘AT1G09700’) to find elements by name. 
The MOLGENIS generator and documentation are available online at 
http://www.molgenis.org/ under a dual license, either LGPL for universities or a 
commercial license for companies.  
3.6 Results 
We have used the MOLGENIS generator to produce a growing catalogue of software 
infrastructures, see www.molgenis.org/variants. Recently, we had a unique opportunity to 
compare hand-written with generative software development. We were approached by a 
company using the BioArray Software Environment (BASE), the community standard, 
hand-written, microarray database (Saal, et al., 2002). They had customized their BASE 
software to accommodate their research and had a hard time keeping it up to date. So they 
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asked us to replace it with a ‘MOLGENIS for BASE’ variant to ease the evolution of their 
software, with the initial version required to work directly on top of the existing BASE 
database schema. Interested readers can compare BASE with the MOLGENIS generated 
version at www.molgenis.org/variant/base.  
Table 2 summarizes how we found that generative development improved 
implementation efficiency by a factor of 48:  
Table 2 | Hand-written versus generated software.  








BASE v1.2.17b (PHP) 47,566 1,323 0.027   1 
MOLGENIS for BASE (DSL) 1,180 1,538 1.3 48 
Implementation efficiency of generated MOLGENIS was 48 times better than hand-written BASE, 
calculated using metric FP/SLOC. Function points (FP) are units of usable functionality to the end-
user (Albrecht and Gaffney, 1983; Fenton and Pfleeger, 1997). Source lines of code (SLOC) are 
meaningful, non-commented lines that have to be written by hand in PHP, Java or DSL (Park, 1992). FP 
were derived by counting the number of inputs and actions (database fields and buttons shown on screen), 
SLOC were derived using the SLOCCount program (http://www.dwheeler.com/sloccount/). Only 
functionality common to both systems was included, i.e. data management was included, processing tools 
were excluded.  
These results far surpassed our expectations, especially because BASE is programmed 
using a scripting language (PHP) which is typically much more concise than a compiled 
programming language (such as JAVA). We used the metric of FP/SLOC, that is the 
number of function points (FP) per source lines of programming code (SLOC) that has to 
be written by hand (Albrecht and Gaffney, 1983; Fenton and Pfleeger, 1997; Park, 1992). 
To keep the comparison fair, we only included FP that both shared, i.e. we did not count 
BASE plug-ins for analysis plug-ins and MOLGENIS plug-ins to accommodate BASEs 
security system (1,542 SLOC).  
The obvious question is whether reduction in source lines of code (SLOC) actually reduces 
the development time. Research has shown that SLOC are highly correlated to development 
effort and time (Boehm, et al., 2000; Reifer, 2004, 
http://sunset.usc.edu/research/COCOMOII/). Furthermore, larger software typically  
has more errors per SLOC which are harder to find and fix and makes the development 
time rise non-linear with software size (Boehm, et al., 2000; Jones, 2002; Sassenburg, 
2005). Moreover, generators don’t make occasional errors making the software easier to 
debug and generators don’t make ad-hoc decisions ensuring uniform software that is easier 
to understand. Obviously, the above comparison assumed a ready-to-use generator in place. 
For the sake of argument, we recalculated implementation efficiency assuming that we also 
needed to program the generators from scratch. Implementation of MOLGENIS the 
generators, reusable assets and DSL parser required 11,964 SLOC. Thus, FP/SLOC 
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becomes 1,538 / (11,964 + 1,180) = 0.12, still 4.3 times more then BASE, suggesting 
return-on-investment of generation within one project. 
3.7 Discussion 
In a recent perspective paper (Swertz and Jansen, 2007) we evaluated the general benefits 
and pitfalls of generative development, such as ‘ability to develop infrastructure in short 
cycles to get the application right’, ‘putting developers and biologists on the same page’ 
and ‘increased quality and functionality’. In  (Swertz, et al., 2004) and (Swertz, Submitted) 
we evaluated the application of the generative strategy to the cases of microarray and 
genetical genomics experiments respectively. Here we discuss implementation alternatives 
and sketch future prospects. 
Implementation alternatives 
In MOLGENIS we made certain design and implementation choices but there exists 
obviously alternatives, see (Czarnecki, 2005) for an overview. Instead of code generation 
we could also have designed software that interprets the DSL file and then configures the 
software on the fly.  We actually did this in a previous version of MOLGENIS (Swertz, et 
al., 2004). However, we replaced interpretation with generation because (i) generated code 
is understandable by humans and therefore easier to check/debug than tracing program state 
in memory, (ii) interpretation has a runtime penalty that we cannot afford when using high-
throughput datasets (while generation allows for specific optimizations) and (iii) generation 
enforces a clear separation between variation points (in DSL) and the implementation 
thereof (in generators). For example, when we needed specialized DataMappers optimized 
for ‘large scale’ data we could simply switch to new generators that uses MySQLs 
‘multiqueries’ optimization (option to add many data rows in one SQL statement saving 
many roundtrips over the network) which would be much more complicated to do in a 
interpreter.  
Instead of embedding our DSL inside XML we could have used an existing 
programming language, e.g. a scripting language like Ruby or Python, or we could have 
created a new textual language, e.g. using compiler compilers like LEX and 
YACC (Mernik, et al., 2003), or a graphical language, e.g. MetaEdit+, FODA (Kang, et 
al., 1990), Taverna (Oinn, et al., 2004). We chose to embed the MOLGENIS-DSL inside 
the existing language XML because the design of a new programming language from 
scratch is very challenging. However, now the DSL is more mature we consider investing 
in a graphical editor to further ease the editing of DSL.  
Instead of building our generator with Freemarker we could have used other 
templating frameworks, e.g. XVCL (Zhang and Jarzabek, 2004), XSLT, Velocity, or 
transformation systems that rewrite the syntax tree of reusable assets after its source code is 
parsed, e.g. Stratego/XT (Visser, 2004), or metaprogramming capabilities provided by 
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some computer languages, e.g. Java bytecode generation. We implemented the generator 
using templates because this makes the generator more ‘visible’ than transformational or 
metaprogramming approaches: a generator now looks like a normal source file except for 
small places of markup to allow for variation. We used Freemarker because it provided 
more compact syntax than alternative XSLT and better error messages than alternative 
Velocity. See http://www.codegeneration.net for more examples. 
Future prospects 
Use of generative methods enables bioinformaticists to build biological software 
infrastructures faster then before. Much less time is spent on customizing and gluing 
individual components. In this paper we have shown that you don’t need heavy-weight 
technology to implement generative methods. Simple text-based templates suffice to create 
biological software generators and already pay within one project.  
As next step we want to expand MOLGENIS to also generate data processing tools, 
including friendly user interaction. We expect to collaborate with other promising 
‘generative bioinformatics’ projects in this area such as Taverna (Oinn, et al., 2004) to 
model/execute analysis workflows and GALAXY (Taylor, 2007) to generate user interfaces 
for processing tools.  
Also, we envision expanding the catalogue of MOLGENIS variants to exploit 
generative powers for more areas of life sciences. We have been approached by groups 
working in related areas like mass spectrometry, large scale animal experiments, and 
clinical trials. We hope that many bioinformaticians will join our effort on 
www.molgenis.org/variants so in time every biologist may find a MOLGENIS variant that 
suits their needs. 
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Motivation | Genomic research laboratories need adequate infrastructure to support 
management of their data production and research workflow. But what makes infrastructure 
adequate? A lack of appropriate criteria makes any decision on buying or developing a 
system difficult. Here, we report on the decision process for the case of a molecular 
genetics group establishing a microarray laboratory. 
Results | We evaluated twenty existing microarray databases (Table 1) and then decided to 
build a new system, Molecular Genetics Information System (MOLGENIS). Five typical 
requirements for experimental genomics database systems were identified: (i) evolution 
ability to keep up with the fast developing genomics field; (ii) a suitable data model to deal 
with local diversity; (iii) suitable storage of data files in the system; (iv) easy exchange with 
other software; and (v) low maintenance costs. The computer scientists and the researchers 
of the local microarray laboratory considered alternative solutions for these five 
requirements and chose the following options: (i) use of automatic code generation; (ii) a 
customized data model based on standards; (iii) storage of datasets as black boxes instead 
of decomposing them in database tables; (iv) loosely linking to other programs for 
improved flexibility; and (v) a low-maintenance web-based user interface. MOLGENIS 
was implemented using code generation in a period of three months. This case can provide 
valuable insights and lessons to both software developers and a user community embarking 
on large-scale genomic projects.  
About Chapter 4 
This chapter reports the first of four case-
studies. The purpose of this case was to 
refine the ‘generative strategy’ (Chapter 2) 
for software infrastructures that support the 
work in the ‘wet’ lab: to enable biologists to 
log their lab activity, biomaterials and 
measurement results and to store large 
datasets as ‘black boxes’ (in contrast to 
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4.1 Introduction 
The design and implementation of information systems for experimental genomics research 
raises many challenges: analytical methods such as microarrays and mass spectrometry are 
under continuous development. A growing variety of research topics are addressed using 
such methods, and modern high-throughput experiments result in an increasing amount of 
data files and tools for processing these data. This paper summarizes the requirements for 
such experimental genomics databases and discusses design alternatives for dealing with 
these requirements in a sensible manner. The insights presented will enable ‘wet’ 
researchers and ‘dry’ software engineers and bioinformaticians to take better decisions 
regarding genomics experiment information management in their respective situations. 
This is illustrated using the case of Molecular Genetics Information System 
(MOLGENIS), a local microarray database. The first version of MOLGENIS was 
developed to support the transcriptomics research workflow of the Molecular Genetics 
group of the University of Groningen (Fig 1). In this group more than 20 people with 
varying computer skills produce and experiment with amplicon based DNA microarrays 
from several bacterial species, e.g. Lactococcus lactis, Bacillus subtilis and Streptococcus 
pneumoniae (Kuipers, et al., 2002). Versions for genomics research groups working on 
plants, animals and humans, using different microarray platforms, are currently under 
development, and proteomics extensions for mass spectrometry experiments are being 
considered. MOLGENIS was implemented using code generation to speed up development 
and maintenance of (multiple) custom microarray databases in fast-developing 
experimental genomics domains. 
The decision to develop our own system instead of using an existing one was based on 
our specific needs. Frequently used arguments in favour of using an existing system instead 
of developing a new one are (1) it is often cheaper; (2) the system will be available faster; 
(3) one is ensured of software support and updates; and (4) the technology is proven. 
Typical arguments in favour of developing one’s own system instead of buying a system 
are (1) the system can be tuned and adapted to meet specific needs and (2) there is no 
vendor lock-in, i.e. becoming dependently on the software vendor. The Molecular Genetics 
group decided on the development of a tuned system, given the risk of high costs for 
adaptation of an existing system to their specific requirements, and the low fixed price 
agreed on by the systems development group: only a simple server and the equivalent of 4 
person months work for a computer scientist. 
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4.2 Requirements analysis and design issues 
Close collaboration between the systems development group and several genomics research 
groups resulted in identifying the general requirements that determine the shape and 
structure of genomics experiment management systems. Strong interactions with the 
molecular genetics laboratory detailed these requirements for the MOLGENIS system. The 
requirements were the following: (R1) evolution ability, (R2) suitable data model, (R3) 
suitable treatment of data files, (R4) exchange with various software tools and (R5) low 
maintenance costs. For each requirement, the following topics are addressed: (i) design 
issues, (ii) alternative solutions, (iii) the (dis)advantage(s) of each solution and (iv) the 
solution chosen for the MOLGENIS case study as well as for existing software 
implementations (summarized in Table 1).  
(R1) Evolution ability 
The experimental genomics research domain is a fast developing domain characterized by a 
variety of research topics, high-throughput analytical methods and accompanying datasets, 
exchange formats and (pre)processing software. Designers of experimental genomics 
databases have to anticipate diversity between groups and unpredictable changes in 
requirements. For example, MOLGENIS had to support frequent data model changes, 
modifications of the user interface and addition of reports based on complex queries if e.g. 
new research findings, method improvements and collaboration projects, required it. The 
question therefore arose of how to deal with such evolving requirements. It meant that 












































































































































Sample information  
Experiments 
User authentication 
Userrole based security 
Projects 
Black box data storage 
Decomposed data storage 
External data processing  
Embedded data processing 
Low maintenance GUI 
Requires client installation 
Local server installation 
Free for academics 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(r)evolution ability should be the central quality for the software design and implementation 
process. 
Evolution ability (or modifiability) can be defined as the capability of modifying a 
system quickly and at a low cost to keep up with changing functional requirements. Hand 
coded information systems typically show a low evolution ability because specific 
functionality is scattered throughout the hand-coded packages. For instance, the simple 
addition of an extra annotation field (e.g. a ‘tissue’ attribute) requires costly, bug-prone and 
time-consuming changes in the database, user-interface programs and application logic 
software modules. To limit the need for labour-intensive reprogramming, one could add 
configuration options with which functionality can be enabled or disabled at runtime, e.g. 
the specific annotations for human samples can be enabled or some user-defined query can 
be added. This offers some evolution ability but only for those changes predicted by the 
system designers. 
Finally, one can invest in code generation in which metadata descriptions are used to 
(re)program the system automatically. This results in short and low-cost change-to-
production cycles without the need for a programming team. Then, to modify the system, 
only a change in metadata is needed because the generator takes care of recoding the 
system. A positive side-effect of generation is the uniformity of the generated application, a 
feature highly appreciated by the user, because all design rules are made explicit within a 
generator.  
For MOLGENIS it was decided to invest in such a generator based approach. Only a 
few databases address and solve the novel issue of evolution ability (R1; Table 1). 
(R2) Suitable data model 
Experimental genomics research projects using the same analytical methods have similar 
information needs. Therefore, standardization efforts emerged to simplify data exchange 
between such projects through definition of standard data models and formats. Well known 
and important standardization proposals such as MIAME (Minimum Information About a 
Microarray Experiment), MAGE (MicroArray Gene Expression) and PEDRO (Proteome 
Experimental Data Repository) (Brazma, et al., 2001; Spellman, et al., 2002; Stoeckert, et 
al., 2001; Taylor, et al., 2003) are by design of a general and comprehensive nature, while 
each genomics research group has unique and specific information requirements, e.g. 
research focusing on a human medicine has different annotation requirements compared 
with research on crop modification. In particular, MOLGENIS had to support traceable 
administration and management of data and materials describing design and production of 
DNA microarrays, sampling and experiments on bacterial species, and the organization of 
research into projects. The data concerning these projects had to be stored securely because 
some of the projects are with industrial partners, i.e. the data model should offer support for 
secure multi-user collaborations, authentication and group permissions. The main question 
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is whether such (maturing) exchange standards should be used (unchanged) for the local 
experiment information management or a customized data model should be developed. 
It is recognized that it is impossible to create one model that is completely expressive 
of the variety of microarray based research (Spellman, et al., 2002). Therefore, given the 
focus on exchange, most standards make parts of their models optional and provide 
extendible annotations such as name–value-type tuples to store extra data keyed by name 
and type (also known as triplets in MIAME) or generic annotation and description objects 
(such as in MAGE). This way information irrelevant to a specific context can be left out 
and relevant entities that are lacking can be added. These reduction and extension 
possibilities are very valuable for data exchange to ensure that the specifics of all 
microarray facilities fit into the standard format. However, they are inadequate for data 
management because constraints are too loosely defined. For example, an object describing 
‘temperature’ can be stored, optionally, via a triplet, while the specific research context 
requires this annotation to be enforced for every sample. Thus, standard models will have to 
be restricted, adapted and extended into a customized data model that enforces these local 
requirements explicitly while capitalizing on the valuable foundation of accumulated 
domain knowledge of standardization organizations like MGED (the MICROARRAY GENE 
EXPRESSION DATA SOCIETY). 
For MOLGENIS, given the bacterial research context of its first implementation, some 
information from the standards was not applicable and has therefore been left out (e.g. 
tissue), some information that fit the standard but only as optional or as an ‘extensible 
annotation’ was made required (e.g. experiment factors like growth medium, temperature, 
rpm of shaker, stress) and some information that were missing altogether was added (e.g. 
project, plate management and user role-based security). Finally, the complexity of the 
model was reduced where possible to make the model more comprehensible: for instance, a 
sample or a sequence was represented as one table row instead of a complex of objects. As 
summarized in Figure 2, the system contains a total of 22 tables (collections of objects, e.g. 
‘samples’) and about 90 attributes (the atomic information elements of a table, e.g. 
‘sampling date’). Existing systems were compared in general terms with regard to the 
specific requirements of the Molecular Genetics group (R2; Table 1). 
(R3) Suitable treatment of data files 
High-throughput analytical methods for genomics research generate (large) data files of 
heterogeneous sorts and formats. For example, MOLGENIS had to store data reliably from 
a dozen file types describing, among others, DNA microarray designs, spotter settings, scan 
images and expression quantifications. The main question is whether such a file should be 
treated as a black box and stored as a whole, the black box option, or should be decomposed 
into individual data elements upon storage in the database, the decomposition option. In 
addition, in the case of the first option, should files be stored inside the database or stored in 
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some directory structure to be referred to by the database? The answer may differ 
depending on the dataset. 
The advantages of the black box option are the flexibility and simplicity of the 
solution: no development effort is needed to support specific and/or future formats. For 
most purposes, this option is sufficient because the input data are directly readable by the 
next device or analysis software in the DNA microarray production and experiment 
workflow, i.e. without format transformations. The disadvantage of the black box option is 
that the data items inside the file are not directly searchable, which is the advantage of the 
decomposition option. The severe disadvantages of decomposition are its laboriousness and 
format specificity: a decomposer and a recomposer must be developed for each device and 
its associated file format and possibly it needs adaptations to accommodate future format 
changes depending on the software version. 
The options for dealing with datasets are not mutually exclusive: one could decompose 
(a part of) the dataset into the database and store the file as a black box as well. However, in 
such mixed options, consistency between the file and its decomposition might well become 
a problem.  
To ensure flexibility and low-maintenance costs the MOLGENIS system currently 
treats all files as black boxes and stores them in a protected directory structure to ensure 
MOLGENIS’s user/project-based security rules. For example, the array designs are stored 
in three related files describing the spotter settings, physical layout and grid layout. Most 
Figure 2 | Data model of MOLGENIS for microarray experiments. Arrows indicate foreign key 
references. There are, besides an authorization module (M0), five functional modules available: 
(M1) Amplicon Design, to manage the sequences to be spotted and the genomes used to design
them; (M2) Plate Synthesis, to produce and manage biomaterial plates of purified amplicons; (M3)
Array Design, to store physical array properties as used by the spotter,and the plates of reporter
sequences to be used; (M4) Array Production, to manage batch array production including the
plates used and; (M5) xperiment Management, to organize hybridizations and samples into
experiments and projects including lists of obligatory annotations. 
Module M0 User Tables* 
[E0c] _USER_ROLE 
[E0a] _USER 





















Module M5 Experiment 
[E5g] Hybridization [E5a] Project [E5d] Experiment 
[E5f] Sample 
[E5e] Strain 
[E5c] Stress [E5b] Medium 
*most references to E0a are omitted to keep the schema simple
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existing systems employ the decomposition option on all datasets (R3; Table 1). This is 
probably because systems featuring the decomposition option also have embedded 
processing tools for which centralized decomposition on data entry is more convenient 
(which also shows that the issues presented here cannot be decided in isolation). 
(R4) Exchange with software tools 
Software is indispensable for manipulating experimental genomics datasets. Automatic 
launch of — and persistent data exchange with — these programs from within the 
experimental genomics database is required for reducing repetitive data management 
activities. For example, MOLGENIS had to exchange data with dedicated software tools in 
a flexible manner in order to make it possible to use multiple and/or new tools 
interchangeably without recurring development costs. These included tools for configuring 
laboratory devices (e.g. slide spotter), data visualization and manipulation (e.g. amplicon 
selection and design, scan image quantification) and data (pre)processing (e.g. 
normalization of expression data). The main question is whether to integrate seamlessly 
such software tools programmatically into the system or accept a form of less-than-
seamless integration using file-based data exchange with those tools. 
Seamless integration demands a perfect fit between the program and experiment 
database with regard to design and implementation, e.g. the programming language, GUI 
toolkit. Existing tools rarely fit the database system, which makes software embedding so 
time-consuming and expensive that people often completely redevelop the tool. 
Furthermore, this laborious embedding process has to be repeated for each new tool, and 
maybe even version, making the database system inflexible and maintenance costly (that 
can be reduced if there exists some standard interface, often labelled ‘plug-in’). 
Alternatively, quite high levels of user-perceived integration can be achieved by using some 
form of less-than-seamless integration such as using the operation system feature to start 
software automatically based on a specific file type or extension. This form of tool 
integration ensures flexibility without high design and maintenance costs, and only requires 
additional user interventions when (re)storing the data into the database. 
For MOLGENIS this flexibility was preferred because it made it possible for the 
researchers to apply a best-of-breed approach when using tools without high development 
and maintenance costs (Figure 3). For instance, hyperlinked Hybridization scans (*.tif) can 
be opened by the preferred commercial spot quantification software, and hyperlinked 
Genome Primer (van Hijum, et al., 2003) amplicon design files and quantification files 
(*.xls) can be opened by the locally developed MicroPrep normalization software (van 
Hijum, et al., 2003). The data is written back into MOLGENIS through file uploads. Many 
existing systems have developed their own tightly integrated solutions through (re)creation 
of tools, offering functions like visualization and quantification, while others are limited to 
data management only (R4; Table 1). 
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(R5) Low user interface maintenance costs 
The costs of bringing the experimental genomics database to the researcher workbenches, 
typically distributed over multiple sites or even in multiple organizations, should be 
minimal during the complete lifespan of the system. For example, the molecular genetics 
group required low maintenance costs besides low acquirement costs (for server and 
DATABASE MANAGEMENT SYSTEM, DBMS). While server maintenance is covered above, 
the question remains as to how to lower client maintenance and administration costs. 
There are several complicating factors that can make client administration and 
maintenance a big part of the ‘total costs of ownership (TCO)’. First and foremost, the 
collection of PC clients is often of a heterogeneous nature, e.g. various versions of 
Microsoft Windows, Linux and other systems. Furthermore, the experiment management 
system will need to be accessed across departmental borders and thus by systems not within 
the control of departmental computer administrators. An ideal situation would be (1) 
PLATFORM-INDEPENDENT front-end software that (2) does not require maintenance when 
the system is changed and (3) is available automatically for new clients when the database 
is accessed for the first time, to relieve the burden for the departmental computer 
administrators. 
The first requirement can be met by using a platform-independent layer such as the 
JAVA virtual machine or .NET software. Modern web browser software can also be regarded 
as such a platform-independent layer. In addition, automated maintenance and deployment 
via the Internet is available for all these platforms, satisfying the second requirement, e.g. 
Java Web Start. However, the third requirement is still a problem with most of the above 
solutions because the platform software needs to be installed and maintained for each client 
before he or she can access the database system. Usually, only web browsers are installed 
Figure 3 | MOLGENIS exchanges data with several classes of software tools. Researchers are 
not locked to a specific application or version because MOLGENIS uses the “black box” option. 
MOLGENIS
  Primer/Amplicon 
Design  
  ArrayPro™   
Spot quantif. 
  GeneTac™ LSIV 
Slide Scanner 
  Hybridisation 
Station  
  Genetix™  
Array Spotter 
  MWG  
pipeting robot 
  GeneSpring™ 
Analysis 
  Public Genomic 
Databases 
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for every client, which makes the web platform a good candidate for developing front-end 
applications (unless more advanced capabilities are needed, e.g. for visualization). 
MOLGENIS uses a web user interface utilizing HTML 4.0, CSS and JAVASCRIPT 
capabilities. As Figure 4 illustrates, all functionality is quickly accessible via a tab menu at 
the top of the screen, with options for printable layout, flexible attribute based 
search/filtering, hyperlinks to datasets (as described above) and a report section in which 
the results of full-fledged, administrator-defined SQL queries can be rendered (e.g. ‘how 
many slides were used per project’ or ‘list hybridizations by species’). Most existing 
microarray databases use Java and/or the web technology (R5; Table 1). 
4.3 Implementation 
The systems development group consisted of two computer scientists, both with a 
background in information system development but without an in-depth background in 
biology. The requirements analysis, design and implementation were completed in a period 
of 3 months and took about 4 person months of work. Prototypes of (parts of) the system 
were delivered to the researchers in an early stage of the project in order to trigger detailed 
feedback in terms of needs and requirements. The choice for code generation, implemented 
using the INVENGINE software allowed for rapid application development because it only 
required the definition of application metadata, i.e. data model, screen descriptions and 
layout rules. The subsequent MOLGENIS versions are generated from these “meta” 
models, described in a small “domain specific” language. 
Invengine is implemented using open industry standards: it requires an SQL92 
standard relational DBMS for data storage, uses XML, DOM and XSLT for metadata 
 




Figure 4 | MOLGENIS user interface. Navigation tabs provide quick access to all microarray 
information (1) and (2) to SQL reports;(3) the layout can be switched to make the contents 
printable; (4) a filtering dialog offers user-definable dataset filtering; (5) datasets are hyperlinked 
so that they can be viewed by (6) the preferred locally installed software.  
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definition and generation and has an APACHE WEB SERVER with PHP extension for the 
server side application generation. Invengine uses three separate non-redundant metadata 
description files, which are used to generate an SQL back-end and to modify the application 
logic (Figure 5): 
1. The Schema file, an XML file, defines the information structure. Addition of a table or 
an attribute would need changes in this file only.  
2. The GUI file, an XML file, defines the user interface and reports structure based on the 
Schema information. Addition of a form, a menu, or a report driven by a complex SQL 
query or changing navigation order would need changes in this file only. 
3. The Layout file, an XSLT file, defines how an application will be presented to the 
researcher, completely independent of the above. Change of corporate colours or the 
decision that date fields need a ‘calendar control’ would need changes in this file only.  
The SQL relational database definitions for, currently, MYSQL and POSTGRESQL are 
generated using an XSLT transformation by which an XSL template (mapping the Schema 
XML to SQL) is applied on the Schema file. At runtime the Invengine software builds user 
screens (such as that in Figure 4) and handles user events using the Schema, GUI and 
Layout files. The production server hardware consists of a Pentium 4 with 300GB of hard 
disk space running a Mandrake Linux distribution and a PostgreSQL DBMS. Maintenance 
efforts are negligible. Code generation, also called model-driven generation, is considered 
part of the software engineering craft (e.g CODE GENERATION NETWORK). 
 
Figure 5 | Architecture of 
Invengine. Invengine is the 
framework, that  provides the logic 
that powers MOLGENIS. At runtime 
two XML meta data files are 
interpreted by PHP software 
modules: (1) a Request Handler 
translates HTTP user requests to 
database transactions or screen 
navigation events, (2) Data 
Services, generated from the 
Schema file, define and execute 
SQL92 and file system operations, 
(3) View Services, generated from 
the GUI file, build XML 
representations of the GUI screens 
and (4) a Layout (UI) driver 
generates default and printable 
HTML layouts from the XML defined 
screens using the Layout file (a 
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4.4 Discussion 
This paper discusses considerations concerning information management, software 
architecture and software engineering within the context of experimental genomic database 
systems. In particular, the general problem of variability and evolution is emphasized, and 
approaches to easing this problem are presented. The decisions cannot be taken in isolation, 
e.g. the decision how to integrate tools may well influence the decision on how to deal with 
datasets. 
The development of a genomic experiment information system is not a trivial task. It 
requires collaboration between biologists, bioinformaticists and IT specialists. The 
information systems developer has to master the genomics domain to a certain level of 
detail, which requires much more effort than for many other application areas. 
Nevertheless, the MOLGENIS system was developed and tuned to the needs of genomic 
researchers within a period of 3 months, requiring a low budget (4 person months work, 
simple server) and resulting in a customizable system. 
Very short prototyping cycles were enabled by the decision to use code generation 
technology to separate clearly the functional model from its implementation, using 
metadata to parameterize differences. In addition, as expected, these adaptations still go on, 
following new insights of researchers and new research questions. Moreover, flexibility and 
simplicity were gained by limiting MOLGENIS to data management only, while leaving 
the file decomposition and processing tasks to dedicated software. This ensures that 
MOLGENIS does not need to be adapted to new (versions of) data formats and tools. A 
plug-in system will ease the embedding processing capabilities if desired because 
standardization of the experiment process and a growing user community will make 
seamless tool development more feasible. Plug-ins for quality control, normalization and 
MAGE-ML exports are planned. 
Projects have been initiated to adapt the MOLGENIS data model beyond bacterial 
DNA microarrays (building on the valuable MGED standards), producing suitable models 
for storage and analysis of data from medical, animal and plant transcriptomes as well. 
Furthermore, use of the model-driven code generation approach to experiment management 
is being considered for several proteomics research groups working with HIGH-
THROUGHPUT LIQUID CHROMATOGRAPHY and MASS SPECTROMETRY experiments 
(HPLC/MS/MS) within the University of Groningen. Finally, these insights extend to other 
areas as well, e.g. to biotechnology information and knowledge grid-like systems, such as 
the E.U. Bio-GRID project, that have to deal with similar variability and evolution 
problems. We are convinced that the insights discussed in this paper are also applicable to 
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Motivation | A common software infrastructure for the growing number of genetical 
genomics experiments would ease sharing of data and analysis tools within and across 
studies on human, mouse, A. thaliana, C. elegans and other organisms. This common 
infrastructure is still left wanted. 
Results | We report on MGG, a highly customizable software infrastructure for genetical 
genomics data, with a graphical user interface for biologists and programmatic interfaces 
for bioinformaticians. A tailor-made variant of MGG suiting your experiments can be 
generated using the MOLGENIS generator. With this initiative, genetical genomics groups 
can stay on the same track: they can share data and software tools notwithstanding large 
variation between research aims. This greatly increases utility for biological research, while 
costs and development time are much reduced. 
Availability | Download MGG, or generate your own customized variant, at 
http://www.molgenis.org/variants/mgg.  
 
About Chapter 5 
This chapter reports the second of four 
case-studies. This purpose of this case 
was to refine the ‘generative strategy’ 
(Chapter 2) for software infrastructures to 
support the ‘dry’ lab: to (i) deal with the 
diversity of resources (data, algorithms, 
tools) such that we ease reuse and 
integration where possible, and 
specialization when needed and (ii) to 
handle the large dataset uploads that have 
to be parsed into their basic information 
elements to enable querying (in contrast to 
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5.1 Introduction 
The strategy of genetical genomics (Jansen and Nap, 2001) has been applied to the genetic 
study of gene expression data in a wide range of organisms including human, yeast, mouse, 
rat, C. elegans and A. thaliana. See Rockman and Kruglyak (2006) for a recent review. The 
genetic study of gene expression data can also be combined with the genetic study of other 
types of biomolecular data. A recent study used Qiagen-Operon microarrays to observe 
gene expression (Keurentjes, et al., 2007) and high-resolution LC-MS to observe metabolite 
abundance (Keurentjes, et al., 2006). They treated gene expression and metabolite 
abundance data over all individuals as quantitative traits, and used quantitative trait locus 
(QTL) mapping to identify expression QTL (eQTL) and metabolite QTL (mQTL) and to 
reconstruct regulatory and metabolic networks.  
Some computational tools for the genetic study of biomolecular data have been made 
available (Carey, et al., 2007; Fu, et al., 2007; Li and Burmeister, 2005; Mueller, et al., 
2006). These tools are typically implemented using the open source statistical R software. 
Computational tools and data storage are integrated in GeneNetwork.org (Chesler, et al., 
2005), a first and successful software infrastructure for genetical genomics data from the 
mouse community. However, GeneNetwork.org is designed neither to evolve substantially 
over time nor to be customized to other organisms and types of biomolecular data: that 
would require many minor, and sometimes major, changes in hand-written software code.  
Here we describe MGG: a highly customizable software infrastructure for genetical 
genomics. MGG thanks its unprecedented customizability to the strategy of ‘generative 
software development’ recently introduced by several bioinformatics projects. See Swertz 
and Jansen (2007) for a recent review. MGG stores assays, traits, subjects and data in four 
core data types and has systematic extension mechanisms to add custom variants thereof. 
Biologists can use a graphical user interface (GUI) to add and find back data, and 
bioinformaticists can use application programming interfaces (API) in R, Java and SOAP to 
connect MGG to processing tools. The MOLGENIS generator (Swertz, et al., 2004; Swertz 
and Jansen, 2007) is used to quickly produce  customized versions of MGG. The common 
data model and uniformly generated interfaces help sharing of data, customizations and 
processing tools, notwithstanding large variation between research aims. We invite 
genetical genomics researchers at www.molgenis.org/variants/mgg to view the demo, 
download, use and extend MGG. 
5.2 Data model 
Figure 1 shows MGG’s four core data types: Subject, Assay, Trait, and Data. In short, 
subjects describe the biological samples  mousestudied, assays describe the biomolecular 
and/or computational protocols used, traits are the biological and/or computational features 
in the assays, and data are the observations/calculations for traits produced by the assay. 
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Variants of core data types can be added. In fact, 
Figure 1 shows Subject and Trait to point to an 
additional core data type called Item. The solid 
triangled line indicates that Subject and Trait (line) 
are variants of Item (triangle) ‘inheriting’ all its 
properties. If each Item has a name, an 
identification number and a type, then each Subject 
and Trait also has a Name, ID and Type. Table 1 




Table 1 | Use cases of core data types 
A growth measurement (Assay) reports the time (Data) it took to flower (Trait) for an 
Arabidopsis plant (Subject). 
A two-color microarray measurement (Assay) reports a list of raw intensities (Data) of 
hybridized gene expression probes (Trait) for one pair of Arabidopsis individuals (Subject). 
A marker based genetic profiling (Assay) reports genotype values (Data) for each 
SNP/microsatellite marker (Trait) for one mouse individual (Subject). 
A kinome array measurement (Assay) reports the activity (Data) of certain enzymes (Trait) in a 
mouse individual (Subject). 
An LC/MS time series (set of Assay) reports the intensity (Data) of certain mass/charge peaks 
(Trait), indicating metabolite abundance for a bowel sample on human (Subject). 
A peak identification algorithm (Assay) reports the identification (Data) of certain mass peaks 
(Trait) to be a certain metabolite (Trait). 
Correlation computation (Assay) reports associations (Data) between metabolites (pairs of 
Trait). 
A QTL mapping (Assay) reports all p-values (Data) mapping genes (Trait) to marker positions 
(Trait) for recombinant inbred lines of C. elegans (Subject); this assay is derived from 
microarray and genetic profiling assays (follow derivedFrom relationship in Figure 2). 
 
Extended variants of Subject and Trait are shown in Figure 2. A MassPeak inherits from 
Trait and has properties ID, Name and Type (like Trait), but also additional properties 
Mass, RetentionTime and Intensity. A Marker also inherits from Trait and adds properties 
(StartBP, EndBP, cMPosition, etc) that specify its genomic and genetic location, but here 
these have been combined in an ‘interface’ called Locus. Other data types can also 
‘implement’ the interface to Locus to get the same additional properties (e.g. a Probe also 
has StartBP, EndBP, cMPosition, etc). Thus both a Marker and a Gene have in common 
that they ‘behave like’ a Locus. Table 2 shows examples of data type variants.  
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Table 2 | Use cases of  data type variants 
A Strain is a Subject. 
Sample is a Subject with the additional property that ‘Tissue’ has to be specified. 
Individual is a Subject with the additional property that relationships with Mother and Father 
individuals, as well as Strain, can be specified (arrows). 
TwoColorSample is a Sample with the additional property that ‘Dye’ has to be specified and 
which two Subjects (or subclasses like Individual) are labeled with ‘Cy3’ and ‘Cy5’ (arrows). 
An InbredStrain is a Strain with the additional property that the ‘Parents’ (mother Individual and 
father Individual) are specified and the ‘type’ of inbreeding used. 
An AFLP, micro satellite or SNP Marker (is a Trait) may refer to genetic and possible genomics 
location (Marker behaves as Locus). 
A genetic map (Assay) shows combinations (Data) of genes (Gene is a Trait) and Marker 
positions (Marker behaves as Locus and is a Trait) for a cultivar (Strain) of tulip (Species). 
 
Figure 2C shows three more data types Experiment, Reporter and Protocol. In short, 
experiments have a name and summary and bind all traits and/or subjects and assays 
together; reporters are artificial traits that report for a real trait  (similar to MAGE 
reporters, see Spellman, et al., 2002); and protocols describe assays in a central place, 
optionally including lists of reporters to be used. Table 3 illustrates the usage of these three 
data types.  
Table 3 | Use cases of data types Experiment, Protocol and Reporter 
A Probe (Reporter) is a Trait that reports for the expression of Genes; as Reporter it has the 
additional property ‘reportsFor’, in this case, a Gene (arrow). 
The Affymetrix ‘Mouse Genome 430 2.0’ microarray Protocol contains 495,374 Probes 
(Reporters) organized in 45,037 ProbeSets that report for 39,000 Genes (Traits). 
A genetical genomics Experiment on Stem Cells was carried out on 30 recombinant  
InbredStrains (Subjects). It used the ‘Affymetrix MG-U74Av2’ Protocol to produce expression 
profiles (Assay), having 12,422*16 microarray Probes (Traits). The result included a matrix of 
signals (Data) for each Probe (Traits) and each InbredStrain (Subject). 
A genetical genomics Arabidopsis thaliana flowering Experiment contains genetic profiles 
(Assay) with Data on 144 Markers (Trait) and 160 Arabidopsis recombinant (RI) InbredStrain 
(Subject). Also unidentified metabolite abundance profiles (Assay) are available with Data on 
2,129 MassPeak (Trait) and 160 InbredStrains, and QTL profiles (Assay) with Data describing 
the mapping of 2,475 MassPeak on 144 Markers.  
 
Not shown in Figure 2 are the five data types BibliographicReferences, DatabaseEntry, 
OntologyTerm, URI, and FileAttachement, see Pizarro et al (2006) instead. These data 
types enable annotation of the four data types Item, Assay, Experiment and Protocol in a 
flexible way. For example, a Gene can have more than one OntologyTerms (but doesn’t 
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Figure 2 | Genetical genomics data model. Genetical genomics data can be described using
core data types, e.g. Subject and Trait (A). Specific attributes and relationships can be described
by adding data type variants, e.g. Sample and Gene (B). Additional information can be added, e.g 
Experiment and Protocol (C). See Table 1-4 for uses of this model. Arrows denote relationships 
(Item has a field Experiment that refers to Experiment ID); Triangled lines denote inheritance 
(MassPeak inherits all properties ID, Name, Type from Trait, next to Mass, Intensity and 
Ret(ention)Time); Triangled dotted lines denote use of <interfaces> (Spot ‘implements’ properties 
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have to) and a Metabolite can link to zero or more DatabaseEntry. The drawback of this 
flexibility is that users and tools using Metabolite and Gene will have to inspect each 
instance to see whether it is annotated. That is why we used inheritance (above) for 
essential properties of Trait and Subject variants above to make sure that they are described 
in a uniform way. See Jones and Paton (2005) for a discussion on the benefits and 
drawbacks of alternative  mechanisms to deal with data variety. Table 4 illustrates the 
usage of these annotation data types. 
The simple and concrete data structures described above greatly help to become more 
productive with the data, in line with findings of Brazma  (2006) and Rayner (2006). To 
understand most data in MGG, newcomers just have to learn the four core data types 
because variants thereof follow a uniform pattern. To ensure this simplicity, we did not 
create variants of Data to accommodate various combinations of Trait and Subject, i.e. 
ExpressionData, MassSpectrometryData, QtlMappingData, PeakCorrelationData, etc. 
Instead, we store all data using only Data which greatly reduced the number of variants 
needed. However, we did create variants for Trait and Subject. This concreteness allows a 
programmer of a Genome Browser tool to depend on each Probe and Marker describing 
‘genomic location’ in a common way. This greatly reduces development effort and eases 
the sharing of tools between MGG instances.  
 
Table 4 | Use cases of annotation data types 
A Gene in an Arabidopsis Experiment can be connected to a DatabaseEntry describing a 
reference to related information in the TAIR database (http://www.arabidopsis.org) and another 
DatabaseEntry describing a reference to the MIPS database (http://mips.gsf.de). 
For each Probe a URI was added that describes a hyperlink to GeneNetwork.org. 
The Arabidopsis Experiment was annotated with the BibliographicReferences pointing to the 
paper describing the experiment and expected results. 
A Protocol describes the ‘MapTwoPart’ method for QTL mapping and was annotated with the 
URI linking to the ‘MetaNetwork R-package’, which contains this method, and an 
BibliographicReference pointing to the paper  (Fu, et al., 2007) which describes the 
MapTwoPart protocol. 
A file with a Venn diagram describing the number of masses detected in each RIL population 
was added as FileAttachement to the Arabidopsis metabolite Experiment. 
A list of Genes was selected from a trans band in QTL profiles (Assay) and annotated with 
Gene Ontology terms (OntologyTerm) and relevant literature annotations 
(BibliographicReference).  
5.3 Graphical user interface 
Figure 3 shows the graphical user interface (GUI) to upload, manage, find and download 
genetical genomics data in the database. The GUI is generated in a uniform way lowering 
the barrier for novel users. Experiments can be described with all subjects and traits 
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involvedn. Data can be entered using either the edit boxes or using menu-option 
‘file|upload’o. This option enables upload of whole lists of traits and subjects from a 
simple tab-delimited formatp, which can easily be produced with Excel or R; MOLGENIS 
automatically generates online documentation describing the expected formatq. 
Subsequently, assays involved can be added with the resulting raw data (e.g. genetic 
fingerprints, expression profiles) and processed data (e.g. normalized profiles, QTL 
profiles). These data can be uploaded, again using the common tab-delimited format or 
custom parsersr that bioinformaticists can ‘plug-in’ for specific file formats (e.g. 
Affymetrix CDF and CEL files). The GUI checks the relationships between data, traits, and 
subjects so no ‘orphaned’ data is loaded into the database, e.g. genetic fingerprint data 
cannot be added before all information is uploaded on the markers and subjects involved.  
Figure 3 | Graphical user interface. Genetical genomics information can be explored by
experiment, items, traits or assay. Hyperlinks following cross-references of the data model point to 
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Biologists can use the graphical user interface to navigate and retrieve available data for 
analysis. Optionally, public access to experiment data can be regulated by assigning 
edit/read rights and user roles (not shown). They can use the advanced search optionss to 
find certain traits, subjects, or data. Using menu option ‘file|download’t they can 
download visible/selectedu data as tab-delimited files to analyze them in 3rd party 
software. Bioinformaticians can ‘plug-in’ a custom build screen (see ‘customization’ 
section) that allows processing of selected data inside the GUI, e.g. visualize a correlation 
matrix as a graph v without the additional steps of downloading data and uploading it into 
another tool. Biologists can follow links-out to related information, for example to probes 
in GeneNetwork.org (not shown). Table 5 summarizes use cases of the graphical user 
interface: 
Table 5 | Use cases of the GUI for biologists 
Navigate all Experiments, and for each Experiment, see the Assays and available Data. 
Select a Gene and find all Experiments in which this Gene shows significant eQTL Data (p-value 
< 0.001). 
For a given Locus, select all Genes that have QTL Data mapping ‘in trans’ to this Locus, e.g. 
absolute(QTL locus – gene locus) > 10Mb and QTL p-value < 0.001.  
Download a selection of raw gene expression Data as tab-delimited file (to import into other 
software). 
Upload Experiment information from tab-delimited files. 
Upload Affymetrix Assays using custom CEL/CDF file readers. 
Plot highly correlated mQTL Data in a network visualization graph. 
Define security levels for Assays/Experiments to ensure that appropriate data can be viewed by 
collaborators, and not by other people. 
A MassPeak has been identified to be ‘proline’ and we can follow the link-out URI to Pubchem 
(http://pubchem.ncbi.nlm.nih.gov/), because it was annotated to have ‘cid’ 614, to find 
information on structure, activity, toxicology, and more. 
5.4 Application programming interfaces 
Bioinformaticians can connect their particular R or Java programs to genetical genomics 
data in MGG using an application programming interface with similar functionality as the 
graphical user interface (R/API, J/API). Scripts in other programming languages can use 
web services (WS/API) or a simple hyperlink-based interface (HTTP/API). When MGG is 
customized with additional data type variants, the API is automatically extended by the 
MOLGENIS generator allowing interaction with these new types in the uniform way. 
Figure 4A-E shows how one can use the R/API to upload all trait/subject/datasets 
involved (A). Another researcher can download these data into statistical scripts to calculate 
QTL profiles (B) to find information on metabolites that significantly map to the genomic 
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Figure 4 | Application Programming Interface. Genetical genomics information in MGG can be 
explored programmatically, either using Java, R, SOAP or HTTP request. The figure shows use 
of the R/API to upload data (A), to download data for calculation of QTL profiles (B), to find traits 
putatively controlled by a master regulator locus (C), to plot profiles and calculate correlation for 
network reconstruction (D), and to upload the results thereof to the database so it can be used by 
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A #Pepe comes to the office and on his own PC  
source("http://yourhost/MGG/api/R")  
 





qtlProfiles <- qtlMapTwoPart(genotypes, traits, spike=4)    
 
#uploads all data into the database          
add.experiment(name="metanetwork") 
use.experiment(name="metanetwork") #metanetwork as default 
 
#upload 'items' 
add.markers(name=rownames(markers), chr=markers$chr,  








B #Next day, Joe continues the work from his computer.  
source("http://yourhost/MGG/api/R") 
 
#Pepe told him to use the 'metanetwork' experiment 
use.experiment(name="metanetwork") #metanetwork as default 
find.assays()  #list data sets 
 
#lists you 'find', matrices you 'get' to download 
markers     <- find.markers()  
qtlProfiles <- get.qtlprofiles(name="qtlProfiles") 
 
C #find traits mapping to putative ‘master regulator’ locus
#(MAM locus, marker GH.117, see Fu, 2007) 
traitPerLoc <- apply( abs(qtlProfiles) > 4.11, 2, sum) 
mrlocus     <- names(which(traitPerLoc == max(traitPerLoc)))
traitnames  <- names(which(abs(qtlProfiles[,mrlocus])>4.11))
traits      <- find.traits(name = traitnames) 
 
D #plot profiles and calculate correlation  
 #for network 
qtlThres <- 3.79 
qtlPlot(markers, qtlProfiles, qtlThres) 
corrZeroOrder <-  
qtlCorrZeroOrder(markers, qtlProfiles, qtlThres)      
corrSecondOrder<- qtlCorrSecondOrder(corrZeroOrder) 
 
E #upload the new result for Pepe to analyze 
add.doublematrix(corrSecondOrder, name="corrSecondOrder") 
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location with the most significant QTLs suggesting control by a master regulator (C), and 
to calculate correlation networks (D), building on genetical genomics R packages like 
MetaNetwork (Fu, et al., 2007). The results thereof can be uploaded again for exploration 
by others (E). The GUI and API are structured similarly so that a researcher ‘talking’ to 
MGG with the API can trace what has happened using the GUI. Click the R/API, J/API, 
WS/API and HTTP/API buttons in the GUI to find documentation on using the APIs.  
Upload of an experiment requires integration of many data files providing information 
on assays, traits, subjects and data. The API helps a lot to describe all the necessary steps to 
add data (see Figure 4). The entries in these files should be correctly connected, but in 
practice these connections take some effort to ‘reconstruct’. The data must be imported in 
the right order and the names of gene ids should be identical between all the files describing 
genes, microarray probes and gene expression. With the APIs an import can be quickly 
defined, including (id) conversions if needed, and then automatically run for the import of 
every next data set. Moreover, the J/API supports ‘transactions’ which ensures that all data 
inserts are rolled back when the import fails halfway preventing incomplete data. 
Therefore, we preferred using the API over using file-uploads in the GUI for importing 
genetical genomics datasets on a regular basis. Table 6 summarizes use cases of the 
application programming interface. 
 
Table 6 | Use cases of the API for bioinformatician 
In R, parse a set of tab-delimited Marker, Genotype and Trait files and load them into the 
database (R/API). 
In R, retrieve all Traits, Markers, expression Data, and genotype Data from an experiment as 
data matrices, before QTL mapping with MetaNetwork (R/API). 
In Java, retrieve a list of QTL profile correlation Data to show them as a regulatory network 
graph (J/API). 
In Java, customize generated file readers to load specific file formats (J/API). 
In Taverna, retrieve Genes for MGG to find pathway information in KEGG (WS/API). 
In Python, retrieve a list of QTL mapping Data using a hyperlink to MGG (HTTP/API). 
5.5 Customizing MGG   
We used MOLGENIS (Swertz, et al., 2004; Swertz and Jansen, 2007) to allow quick 
customization and extension of the software infrastructure. On the push of a button, the 
MOLGENIS generator automatically produces a ready-to-use software infrastructure with 
GUI and APIs from a file written in a simple domain specific language (DSL).  
Figure 5A demonstrates how we used MOLGENIS’ DSL to describe the core data types 
Trait and Data as entities; Figure 5B-F demonstrates how to extend MGG; re-running the 
generator on an updated DSL file will instantly produce an extended version of the software 
infrastructure. Figure 5B shows how the addition of Gene and Marker as new variants of 
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Trait takes only a few additional lines. Figure 5D shows how to create a ‘matrix’ data type, 
especially useful inside R (e.g. a Genotype matrix that is stored in TextData and has 
Markers as rows, and Subjects as columns). Figure 5E shows how to create ‘dynamic’ 
hyperlinks to other websites (e.g. to TAIR, Entrez or Ensembl). Figure 5F programmers 
can add a ‘plug-in’ program that is not generated by MOLGENIS but written by hand in 
Java (e.g., a viewer that plots qtl profiles interactively).  
The generator can be run either online or offline, see www.molgenis.org/tools. 
MOLGENIS either generates a ‘server’ edition (which requires installation on server 
Figure 5 | Generating a custom variant of MGG. A file in MOLGENIS domain specific language
is used to generate the database infrastructure (see Figure 5). (A) Properties of core data types 
Trait and Data are described as ‘fields’. (B) Specific variants of core data types can be created in
a few lines using ’extends’. (C) Properties common to multiple data types can be defined once as
‘abstract’ interface to be reused many times using ’implements’. (D) Users can interact with 
database tables as if they were a matrix. Hand-written extensions can be added to the generated
infrastructure using a (E) dynamic hyperlink or a (F) ’plug-in’. See 
http://www.molgenis.org/variant/mgg for the complete DSL file that also describes the GUI.  
A 
<entity name="Trait" extends="Item"> 
 <field name="Id"  type="autoid"/> 
 <field name="Name"  type="varchar" length="128"/>   
 <field name="Description"  type="text" nillable="true"/>   
 <field name="Project"  type="xref" xref_field="Project.Id"  
  xref_label="Name"/> 
 <unique fields="Id"/> 
 <unique fields="Name,Project"/>   
</entity> 
<entity name="Data"> 
 <field name="Id"  type="int" auto="true"/> 
 <field name="Assay" type="xref"  
  xref_field="Assay.Id" xref_label="Name"/> 
 <field name="Row"  type="xref"  
  xref_field="Item.Id" xref_label="Name"/> 
 <field name="Col"  type="xref"  
  xref_field="Item.Id" xref_label="Name"/> 
 <field name="Value" type="object"/>   
 <unique fields="Id"/> 
</entity> 
B 
<entity name="Gene" extends="Trait" implements="Locus"> 
 <field name="Control" type="bool"/> 
</entity> 
<entity name="Marker" extends="Trait" implements="Locus"/> 
C 
<entity name="Locus" interface="true">...  
D 
<matrix name="Genotype"  content_entity="TextData"  
 container_field="Assay"  content_field="Value"  
 row_field="Row"  row_entity="Marker"  
 col_field="Col"  col_entity="Subject"> 
E 
<field type="hyperlink" pattern="webqtl?cmd=get&probe=${ID}"/> 
F  
<plugin name="myplugin" entity="Data" class="NetworkViewer"/> 
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software) or a ‘standalone’ edition that runs on your computer (at the click of a mouse-
button). This choice can be made via a checkbox (online) or configuration file shows how  
‘molgenis.properties’ (offline). The complete DSL file and generated source-code are 
provided at http://www.molgenis.org/variants/mgg under the open source GPL. The  
MOLGENIS generator and documentation are available online at http://www.molgenis.org/ 
under a dual license, either LGPL for universities or a commercial license for companies. 
5.6 Technical details 
Figure 6 summarizes how MOLGENIS generates MGG in three layers: a database (DB), 
an application programming interface that builds on the database (API), and a graphical 
user interface that builds on the API (GUI). Below we summarize the implementation 
details; a manuscript is in preparation providing more detail on MOLGENIS (Swertz, et al., 
Submitted).  
Database 
MOLGENIS generates a SQL file with ‘database CREATE statements’ that is loaded into 
either HSQLDB or MySQL. Each data type in the data model (see Figure 2) is mapped to 
Factory 
Customizing...
 MGG implementation 
Figure 6 | Implementation and customization. nThe MGG software infrastructure is described 
using MOLGENIS domain specific language (DSL, see Figure 5). oCentral software termed 
MolgenisFactory runs several generators, building on MOLGENIS catalogue of reusable assets.
pOn the push of the ‘generate’ button, all the software code for a working MGG implementation is 
automatically generated from the DSL file. GUI and APIs provide simple tools to add and find
back data, while the reusable assets of MOLGENIS hide the complexity normally needed to
implement such tools. For customization, simply change the DSL file and the MOLGENIS 
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DB in MySQL or HSQL 
Complex:
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from Item natural join 

























its own table, e.g. there is a table ‘Trait’. Each inheritance adds another table, e.g. each 
Gene has an entry in table ‘Gene’ and also in table ‘Trait’. One-to-many cross-references 
between data types are mapped as foreign keys, e.g. Data has a numeric field called ‘assay’ 
that must refer to the foreign key ‘id’ of Assay. Many-to-many cross-references are mapped 
via a ‘link-table’, e.g. an additional table AssayToAssay is generated with two foreign keys, 
both to Assay id, to record ‘derivedFrom’ connections between two Assays. 
API 
Programmers can use the simple commands like ‘find’, ‘add’ and ‘update’ via application 
programming interfaces in Java, R, HTTP hyperlinks and Web Services (J/API, R/API, 
HTTP/API and WS/API). These APIs remove the complexity of SQL database commands 
and also check whether incoming data conforms to the data model (e.g. from tab-delimited 
files, http requests, etc).  
The J/API is implemented using industry standard JDBC components for database 
access. Javadoc-style documentation of the Java API is available via the GUI. MOLGENIS 
generates several optimizations to accommodate larger data sets (>100MB). First, the J/API 
uses ‘batched’ updates of JDBC and the ‘multi-row-syntax’ of MySQL to allow inserts of 
10.000s of data entries in a single-command. This method is 5-15 times faster then inserting 
data entries one-by-one. Second, efficient ‘data lists’ are generated for each data type, e.g. a 
TraitList needs up to four times less memory than Java-standard ArrayLists. For example, a 
data set of Affymetrix experiments with 60 assays of each 190.000 expressions can be kept 
in memory on a simple PC with 1 GB of memory. 
The other APIs are built on top of the J/API. The R/API is connected to the J/API over 
the Internet using Servlets for uploading and downloading. This intermediate ‘HTTP/API’ 
works via simple hyperlinks, e.g. http://host/mgg/api/find/Assay?experiment=1 returns all 
assays for experiment ‘1’. Helper functions ease the import of R matrices into the database. 
For example, a matrix (assay of microarray intensities) with 160 columns and 24,000 rows 
(representing individuals and probes) is translated into a list of 160*24,000 table rows, 
where each row has four columns representing matrix-row (individual), matrix-column 
(probe), cel-value (intensity), and the identifier of the matrix (assay), see Figure 4A. 
Programs written in other languages can use the WS/API that shares SOAP services 
described in a WSDL file. The web services are produced using JAX-WS (https://jax-
ws.dev.java.net). Alternatively, programmers working in other languages can also use the 
HTTP/API (use http://host/mgg/api for examples) or add generators for their language. For 
example, addition of a the Python/API generator requires (i) a template that describes 
Python code to interact with the J/API and (ii) a simple Java ‘Generator’ class that applies 
the template to each ‘entity’ in the DSL file to (iii) produce specific data access methods in 
Python for each data type. Current MOLGENIS generators are listed in Figure 6. 
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GUI 
The graphical user interface (GUI) publishes the functionality of the API to biologists. For 
example, a ‘TraitScreen’ is generated to find, update and browse trough Traits. This 
TraitScreen builds on reusable assets: FormScreen remembers the current state of the GUI 
(e.g. data currently viewed), FormView layouts the screen as HTML page and 
FormController changes the screen-state on user input (e.g. previous, next, update). Other 
reusable assets are MenuScreen, TreeScreen, MatrixScreen and PluginScreen, the latter to 
incorporate hand-written screens. The GUI is run as Java Servlet and can be run on a server 
(which is advised when there are multiple users) or as standalone executable that runs on 
any PC with Java. The server implementation consists of a WAR file which can be run on a 
Servlet container such as Tomcat (http://tomcat.apache.org), which serves the application 
over the Internet and facilitates access to a MySQL database. This can be configured in the 
molgenis.properties file (see MOLGENIS installation manual at http://www.molgenis.org). 
The standalone implementation consists of a self-contained, executable JAR-file that is 
build with the HSQL database and Jetty web server (http://www.mortbay.org) embedded.  
5.7 Discussion 
In this paper we reported on MGG, a ‘Molecular Genetics Information System’ 
(MOLGENIS) for ‘Genetical Genomics’. Box 1 summarizes the main features of MGG. 
Use of the MOLGENIS generator tool speeds up customization and ensures that the 
API/GUI of customized MGG systems still behave in a uniform way. This allows the 
community of genetical genomics research groups to use MGG to share data and tools, 
because different installations of the software infrastructure use uniform data, API and GUI 
structures notwithstanding large variation between research aims.  
Groups that already have an infrastructure (e.g. GeneNetwork.org) can assimilate 
MGG to ease evolution of their existing software. After ‘rewiring’ of algorithms and visual 
tools to use the MOLGENIS API’s to manage data, researchers still have the same features 
as before plus the features provided by the generated infrastructure (e.g. data management, 
R/API) and connected tools (e.g. R packages developed elsewhere). Moreover, much less 
software code needs to be maintained by hand when replacing hand-written parts by 
MOLGENIS generated parts, allowing software engineers to add new features for 
researchers faster. We invite the genetical genomics community to join in on 
http://www.molgenis.org/variants/mgg to share the best customizations and plug-ins of 
MGG and to push developments into directions that most benefit genetics research. 
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 Box 1 | Features of MGG – software infrastructure for genetical genomics. 
Store each genetical genomics experiment using only four ‘core’ data types: Trait, 
Subject, Assay, and Data. For example: a single-channel microarray Assay 
reports raw gene expression Data for each microarray probe Trait and each 
individual Subject. 
Customize MGG with extended variants of Trait and Subject. In my MGG, Probe traits 
have a sequence and genome location and Strain subjects have parent strains 
and (in)breeding method. Describe extensions in MOLGENIS language and the 
generator automatically changes the software. 
Upload data from measurement devices, public databases, collaborating MGGs, or a 
public MGG repository with community data. Simply download trait information as 
files from one MGG and upload it into another; this works because of the 
uniformity of the core data types (and extensions thereof).  
Search genetical genomics data using the graphical interface with advanced query tools. 
The uniformity of the ‘code generated’ interfaces make it easy to learn and use 
interfaces for both ‘core’ data types as well as customized extensions. 
Analyze data by connecting tools using simple methods in Java, R, Web Services or 
Internet hyperlinks. For example: map and plot quantitative trait loci in R using 
MGG data retrieved via 
source(http://host/mgg/api/R);  
find.assays(); get.genotypes();  
get.expressions(); 
Plug the best analysis tools into the user interface so biologists can use them. 
Bioinformaticists are provided with simple mechanisms to seamlessly add such 
tools to MGG, building on the automatically generated GUI and API building 
blocks.  
Share data, customizations, connected analysis tools and user interface plug-ins with 
the genetical genomics community, using MGG as exchange platform. For 
example, the MetaNetwork R package can talk to data inside MGG. This makes it 
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Background | A clinical trial coordination centre, such as TCC in Groningen, takes care of 
many heterogenic study databases. Typically, these databases are designed and managed 
individually because of different origins and needs. As a consequence, data preservation 
and distribution is time-consuming because operating procedures and extraction methods 
have to be re-developed for each new study database. Our objective is to obtain - make or 
buy - a flexible infrastructure to preserve clinical databases and make data extractions 
available to the researchers in a timely and labour extensive manner. 
Methods | In order to elicit the detailed requirements, various stakeholders were 
interviewed and some archetypical examples of existing clinical trial research databases of 
TCC were analyzed. Literature and software systems regarding clinical data management 
were reviewed, looking for suitable systems and methods. 
Results | We present a detailed description of the requirements, such as reconstruction of 
historic data extractions. Literature and system reviews showed no available clinical data 
infrastructures that met all requirements. We decided to make a generic system ourselves. 
We explain our design decisions, include a generic and flexible data model, and give 
mechanisms to preserve and extract data in a custom, reproducible and labor extensive way. 
Conclusions | We designed a general way to bring different existing clinical trial databases 
together into one analytical, web-based system. We demonstrated how such a uniform 
system eases reuse of methods by data administrators and provides clinical researchers with 
a uniform (web-based) user interface to quickly extract custom datasets that suit their 
analysis needs. The detailed descriptions also constitute a foundation for local system 
developers to base their own "buy or make" decisions or "custom make" projects upon. 
Availability | a basic implementation without data extraction user interface is available at 
www.molgenis.org/variant/metabase. 
About Chapter 6 
This chapter reports the third of four case-
studies. The purpose of this case was to 
refine the ‘generative strategy’ (Chapter 2) 
for infrastructure to integrate, query and 
(re)distribute clinical trial data. 
Predictability of the variation between 
studies (in contrast to Chapters 4-5) 
allowed use of another mechanism than 
generation. We used a generic model 
where all details about study variants (e.g. 
questions, questionaires) as well as 
contents (answers) is stored. One could 
think of such ‘meta model’ as a special 
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A trial coordination centre has to take care of many (heterogenic) clinical study databases. 
The TRIAL COORDINATION CENTRE (TCC) of the University Medical Centre Groningen 
(UMCG) in Groningen is a typical example (see TCC website). Currently TCC manages 
the results from questionnaires and measurements for about 40 studies, with an increase of 
10 per year. Study size varies from 20 to thousands of patients, and 5 to 25 visits per 
patient. Until now these study databases have been managed and exploited individually 
which becomes cumbersome and labour intensive because operating procedures and 
(extraction) method development have to be repeated for each study database. TCC wanted 
a labour extensive, web-based system to preserve and distribute these heterogenic clinical 
trial data in a uniform way so clinical researchers can easily extract data across several 
trials while TCC developers can reuse structures, procedures, and methods. Literature and 
existing clinical data management systems were analyzed to answer the question: “Make or 
buy such a system?”.  
Academic systems such as TRIALDB (Brandt, et al., 2000; Nadkarni, et al., 1998) and 
OpenSDE (Los, et al., 2005), and commercial systems such as Oracle Clinical (Oracle, 
1999), INTEGRATED REVIEW, Phase Forward’s CLINTRIAL  did not provide all required 
features, such as complete import of existing clinical trial databases, a flattening tool for 
extraction), versioning support so researchers can rerun their analysis at a later date using 
the original data, export to various statistical systems such as SPSS, SAS, or R, capabilities 
to query across studies (meta-analysis), and/or in-depth developer oriented documentation 
to allow TCC members and even TCC customers to extend the system themselves (see 
section 6.2 below). For these (and other) reasons, the conclusion for TCC was to “make 
such a system”. 
This paper is based on  (Swertz and de Brock, 2005) and is organized as follows. 
Section 6.2 describes the requirements definition, a definition of essential features for the 
system to reach the goals within the given context. Section 6.3 discusses the design 
decisions we have taken as well as the resulting functional design, a design of the 
functional parts of the system, necessary to provide the required features. The requirements 
definition and functional design form the blueprint for the implementation. Section 6.4 
continues with discussion and future work. The paper ends with conclusions in Section 6.5. 
6.2 Design objectives 
We started with information analysis. The information analysis formed the basis of the 
requirements definition and functional design. We used the following methods: 
• Interviews: Several interviews took place with various stakeholders: the general 
manager of TCC, some developers and managers of existing clinical trial research 
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databases at TCC, and some clinical researchers (future users). These interviews 
formed the basis for the requirements definition. 
• Systems analysis: Simple and complex examples of existing clinical trial research 
databases at TCC were analyzed to identify commonalities that can be addressed 
uniformly and variation points that have to be supported, i.e., PREVEND (Hillege, et 
al., 2002), COACH (Jaarsma, et al., 2004), and TRAILS (de Winter, et al., 2005). 
These analyses produced technical details for the requirements definition. 
• Literature and systems review: Literature and software systems regarding clinical data 
management were analyzed, looking for examples of the state-of-the-art in clinical trial 
data management that satisfied the requirements. However, as explained in the 
Introduction, it led us to the conclusion that no satisfactory system existed and, hence, 
not to buy but to make such a system. The literature review was also used as additional 
input for the functional design. 
 
What was wrong with the existing situation? 
• Ad hoc implementation of data extractions, e.g., duplicated efforts are needed in order 
to find, retrieve, reformat, convert, standardize, integrate, and aggregate data from each 
study for each data request. 
• No versioning, so no possibility to reconstruct the database state at a specific point in 
history, e.g., at an extraction date as of 2001/12/23. This leads to problems when a 
researcher needs to rerun part of an analysis in relation to a publication under review. 
• Data not directly accessible (via Internet) by clinical researchers so they always had to 
call TCC and wait for custom extractions. 
• No standard data structures, so difficult for researchers to learn and hard for TCC 
developers to reuse previous work, etcetera 
• No additional information (“metadata”) about studies 
• No logging of extractions so researchers cannot not easily recall what data (version) 
and query was used for a certain analysis 
• Nearly impossible to analyze across multiple studies because of structural and semantic 
heterogeneity. 
In summary, our information analysis revealed that TCC wanted a labour extensive system 
with a web-based interface to preserve and distribute such heterogenic clinical trial data in a 
standard way so clinical researchers can easily extract data across several trials while TCC 
developers can reuse structures, procedures, and methods. We will call the required system 
METABASE. 
In the classical distinction between transaction processing and analytical processing, 
the METABASE system would provide the basis for (all) analytical processing within 
TCC. The role of METABASE is depicted in Figure 1. We will define the requirements in 
more detail.  
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The following main METABASE features were identified:  
1. Metadata: provide a flexible database structure to store data in and about studies, i.e., 
data as well as metadata, without structural changes upon adding a new study.  
2. Study import: support easy import of the collected study results data as well as study 
structure data into METABASE.  
3. Authorized extraction: enable authorized clinical researchers to extract relevant 
subsets from several clinical trial databases for data analysis. 
4. Reproducibility: support change history of study database releases as well as 
extraction logs in order to enable reconstruction of an extraction from a specific date. 
Each feature will be treated in a separate subsection, starting with a short motivation and 
followed by an enumeration of required feature details, called “issues”. The issues may 
indicate structures to store specific data, functions to manipulate data, or important aspects; 
in combination they define the feature. With each issue a description and some comments 
are given. 
Metadata 
This feature has to enable addition of new studies without structural changes to 
METABASE, and should offer a stable basis for reusable extraction methods and operation 
procedures. 
Motivation | In most study databases each question of a questionnaire is represented as a 
table column (structure) and all responses of a patient are represented in a table row (state). 
Import of such data in their original form would require the addition of new tables for every 
questionnaire added. This is undesirable because this requires a lot of work and hinders 
reuse of methods and operation procedures because they have to be hand-fitted to every 
table of each newly added study database. 
Issues | Storage of new study databases without structural changes to METABASE requires 
that all necessary metadata describing the study database structure can be stored in 
METABASE. Analysis of example study databases as well as the literature resulted in a set 





Figure 1 | Role of Metabase 
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able to store metadata on all these structural patterns. The Metadata issues are listed in 
Table 1. 
Table 1 | Requirements for the Metadata feature 
Issue Description 
Comments 
Studies Store data about individual studies. 
Data about studies are typically stored in separate files or databases.  
In METABASE data about studies have to be represented as rows in a 
table. 
Forms Store question forms (modules of questions or measurements within a 
study). 
In study databases, forms (questionnaires) are typically stored as 
separate tables.  
In METABASE these have to be represented as rows in a table. 
Questions Store individual questions (may have repeating answer elements). 
In study databases questions are typically represented as table columns 
and repeating answers are typically modeled by adding extra columns.  
In METABASE these table columns have to be represented as values in a 
table.  
Responses Store responses to the questions for a specific patient, visit, or study.  
In study databases such responses are typically stored as column values. 
In METABASE both column head and column value have to be 
represented as values in a table with additional information identifying the 
metadata  
(i.e., questions, visits, patients). 
Codes and 
code lists 
Store codes and code lists. 
In study databases responses to questions are often coded and restricted 
to a limited set of answers, e.g., sex = {man, woman}. These lists may be 
stored in a table but often we need the study protocol codebook for it.  




Store the moments when patients should be and are actually questioned.  
The study protocol states which questionnaires should be worked through 
at which visits. The visiting schema may be available in a separate table. 
However, incidental unplanned visits can occur. In the study databases 
the individual visits are typically identified by a value in a response row.  
In METABASE all these data have to be represented as rows in tables. 
Study import 
This feature has to enable easy import of various clinical research study data and study 
structure data into METABASE. 
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Motivation | Study databases are, after validation, offered to TCC for preservation and 
distribution. Typically, the data is shipped to TCC in the form of delimited text files where 
each file represents an individual database table. To complicate matters, individual study 
databases may know subsequent releases. Finally, each study database may come with 
additional materials such as an experimental setup or planning. Organizing these data for 
preservation is challenging. Simply transforming these data by hand into METABASE 
would incur unnecessary cost for TCC because the similarities of the imported study 
databases are not exploited.  
Issues | The Metadata feature, as described above, provides for storage of the data in and 
about the study databases. What is needed in addition is to provide support for the import 
process. Issues regarding the import feature are listed in Table 2. The order of issues 
corresponds to the sequence of actions needed for import. 
Table 2 | Requirements for the Study import feature 
Issue Description 
Comments 
Preparation Prepare data before import into METABASE. 
For import into METABASE, the data is expected to be validated and 
shipped in delimited text files.  
Mapping Associate source files with columns and elements in METABASE. 
The source dataset will be tagged with metadata as a basis for 
transformation into METABASE. These tags are needed to identify 
which columns map database elements such as visits, patients, and 
questions.  
As the source databases are very similar (though not identical) in 
structure and format, a generic way to design such mappings is feasible. 
Annotation Annotate imported study databases with relevant information. 
Relevant information about the study databases for TCC members 
and/or applied researchers are added and may include study name, 
release version, release date, and additional descriptions on metadata 
elements (such as the complete question text).  
Unflattening Transform study data to the METABASE structure. 
Data is transformed from the table-like source data model to an 
“unstructured” METABASE form. The imported data will also be archived 
in its original format. 
Upload Upload the transformed data into METABASE. 
After transformation the data will be loaded into METABASE.  




This feature has to enable authorized clinical researchers to extract their relevant subsets 
from clinical trial databases. 
Motivation | Researchers need data from the clinical trial databases for analysis, but 
typically only need (or are authorized to) a certain subset of the data. So the data needs to 
be selected from the study database and then packaged into a format suitable to the 
researchers’ analysis software. Researchers typically need a two dimensional data matrix. 
This process is also known as “flattening”. The returned data is a package that contains a 
selection of responses from selected visits and includes the relevant code lists. Building 
such extractions is currently cumbersome and labor intensive. The extraction methods have 
first to be fitted to the specific database structure of the study database. Then, at request, 
TCC members have to determine if the requester is actually authorized to get that extraction 
and finally they need to implement a program to realize the extraction and transformation 
into the suitable format. Little of this work can be reused for later extractions and there is 
no good administration of executed extracts. 
Issues | The availability of a standardized database enables a standardized and reusable 
implementation of extraction algorithms. The consequence is that applied researchers do 
not have to “call TCC” every time they want an extraction, reducing the time to realize a 
new extraction. Meanwhile TCC can spend time on more specialized tasks. To enable the 
authorized extraction facility, a set of extraction issues is identified, see Table 3.  
Table 3 | Requirements of the Authorized extraction feature 
Issue Description 
Comments 
Authorization Assign extraction rights for (parts of) study databases to groups/individuals.  
The administration of these rights should be maintainable by the study owner.  
Selection Select metadata elements of interest as columns of the “flattened” result table. 
Each question (or measurement or question repeat) is represented as a 
column in the flattened table. Metadata about patients and visits are 
automatically added.  
Filtering Define filters on the extracted result rows. 
Filter study data based on patients, visits, and the responses on specific 
measurements. These selections are equivalent to setting conditions in the 
“WHERE clause” in an SQL statement.  
Flattening Execute the flattening and filtering based on extract definitions. 
Transformation from the generic “structure-less” database of METABASE to 
the specific “structured” or “flat” representation to which the filtering is applied. 
Provenance Provide extractions with annotations that describe the extracted data. 
Extractions include annotations such as extraction date, extraction definition, 
database (release) used, and “metadata” (such as code lists). 
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Catalogue Catalogue extraction definitions for traceability and reuse purposes. 
Log executed extractions for tracking and reporting purposes. 
Enable TCC members, study owners, and researchers to create or use  
pre-defined extraction functions. 
Reproducibility 
This feature supports the change history of study database releases and extractions executed 
in order to enable reconstruction of an import or extraction as of a specific date. 
Motivation | Although study databases are validated before they are preserved and 
distributed by TCC, there are often unforeseen events that require later changes to the study 
database. It is therefore not uncommon that a clinical trial database is updated and offered 
again to TCC and overrules the previous release. Another reason for several stored releases 
of the same study is that some researchers already want to delve into intermediate results 
while the study is not yet finished. However, this complicates matters for TCC and the 
biomedical researcher because analysis of the new release may yield different results.  
Issues | It should be clear to the researcher whether extracted data comes from other study 
database releases than the previous extraction and there should be the possibility to get an 
extraction as if it was run at a specific date, e.g., because some published results were 
based on the data as known on a specific date and needed to be redone following comments 
from reviewers. By means of questions, Table 4 explains what is needed to enable 
reproducibility.  
Table 4 | Requirements of the Reproducibility feature 
Issue Description 
Comments 
Releases When was data known inside the original study database? 
Tag the data in the database in order to identify and separate study 
releases. 
See also Section 2.1. 
Import log When and how was data imported inside the meta database? 
Annotate releases in order to identify and separate the raw data as known 
by TCC and extractable from METABASE on a specific date. The imported 
data files are archived separately.  
See also Section 2.2. 
Extraction log When and how was data extracted by a researcher? 
Log extractions in order to execute extractions as of a specific date. For 
instance, because a researcher needs to do another extraction on the 
same data as a previous example.  
See also Section 2.3. 
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6.3 Functional design 
The functional design of METABASE describes the working of and relationships between 
the functional parts of the system. The essence of the requirements definition (Section 6.2) 
is to prevent the need for structural changes to METABASE when new study databases are 
added or new applications are needed. 
The problem that TCC faces is challenging because of the variation both in the supply 
of study databases as well as in the needs of the consumers of study data. Instead of the 
current ad-hoc solutions for these variations in terms of creating new modules for each 
study and each extraction, a more permanent solution is needed. METABASE should 
account for variation coming from suppliers and from consumers of study data. At the same 
time the level of abstraction should not be that high that the users of METABASE (TCC 
members, study providers, applied researchers) cease to understand its structure.  
The essence of the solution is to store the data structures as well as the data states of 
study databases as one uniform and integrated data state in METABASE. In order to store 
incoming study data structures (such as tables from study databases with each column 
representing a question) without structural modifications to METABASE, the structural 
“metadata” about studies has to be imported as well as the study data itself. In the database 
inside the METABASE system there should be room to account for the structural variation 
of study databases. In short, the database of METABASE will have to contain data as well 
as metadata of multiple studies, each with patients, visits, and questionnaires.  
Below we detail the functional design that realizes this essential functionality. The 
following main aspects of the solution are described: 
1. Architecture: an overview of the structure and components of the METABASE 
system. 
2. (Un)Flattening: design of the patterns that underlie the import and export functions, 
i.e., transformation of imports of so-called “flat” study data (with specific structure) 
into “unflattened” METABASE data (with uniform structure) and exported to 
(re)flattened data extractions for analysis (with, typically different, specific structures). 
3. Database: design of the uniform structure of the database in the METABASE system 
that allows METABASE to store study structure data as well as study results data. 
4. Other important design aspects: design of the versioning of released data, logging, 
and authorization aspects that allows for reproducibility, traceability, and authorized 
extractions. 
In the next subsections, each of these aspects will be described. 
Architecture 
As Figure 1 in Section 6.2 already emphasized, METABASE will operate in the context of 
the studies it preserves, and the research interface (a website) to which it distributes (used 
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by the biomedical researchers). The architecture explains globally the components of the 




The essence of the METABASE is to allow for structural variations, both in the imported 
study databases as well as in the extracted data sets. To provide this functionality the 
inverse-like algorithms for unflattening and (re)flatting are needed, i.e., to transform study 
structures into the database upon import and, vice versa, into “flat” result sets upon 
extraction. This is a proven design pattern for clinical trial data and is also known as “Entity 
Attribute Value (EAV) modelling” or “Row modeling” (Nadkarni and Brandt, 1998) and 
are applied in most contemporary clinical trial information systems such as TrialDB, Oracle 
Clinical and now also METABASE. However, in METABASE the EAV modelling is not 
located in the source data but in the (off-line) database, which acts as a data 
warehouse (Inmon, 2002), see Figure 2.  
 
The design pattern of (un)flattening is illustrated via a general example, see Figure 3.
Explanation of flattening/unflattening: 
• Key with value Ki identifies a subject, for example patientID = 1 or visitID = 1. 










Extract log & 
Authorization 
Import log & 
Archiving 
Research 
= data collection = transformation algorithm = retrieved dataset 
Figure 2 | The architecture of the METABASE system. Database: the hart of METABASE, 
which enables flexible storage of study data as well as structure data (metadata); Import module:
enables mapping and unflattening the data coming from the studies into the database of
METABASE; Extract module: enables selection and (re)flattening study data from the database of
METABASE into table-like data sets that biomedical researchers use for analysis; Import/Extract
logs: enable traceability of study release imports and data extractions; Archiving module: archives
the source data as they come in; Authorization module: enables the access rights of users and 
user groups to the database, e.g., based on a specific study, specific patients, specific visits,
and/or specific questions. 
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• Value Ri,j identifies the response of subject Ki to question Qj, for example R1,1 = 69 
where Q1 = “WEIGHT”.  
• In most study databases all responses Ri,j of all subjects Ki are modelled in tables with 
questions Qj as columns. Thus, questions are hard-coded in the structure, so adding 
questions requires adding an extra column. 
• In the data model of METABASE both the questions Qj (column heads) and responses 
Ri,j (column values) are transformed into column values, under column heads Question 
and Response respectively. The questions are not coded into the structure anymore, so 
new questions can be added without restructuring.  
• In a study Response table, column Key provides data that identifies the subject 
answering a question, e.g., the visit of a specific patient in the context of a specific 
study and questionnaire.  
• Only a limited collection of such flatting and un-flattening functions will be needed: 
• For each table of the imported study databases, typically many tables for each set of 
questions (columns) and responses (rows), a table with code lists, and a table with 
visits. 



















Key Q1 Q2 … Qm 
K1 R1,1 R1,2 R1,.. R1,m 
K2 R2,1 R2,2 R2,.. R2,m 
… … … … … 
Kn Rn,1 Rn,2 Rn,.. Rn,m 
import 
(unflattening
Key Question Response 
K1 Q1 R1,1 
K1 Q2 R1,2 
K1 … R1,.. 
K1 Qm R1,m 
K2 Q1 R2,1 
K2 Q2 R2,2 
K2 … R2,.. 
K2 Qm R2,m 
… … … 
Figure 3 | Functional design of flattening and unflattening
extract 
(flattening) 
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• For each type of extraction. Probably a generic tree representation of studies will 
suffice, i.e., selections of question per visit per study. 
Given meta information on what data values represent K, Q, and R respectively, the 
unflattening functions for import are automatically implemented using software generators. 
Similarly, tailor made flattening functions for extraction are generated from this K, Q, R 
meta data in the database (see below). This prevents much of the laborious handwork. 
Database  
The functional design of the METABASE data model details the structure of the database 
to store study structure data as well as study results data from the different study database 
releases. The functional design of the data model is summarized in Figure 4 and explained 
below: 
• The data model consists of 11 tables (also called “entities”), ranging from whole 
Studies to individual Responses.  
• Arrows in Figure 4 denote references, d-a-s-h-e-d arrows denote optional references. 
The underlying foreign key attributes are marked by  => respectively  (=>). 
• We decided to use automatically generated, “meaningless” keys, consisting of only one 
attribute. They are underlined in Figure 4, e.g., StudyID. 
• Figure 4 distinguishes levels – L0 to L4 – and, from L2 on, four columns – C1 to C4.  
• The seven tables of Studies (L0), PlannedVisits and VisitForms (C2), Forms and 
Questions (C3), and CodeLists and Codes (C4) contain the results of the study design.  
• The tables of Releases (L1), Patients, Visits, and Responses (C1) contain the results of 
study execution. (Responses will, by far, be the table with the largest number of rows.) 
• The core of METABASE is the administration of Responses during Visits given by 
Patients. Responses, Visits, and Patients represent the actual study results. 
• Studies can have several Releases. A study will typically have a general goal attribute 
while a release will typically have a creation date and a date of import. A release may 
be locked and/or retrievable. 
• Code Lists and Codes limit the lists of allowed Responses to certain Questions. Code 
lists map codes values to code labels (descriptions), e.g., 1 ≡ “male” and 2 ≡ “female”. 
• During study planning, lists of Questions will have been determined, typically 
organized in one or more questionnaires, also known as Forms.  
• Some Questions may allow several (repeating) Responses. Some Questions may not be 
answered (have missing values).  
• During study planning, a protocol of Planned Visits may have been defined, possibly 
including the Forms that have to be (partially) treated then (Visit Forms). It may be that 
the actual Visits deviated from planning, that the planned visit was spread over more 
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Figure 4 | Data model for the database of METABASE
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(as in a hospital environment). It is therefore possible that actual Visits could not be 
linked to Planned Visits or vice versa. 
• Visits can be nested: Visits refer to Visits (by ParentID).  
• NodeID contains the path of VisitID’s to the topnode/topvisit (separated by dots).  
• OriginalKey holds the key-value for this field in the original data and is used for 
import-purposes only.  
• VisitDate holds the date the visit has occurred. 
• Patients may have filled out more than one form per visit. This means that there could 
have been recurring forms at each visit.  
• Sequence is an ordinal number denoting the order of the VisitID-FormID combination 
per patient. Therefore, (PatientID, FormID, Sequence) is another key inVisits. 
Other important design aspects 
The functional design provides developers of clinical trial information systems with 
guidelines and does not aim for a complete cookbook description of the implementation. 
For example, the following aspects are considered relatively easy and therefore are not 
explained in detail in this paper: 
• Logging of events such as imports and extracts from the database. 
• Archiving of imported study datasets, i.e., the data files. 
• Provenance descriptions, i.e., annotation of extractions with accompanying code lists 
and study-related metadata. 
• Extraction catalogue, i.e., a list of predefined extraction queries that can be reused by 
others. 
However, there are some design aspects that need to be addressed, see Table 5. 
Table 5 | Functional design of reproducibility and authorization  
Aspect Design summary 
Reproducibility To enable historic views (not only the most recent release of study 
data), the design pattern is as follows: 
Each table (except Studies) will - directly or indirectly - have a 
“release” column. This shows which element was known in which 
specific releases. 
Releases are annotated with the date the release was created and 
the date the release was imported into METABASE. 
Authorization To assign rights to extract specific study data and/or rights to 
authorize others to do so, the design pattern is as follows: 
Users and Users Groups can be administrated. 
Extraction rights can be granted on study elements, i.e., on studies, 
visits, patients, etcetera. 




Administration rights can be granted on the level of studies to study 
owners to allow them to grant rights to other users. 
The consequence is that data extractions can only be executed by 
authorized people and that TCC members are not required to 
manage all individual rights and extraction requests. 
6.4 Discussion and future work 
While the requirements analysis and functional design cover a large part of the 
development of METABASE there are some remaining questions. 
 
How about extractions by researchers? | TCC also needed a tool so researchers can 
easily navigate the generic METABASE concepts (i.e., studies, forms, visits, etc.) and 
choose what data they want to have in a flat result file (for statistical analysis). It is well-
known that information extraction from “unflattened” clinical studies is not 
straightforward (Los, et al., 2005; Nadkarni and Brandt, 1998). All data elements have to be 
joined together leading to complicated queries (in SQL). Furthermore, it must be made 
possible for clinical researchers with little informatics background to define new extraction 
queries, hence the need for a visual query system. Because existing query systems from 
TrialDB (Nadkarni and Brandt, 1998), OpenSDE (Los, et al., 2005), Oracle Discoverer for 
life science data (Oracle, 2004), and IBM Data Discovery and Query Builder  (IBM, 2007) 
did not fit the uniform METABASE data model, the need for flattened extraction and the 
need for export to SPPS, it was decided to develop such a tool (which development will be 
described in detail in future publications). 
 
How about data from the clinic? | Originally, METABASE was targeted at clinical data 
that was collected during research studies (project-like). However, researchers wanted to 
include “production” data from the daily clinic into their analysis as well. Evaluations 
showed that the proposed solutions can also be used to distribute snapshots of data 
collected during daily operations within the hospital. Essential are the notion of Releases, 
the fact that from a research perspective everything boils down to “questions and answers”, 
and the point that visits can be nested (i.e., Visits refer to Visits by ParentID). 
 
How about calculated fields? | TCC is often asked not only to redistribute study data in 
their original format but also to transform it to better suit the researchers needs. Examples 
of these transformations include data aggregations, but also reformatting for specific 
analysis applications (e.g., SPSS), conversion, standardization, homogenization, and 
integration (e.g., equivalent data from separate studies). METABASE does not pre-compute 
at import time but the source database can of course include pre-computed values as answer 
to a kind of question (such as percentage response, drop outs, bias). Therefore there is a 
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need to support and ease extension of METABASE with such post-processing functionality 
when necessary. The exact forms of these transformations are not yet foreseen because it 
depends on specific studies and specific researcher requests. The expectation is that using 
(an extended version of) the METABASE concept we can build up a reusable post-
processing catalogue, i.e., a list of available post-processing algorithms. 
 
How about meta analysis? | Controlled vocabularies, such as the National Library of 
Medicine’s Unified Medical Language System (UMLS) (Lindberg, et al., 1993), Medical 
Subject Headings (MeSH) (Nelson, et al., 2004), or Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition (DSM-IV) (Association, 1994), are indispensable to ease 
integration and meta-analysis. They play a major role in the code and code list tables. 
Furthermore, we added “meta code lists and meta codes” to allow for the mapping of 
different codes upon each other. 
 
How about implementation? | Although it is outside the scope of this conceptual paper, 
we will say a few words about our implementation. Since METABASE is not a transaction 
processing system but the basis for analytical processing, we can quite freely add indices to 
the database of METABASE in order to boost performance. In order to reduce the number 
of joins during extraction and post-processing, we added the (redundant) attribute 
ReleaseID to all four tables on level L3. We decided to completely load each study release 
into METABASE. Alternatively, an approach could have been chosen where only the 
differences between releases were stored. While it may save storage space, this will make 
the queries much harder to formulate and to compute.  We implemented the one-attribute 
keys as auto-numbers to improve performance and reduce memory usage.  
6.5 Conclusions 
In conclusion, a hybrid data model that mixes traditional relational tables for “common” 
information over studies with the inverse notions of unflattening and (re)flatting, 
respectively needed to transform the “specifics” of study structures into a uniform system 
upon import and, vice versa, into “flat” result sets upon extraction, was essential for 
designing a system satisfying all requirements. Thus, we succeeded in developing a 
flexible, uniform, and web-based system to treat clinical trial databases and their historic 
releases in order to make data extractions available in a labour extensive way. The design 
decisions outlined in this paper can be of great value for other developers embarking to 
develop a METABASE-like system. 
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We here describe the MetaNetwork protocol to reconstruct metabolic networks using 
metabolite abundance data from segregating populations. MetaNetwork maps metabolite 
quantitative trait loci (mQTLs) underlying variation in metabolite abundance in individuals 
of a segregating population using a two-part model to account for the often observed spike 
in the distribution of metabolite abundance data. MetaNetwork predicts and visualizes 
potential associations between metabolites using correlations of mQTL profiles, rather than 
of abundance profiles. Simulation and permutation procedures are used to assess statistical 
significance. Analysis of about 20 metabolite mass peaks from a mass spectrometer takes a 
few minutes on a desktop computer. Analysis of 2,000 mass peaks will take up to 4 days. In 
addition, MetaNetwork is able to integrate high-throughput data from subsequent 
metabolomics, transcriptomics and proteomics experiments in conjunction with traditional 
phenotypic data. This way MetaNetwork will contribute to a better integration of such data 
into systems biology. 
Availability | download the MetaNetwork package and manual at 
http://gbic.biol.rug.nl/supplementary/2007/MetaNetwork.  
 
About Chapter 7 
This chapter reports the fourth of four 
case-studies. The purpose of this case was 
to refine the ‘generative strategy’ (Chapter 
2) for processing, in contrast to data 
management in Chapters 4-6: to enable 
processing steps to be chained together in 
alternative combinations. This required 
focus on ‘modular reusable assets’ (see 
Chapter 2) that have common input and 
output types such that they can ‘talk’ to 
each other (and to the Chapter 5 case), as 
well as ‘standardized’ naming and behavior 
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8. Discussion and Future work 
CASES 
4. Infrastructure for the 
wet-lab 
5. Infrastructure for the 
dry-lab 
6. Infrastructure for 
clinical trials 
7. Reusable assets for 
processing 




The genetic diversity of primary and secondary metabolites is incredibly high, notably in 
plants (Wink, 1988); however, our understanding of such metabolism and its regulation is 
still limited (Baxter and Webb, 2006). In a recent paper (Keurentjes, et al., 2006), we have 
made the first attempt to unravel the genetic architecture of METABOLISM in a model plant 
using “genetical metabolomics.” This is a derivative of the strategy of GENETICAL 
GENOMICS (Jansen and Nap, 2001) that has been applied in recent years to the genetic study 
of GENE EXPRESSION data in a wide range of organisms (Brem, et al., 2002; Bystrykh, et 
al., 2005; Chesler, et al., 2005; Cheung, et al., 2005; DeCook, et al., 2006; Hubner, et al., 
2005; Keurentjes, et al., 2007; Morley, et al., 2004; Schadt, et al., 2003; Yvert, et al., 2003). 
For TRANSCRIPTOME data, this strategy works as follows: determine gene expression 
(preferably genome-wide) in genetically different individuals, treat the transcript 
abundances of each gene over all individuals as a quantitative trait, use molecular markers 
to fingerprint the individuals, use QUANTITATIVE TRAIT LOCUS (QTL) mapping to identify 
regulators (expression quantitative trait loci (eQTL)) and (re)-construct regulatory 
networks. For such network reconstruction, correlations of either transcript abundances 
 (Bing and Hoeschele, 2005; Keurentjes, et al., 2007; Lan, et al., 2006) or eQTL 
profiles (Keurentjes, et al., 2007; Zhu, et al., 2004) are applied. Keurentjes et al. (2006) 
developed and applied a similar strategy to metabolite abundance data. 
Specifics of MetaNetwork 
Similar to the approach used in gene expression studies, the genetic determinants of 
variation for metabolite abundance (mQTL) can be mapped. However, algorithms used for 
the analysis of transcript abundance have to be accommodated to the specifics of metabolite 
abundance. In the work of Keurentjes et al. (2006), one-third of the mass peaks segregating 
were not present in the parental lines, presumably caused by new allelic combinations. 
Likewise, many segregating mass peaks were not present in an appreciable proportion of 
the segregants, causing clear spikes at zero in the corresponding metabolite abundance 
distributions. Standard parametric approaches for QTL mapping (e.g., t-test (Morley, et al., 
2004), ANOVA (Bystrykh, et al., 2005; Chesler, et al., 2005; Hubner, et al., 2005), 
maximum likelihood (Schadt, et al., 2003)) make use of the assumption that the residual 
variation follows a normal distribution and departure from this assumption due to a spike 
can inflate errors of type I and II (Broman, 2003). Standard non parametric approaches for 
QTL mapping (Wilcoxon–Mann–Whitney test (Brem, et al., 2002; Yvert, et al., 2003)) can 
solve this problem, but they are less useful in consideration of multiple QTL 
models (Broman, 2003). A more suitable approach is to perform QTL analysis on the 
binary trait defined by whether an individual has a non-zero abundance, and on the 
quantitative trait for those individuals who have non-zero abundance. To combine these two 
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analyses, METANETWORK implements a two-part parametric model (Broman, 2003) form 
QTL mapping and outputs QTL profiles (-10log P significance values plotted at marker 
positions along the genome). 
Network reconstruction approaches based on the correlation of transcript 
abundance (Bing and Hoeschele, 2005; Lan, et al., 2006) may also be suitable for 
metabolite abundance. However, whereas transcripts are translated into molecules of 
another type (proteins), metabolites are transformed by enzymes into molecules of the same 
type (other metabolites). Therefore, if one metabolite is the precursor of another metabolite, 
an mQTL involved in the transformation will exert reversed effects for the precursor and its 
successor. Counterbalancing of positive and negative effects of multiple mQTLs may make 
it difficult to infer associations between metabolites from abundance correlations. 
Metabolites in the same pathway will show similar peaks in their QTL profiles, so that a 
correlation analysis based on QTL profiles may overcome this problem. MetaNetwork 
subsequently uses such correlations to determine associations between metabolites and to 
re-construct metabolic networks. 
Challenges in MetaNetwork 
Within the context of the genetical genomics experimental space, MetaNetwork encounters 
numerous challenges due to the size and the scope of the data set and the complexity of 
metabolic networks. Testing multiplicity is obviously a general challenge in QTL 
mapping (Sabatti, et al., 2003). The genome-wide mapping of each of many (correlated) 
mass peaks can result in a large number of false positives and/or false negatives. 
MetaNetwork uses Storey’s method (Storey and Tibshirani, 2003) to control false discovery 
rate (FDR). Candidate gene multiplicity is another challenge: an mQTL may still harbor 
hundreds of candidate genes (Broman, 2005). Incorrect connections between metabolites 
affected by different enzymes may be predicted if the genes for those enzymes appear to 
colocalize on the genome. To predict or to prioritize candidates among many potential 
genes in a mQTL region requires additional strategies such as fine mapping and/or follow-
up laboratory experiments. Appropriate information can also be derived from the use of 
assumedly independent (in silico) information in databases with metabolic pathway 
information, such as KEGG (Kanehisa and Goto, 2000), MetaCyc (Zhang, et al., 2005) or 
AraCyc (Mueller, et al., 2003), or data on eQTL studies, enzyme activity assays, or 
phenotypic data on the same segregants. Mass peak multiplicity, that is, metabolites 
represented by multiple mass peaks, is another challenge (Dijkstra, et al., 2007). For 
example, a metabolite with mass m can have one or more charges and peaks can appear at 
masses m, m/2, m/3 and so on. Or different isotopes of this metabolite have different 
numbers of neutrons and peaks appearing at m+1, m+2, m+3 and so on. Unfortunately, 
error-free assignment of different mass peaks to a single metabolite is still difficult with 
today’s mass spectrometry methods (Tikunov, et al., 2005). However, MetaNetwork can 
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provide important independent information to improve on this: it can predict possibly 
related peaks based on highly correlated mQTL profiles (r > 0.95). 
Applications of MetaNetwork 
To date, our MetaNetwork applications have been based on untargeted metabolite 
abundance data collected from recombinant inbred lines (RILs) of Arabidopsis thaliana 
plants using LIQUID CHROMATOGRAPHY and MASS SPECTROMETRY 
technology (Keurentjes, et al., 2006). It measures a large range of different metabolites 
mainly involved in secondary metabolism, including phenylpropanoids, flavonoids and 
glucosinolates (Vos, 2007). Many of these metabolites show a spike in their abundance 
distribution and MetaNetwork was specifically developed to handle such data. However, 
the MetaNetwork protocol can equally well handle abundance datawithout 
spikes.Moreover, it can handle data obtained from other mass spectrometry techniques, 
such as gas chromatography–mass spectrometry (Lisec, et al., 2006) that can detect polar 
primary metabolites. 
In addition to mass spectrometry technologies for targeted or untargeted measuring 
amounts of metabolites (Keurentjes, et al., 2006; Kliebenstein, et al., 2001), other high-
throughput technologies for measuring amounts of other molecular entities, such as 
microRNAs, proteins and their posttranslational modifications, are rapidly being 
developed (Hoheisel, 2006). The methodology described here is directly applicable to these 
and other quantitative types of data and helps biologists to understand how biological 
systems function. 
Implementation of MetaNetwork 
MetaNetwork is implemented in  R, an open source software environment for statistical 
computing and graphics (Ihaka and Gentleman, 1996). MetaNetwork is executed via a 
command line. However, users with little experience of command-line-driven applications 
and/or computer programming can easily runMetaNetwork using default parameter 
settings. An advanced user of R can change parameter settings or modify the underlying 
protocol, for example, by replacing the module for calculation of correlations by one for 
calculation of mutual information (Butte and Kohane, 2000), or the module for QTL 
analysis on RILs by one for QTL analysis on other types of segregating or natural 
populations. Future MetaNetwork releases will offer more options, for example, multiple 
QTL analysis  (Jansen, 1993; Jansen, 2003) in the two-part model, combined analysis of 
metabolite abundance data with other types of biomolecular data (Keurentjes, et al., 2007) 
and direct access of the R-tools to a metabolite abundance database. A seamless software 
infrastructure that supports MetaNetwork data management and analysis workflows is 
under development using code generation techniques (Swertz and Jansen, 2007). For more 




Algorithm of MetaNetwork 
The flowchart of the MetaNetwork protocol is shown in Figure 1. Given the scope of this 
manuscript, we will limit ourselves to the definition of the two main steps in the procedure: 
QTL mapping of metabolite abundances; and reconstruction of metabolic networks from 
correlations of QTL profiles. It should be noted that MetaNetwork does not offer data pre-
Figure 1 | MetaNetwork flowchart. The shaded squares represent computational steps where 
names of R-functions are indicated between parentheses and the superscript numbers refer to
steps in Box 1. The ellipses represent significance thresholds and cylinders represent biological
results where the result names as R objects are indicated between accolades. The solid line
represents the step that is by default “on” in MetaNetwork and the dashed line represents the step 
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processing, for example, alignment of mass peaks has to be performed by external 
applications such as METALIGN (Vos, 2007). 
MetaNetwork detects the genetic determinants underlying variation in metabolite 
abundance with the help of a two-part QTL analysis. Part one tests whether the 
presence/absence ofmetabolites has a genetic basis: whether different genotype classes at a 
given marker differ in their numbers of non-zero observations. Part two tests whether 
quantitative variation in non-zero abundances has a genetic basis: whether the non-zero 
observations for each of these genotype classes at a given marker differ in mean abundance. 
The “P-VALUE” of the QTL is computed as the product of the two “P-values” in the two 
parts. With binary data only (no quantitative data) or quantitative data only (no spike), the 
“P-value” of the missing part is set to one. These “P-values” are not yet corrected for 
multiple testing at many markers and also not for testing multiple metabolites. 
MetaNetwork can run simulation and FDR procedures (Storey and Tibshirani, 2003) to set 
an empirical threshold for the “P-values” at desired multiple-testing significance levels. 
MetaNetwork will output all relevant information such as the estimated effect of each 
mQTL, its support interval on the genome and the proportion of variance explained by it 
(see Box 1). 
MetaNetwork explores the associations between metabolites by comparing theirQTL 
profiles based on correlations. A permutation procedure sets an empirical threshold for the 
correlation at a desired significance level. MetaNetwork generates files with network 
connections that can be visualized using CYTOSCAPE, an open source software suite for 
visualization of biomolecular interactions (Shannon, et al., 2003) (see Box 1). 
7.2 Materials 
EQUIPMENT 
• Computer operating systems: Windows XP, GNU Linux or Mac OS X  
• R (http://www.r-project.org): software environment for statistical computing and 
graphics. The R application (current version 2.4.1) and installation manual can be 
found at http://www.r-project.org. In this paper, we assume an application under 
Windows XP 
• Required R-packages: “qvalue” for FDR control. R packages can be easily installed via 
Packages | install package(s). The user can choose a mirror site close to his location 
and then select the package “qvalue” for installation. Please go to http://www.r-
project.org for help if necessary 
• MetaNetwork package, user manual and example data files can be downloaded from 
http://gbic.biol.rug.nl/supplementary/2007/MetaNetwork  and saved locally. Install 
MetaNetwork package via Packages | install package(s) from local zip files: browse the 
zip file of MetNetwork package 
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• Cytoscape: open source software for visualizing biomolecular interaction networks. 
Cytoscape (current version 2.3.2) can be downloaded from http://www.cytoscape.org. 
Cytoscape requires Java version 1.4.2, which can be downloaded from 
http://java.sun.com/j2se/1.4.2/index.jsp 
7.3 Procedure 
Preparing and starting 
1| Prepare input files. Three kinds of information are required in QTL analysis: the genetic 
linkage map of molecular markers (markers, see Table 1); the genotypes of each individual 
at each marker position (genotypes, see Table 2); and the trait values (metabolite 
abundances) of each individual (traits, see Table 3). Optionally, the user can provide mass 
weight information for the mass peaks, to allow for a combined analysis of mass data and 
QTL profiles (peaks, see Table 4). The files should be formatted as COMMA SEPARATED 
VALUES (CSV), for example, as “markers.csv,” “genotypes.csv,” “traits.csv” and 
“peaks.csv,” respectively. Files can be formatted by using Microsoft’s Excel via File | Save 
as, and choosing the file type “CSV (comma delimited) (*.csv)” from the pull-down menu 
of “Save as type.” 
 
2| Load the MetaNetwork package by starting the R application and typing the command  
> library(MetaNetwork) 
This loads the functions of MetaNetwork and the required qvalue package. 
 
3| Change the working directory (optional). The default directory of R is most likely to be 
“C:/Program Files/R/R-2.4.1,” where R is installed. Users can change it to the directory 




The order of Steps 4–7 does not matter. 
4| Load the marker data. Load marker data (see Table 1 for format) from a file into an R 
object using the function “loadData,” for example, load file “markers.csv” into R object 
“markerData” using the command 
> markerData <- loadData("markers.csv") 
If the user did not set the working directory in Step 3, he should give the full path of the 
file. The same holds for Steps 5–7. 
> markerData <- loadData("C:/MetaAnalysis/markers.csv") 
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5| Load the genotype data (see Table 2 for format) using the command 
> genotypeData <- loadData("genotypes.csv") 
 
6| Load the trait data (see Table 3 for format) using the command 
> traitData <- loadData("traits.csv") 
 
7| Optionally, load the peak data (see Table 4 for format). Load peak data to allow for a 
combined analysis of peak masses and QTL profiles using the command 
> peakData <- loadData("peaks.csv") 
Running the analysis 
8| Run MetaNetwork. Run the “MetaNetwork” function on data from previous steps and 
with default settings using the command 
>MetaNetwork(markers=markerData, genotypes=genotypeData, traits=traitData, 
spike=4) 
Table 1 | Example table of marker data 
 Chr cM   
PVV4 1 0.0   
AXR-1 1 6.4   
HH.335C-Col 1 10.8   
… … …   
Data should be formatted as comma separated 
values (“*.csv”). A “markers” file consists of a table 
with marker positions, where rows represent 
markers and columns represent their positions: 
column 1 represents the chromosome number and 
column 2 the genetic map position in centi-Morgan 
(cM). 
 
Table 2 | Example table of genotype data 
 RIL1 RIL3 RIL4 … 
PVV4 1 1 2 … 
AXR-1 1 1 2 … 
HH.335C-Col 1 1 1 … 
… …  … … 
A “genotypes” file consists of a table of 
genotype data, where rows represent the 
markers and columns represent individuals. For 
recombinant inbred lines, the genotype values 
are “1” or “2” for two homozygous genotypes, 
respectively. The marker names should be 
consistent with marker map (Table 1) and 
missing values should be represented as “NA” 
Table 3 | Example table of trait data. 
 RIL1 RIL3 RIL4 … 
LCavg.1537 NA 942 2402 … 
LCavg.1594 NA 4 10 … 
LCvag.1610 NA 55 62 … 
… … … … … 
A “traits” file consists of a table of phenotype trait 
values, for example, metabolite mass peak 
intensities, where rows represent metabolite mass 
peaks and the columns represent individuals. The 
names of individuals should be consistent with 
those in the genotypes file (Table 2) and missing 
values should be represented as “NA”. 
 
Table 4 | Example table of peak data 





A “peaks” file consists of a table which (column 
2) provides mass/charge values for each trait 
(column 1). The trait names should be 




The arguments “markers,” “genotypes” and “traits” take values from the R objects 
“markerData,” “genotypeData” and “traitData” loaded in Steps 4–6. Absence of a mass 
peak in a considerable number of individuals leads to signal intensities equal to or less than 
the detection limit and therefore causes a spike in the trait distribution at zero. The 
argument “spike” has to be specified to separate presence/absence (binary) from available 
trait abundance (quantitative) in the trait data, for example, here using a threshold of four 
times the local noise3. The order of arguments does not matter (see Table 5). The above 
command will run analysis steps A–E and G by default (see Box 1). These steps can be 
individually excluded from, or optional steps F and H can be included in, the analysis using 
the commands outlined in Box 1. During MetaNetwork analysis (see Box 1), a summary of 
the process (e.g., the progress of the procedure, generated R objects and output files and the 
Figure 2 | The view of the R console for the MetaNetwork application. The procedures, R object 
names and file names for saving results and processing times are shown. 
> library(MetaNetwork)
Loading required package: qvalue
Step A: QTL mapping....
         result in R object 'qtlProfiles'
         result in ./MetaNetwork/qtlProfiles.csv
         process time 27.87 sec
Step B: Simulation test ( n = 1000 ) for QTL significance (-log10P) threshold ...
alpha-0.05: QTL threshold = 4.087587
fdr = 0.05 : QTL threshold = 1.105846
choose most stringent QTL threshold in R object 'qtlThres':
logp = 4.09; FDR = 0.0002231022
process time 19.37 min
Step C: QTL summary....
         result in R object: 'qtlSumm'
         result in ./MetaNetwork/qtlSumm.csv
         process time 1.84 sec
Step D: Zero-order correlation ....
         result in R object: 'corrZeroOrder'
         result in ./MetaNetwork/corrZeroOrder.csv
         process time 4.09 sec
Step E: 2nd-order correlation ....
         result in R object: 'corrSecondOrder'
         result in ./MetaNetwork/corrSecondOrder.csv
         process time 6.17 sec
Step F: Permutation test for 2nd-order correlation significance threshold...skipped
         using user-provided correlation threshold: 0
Step G: Create Cytoscape network files...
         SIF file is: ./MetaNetwork/network.sif
         EDA file is: ./MetaNetwork/network.eda
Step H: Detection of peak multiplicity...skipped
> qtlPlot(markerData, qtlProfiles, qtlThres)
> setwd(”C:/MetaAnalysis”)
> genotypeData <- loadData(”genotypes.csv”)
> traitData    <- loadData(”traits.cvs”)
> markerData   <- loadData(”markers.csv”)
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computing time) will be displayed in the R Console (see Figure 2) and saved in the file 
“output.txt” for future reference. 
 
CRITICAL STEP R objects exist only during the working period of the R Console. To 
serve later MetaNetwork analyses, R objects can be saved during closure of the R console. 
Visualization 
9| QTL profiles visualization. The QTL likelihood along the genome (-10logP calculated at 
each marker position) can be visualized in R with function “qtlPlot” using the command 
>qtlPlot(markers=markerData, qtlProfiles=qtlProfiles, qtlThres=qtlThres) 
where argument “markers” takes values from object “markerData” generated in Step 4; 
argument “qtlProfiles” is the QTL test statistic and takes the values in the object 
“qtlProfiles” generated in Step 8A (see Box 1) of MetaNetwork; argument “qtlThres” is the 
threshold for significant QTLs and takes the value from object “qtlThres” generated in Step 
8B of MetaNetwork. 
 
10| Network visualization using Cytoscape. Launch Cytoscape and choose “File | Import | 
Network (multiple file types)” to load network file (“network.sif”) and “File | Import | Edge 
Attributes” to load edge attributes file (“network.eda”) generated in Step 8G (see Box 1). 
Different layout and visualization styles can be applied to view the network, for example, 
applying the threshold “corrThres” from Step 8F (see Box 1) as a filter to only show 
significant edges. For details, please see the Cytoscape manual (http://www.cytoscape.org). 
 
TIMING  
FIGURE 2 shows the timing of the analysis of 24 metabolites from 162 RILs in 
Arabidopsis at 117 markers3, using a Windows XP PC with an AMD Athlon 64 CPU 
(2.20 GHz) and 1 GB of RAM. The computation time increases with the number of traits 
and markers: linearly for QTL mapping (Steps 8A and C), and quadratically for correlation 
(Steps 8D and E) and peak multiplicity finding (Step 8H). The computation time of QTL 
threshold simulation (Step 8B) and correlation threshold permutation (Step 8F) increases 
linearly with the number of simulations/permutations. The timing for optional steps 8F and 
H are not shown: 10,000 permutations take 5,270 min (use of a computer cluster is 
suggested); peak multiplicity finding takes a few seconds. The total computation time for a 
default MetaNetwork analysis of 2,000 mass peaks is up to 4 days. 
 
OPTIONS  
The arguments of MetaNetwork are described in Table 5. 
 
TROUBLESHOOTING 
The most important sources of error and possible solutions are given in Table 6. 
  
Box 1 | Processes of MetaNetwork analysis (step 8) 
 
MetaNetwork will firstly check the order of the markers in “markers” and “genotypes” and 
the order of the individuals in “genotypes” and “traits”. MetaNetwork will re-order the 
values if necessary and gives an error message about possible inconsistencies between 
the data. After this data check, MetaNetwork will start its multiple analysis steps. See also 
Figure 1 and Figure 2. 
 
(A) mQTL mapping using a two-part model. MetaNetwork calls the function 
‘‘qtlMapTwoPart’’ and computes log-transformed ‘‘P–values’’ (-10log P) for mQTL 
likelihood. The -10log P values are positive since 0 < P <1. However, the function 
‘‘qtlMapTwoPart’’ assigns a positive or negative sign to indicate the direction of the mQTL 
effect; a positive sign indicates that individuals with genotype “2” at the mQTL have more 
non-zero and/or higher non-zero abundance observations than those with genotype “1”; a 
negative sign indicates that the reverse has been observed. The results are saved in R 
object “qtlProfiles” and file “qtlProfiles.csv”. MetaNetwork skips Step A when argument 
“qtlProfiles” is set, for example, to use QTL profiles previously computed and stored in R 
object “qtlResult”, using the command 
 
> MetaNetwork(markers=markerData, genotypes=genotypeData,    
  traits=traitData, spike=4, qtlProfiles=qtlResult) 
 
(B) Computation of thresholds for significant mQTLs. MetaNetwork calls the functions 
“qtlThreshold” and “qtlFDR” to generate an empirical threshold for significant mQTL. The 
function “qtlThreshold” computes “P-values” in 1,000 simulations and derives a genome-
wide threshold at a = 0.05 level. The function “qtlFDR” computes a multiple-testing 
threshold at q = 0.05 level (Storey and Tibshirani, 2003) as control for the multiple testing 
among all etabolite mass peaks in “traits”. The more stringent threshold from the two tests 
is saved in R object “qtlThres” and is used in later steps. Step B will be skipped when 
argument “qtlThres” is set, for example, to use thresholds previously computed and stored 
in the R object “qtlThres”, using he command 
 
> MetaNetwork(markers=markerData, genotypes=genotypeData, 
traits=traitData, spike=4, qtlThres=qtlThres) 
 
(C) mQTL summary analysis. MetaNetwork calls the function “qtlSummary” to 
summarize mQTLs, containing information for their map positions, likelihood, additive 
effects, 1.5-drop off support intervals and the percentages of explained variation. The 
results are saved in R object “qtlSumm” and file “qtlSumm.csv”. Step C will be skipped 
when argument “qtlSumm” is set, for example, to use summary information previously 
computed and stored in the R object “qtlSumm”, using the command  
 
> MetaNetwork(markers=markerData, genotypes=genotypeData, 
traits=traitData, spike=4, qtlSumm=qtlSumm) 
 
(D) Zero-order correlation between metabolites. MetaNetwork calls the function 
“qtlCorrZeroOrder” to compute pairwise zero-order correlation coefficients among 
metabolites. Argument “corrMethod” provides two options: when set to “qtl” (default), the 
correlation between QTL profiles is calculated; when set to “abundance,” the Spearman 
correlation between metabolite abundances is calculated. The results are saved in R 
object “corrZeroOrder” and file ‘‘corrZeroOrder.csv.’’ Step D will be skipped when 
argument “corrZeroOrder” is set, for example, to use correlations previously computed and 
stored in the R object ‘‘corrZeroOrder,’’ using the command 
 
> MetaNetwork(markers=markerData, genotypes=genotypeData, 
traits=traitData, spike=4, corrZeroOrder=corrZeroOrder) 
 
  
Box 1 | Continued 
(E) Second-order partial correlation analysis. MetaNetwork calls the function 
“qtlCorrSecondOrder” to compute pairwise second-order partial correlation. Partial 
correlation between two metabolites is the correlation corrected for covariance and can 
remove spurious correlation due to common anteceding causes or intervening variables. 
Therefore, it is a technique for discovering meaningful associations (de la Fuente, et al., 
2004). The results are saved in R object “corrSecondOrder” and file 
“corrSecondOrder.csv”. Step E is skipped when argument “corrSecondOrder” is set, for 
example, to use correlations previously computed and stored in the R object 
“corrSecondOrder”, using the command 
 
> MetaNetwork(markers=markerData, genotypes=genotypeData, 
traits=traitData, spike=4, corrSecondOrder=corrSecondOrder) 
 
(F) Computation of the significance threshold for partial correlation coefficients. To 
include optional step F, the argument “corrThres” must be set to NULL using the command 
 
> MetaNetwork(markers=markerData, genotypes=genotypeData, 
traits=traitData, spike=4, corrThres=NULL) 
 
MetaNetwork then calls the function “corrThreshold” to generate an empirical significance 
threshold for partial correlation coefficients different from zero. The function 
“corrThreshold” derives the threshold at Bonferroni-corrected significance level of a = 0.05 
from 10,000 permutations. This step is computer-expensive (see TIMING) and is therefore 
skipped by default. The results are saved in the R object “corrThres”. 
 
(G) Generation of network files for visualization. MetaNetwork calls the function 
“createCytoFiles” to output a network file (“network.sif”) and an edge-attribute file 
(“network.eda”) for significant correlations. These two files can be loaded into Cytoscape 
for graph visualization. Users who do not want to visualize the networks in Cytoscape can 
skip Step G by setting argument “cytoFiles” to FALSE, using the command 
 
> MetaNetwork(markers=markerData, genotypes=genotypeData, traits=
 traitData, spike=4, cytoFiles=FALSE) 
 
(H) Peak multiplicity prediction. To include optional Step H, the argument “peaks” must 
be set to include peak data loaded in Step 7 using the command 
 
> MetaNetwork(markers=markerData, genotypes=genotypeData, 
traits=traitData, spike=4, peaks=peakData) 
 
MetaNetwork then calls function “findPeakMultiplicity” to relate multiple mass peaks for the 
same metabolite, outputting information about related peaks, their correlation coefficients, 
masses, mass differences, mass ratios and predicted relationships. If two mass peaks are 
highly correlated (r=0.95) and their mass difference is 1 or 2, or their mass ratio is 2, 3 or 
1/2, 1/3, they are predicted to be multiple peaks of the same metabolite (isotopes, multiple 
charges). The results are saved in the R object “peakMultiplicity” and file 
“peakMultiplicity.csv”. This step can be included if the peak data have not yet been 
cleaned for peak multiplicity. 
 
For description of each argument, see also Table 5. A detailed description of each 
function can be found in METANETWORK SUPPLEMENTARY MANUAL and R-help. For 
example, users can get information about the function “MetaNetwork” or about argument 




Table 5 | The description and possible values of the MetaNetwork arguments and their 
relationship with subfunctions 
Arguments Description Possible value(s) Subfunctionc 
markersa Map position 
of all marker 
loci 
 
A matrix of marker positions. 
The rows represent markers and 
the columns represent the 
chromosome number (column 1) 
and centi-Morgan (cM) the 
position on the chromosome 
(column 2). The values should 
be numeric and the markers 






A matrix of marker genotypes for 
each marker and each 
individual. The rows represent 
markers that should have the 
same order as in ‘‘markers’’ and 
the columns represent 
individuals. The values should 
be numeric: values “1” and “2” 
for the two homozygous 
genotypes, respectively, and 







A matrix of phenotypes for each 
trait and each individual. The 
rows represent traits and the 
columns represent individuals 
that should have the same order 
as in “genotypes”. The values 
should be numeric and “NA” is 





spikea Value for  
“null” 
phenotype 
A numeric cutoff value: any trait 
observation below this cutoff 
value is considered ‘‘noise’’ and 






peaksa Mass weight A one column matrix of mass 
weight for each mass peak. The 
rows represent mass peaks with 
trait names as row names. The 
values should be numeric and 
“NA” is for the missing value 
findPeakMultiplicityH 
qtlProfilesb QTL A matrix of log-transformed ‘‘P- qtlMapTwoPartA,d 





values’’ ( -10log P) for linkage 
between markers and traits. The 
rows represent the markers and 
the columns represent the traits. 
By default, +/- sign is added to 
indicate the sign of the mQTL 
effect: positive if the mQTL has 
higher metabolite abundance for 
individuals with genotype “2” 
than for those with genotype “1”; 
values are negative if the 






The threshold used to assess 
whether marker-based ‘‘P-
values’’ (-10log P) are significant 






qtlSummb Summary of 
QTL 
Data frame with the following 
headers: traitName: name of 
trait; QTLchr: the chromosome 
number where an mQTL locates; 
QTLmk: the name of the marker; 
QTLleft: the cM position of the 
left border of an mQTL; TLpeak: 
the cM of the marker; QTLright: 
the cM position of the right 
border of an mQTL; -log P: the -
10log P value of an mQTL; 
VarP1: the percentage of 
qualitative variance explained by 
an mQTL; VarP2: the 
percentage of quantitative 
variance explained by an mQTL; 
additive: the half difference of 
metabolite abundance between 




The matrix of pairwise 
correlation coefficients on mQTL 






The matrix of pairwise second-
order partial correlation 




corrThresb Threshold The threshold used to find partial 









If corrMethod=”qtl” (default), it 
calculates the correlation 
between metabolites based on 
QTL profiles . If 
corrMethod=”abundance”, it 
calculates the Spearman 
correlation between metabolites 
based on metabolite abundance 
profiles. 
 
cytoFiles  Logical values “TRUE” or 
“FALSE” for writing network files 
(“network.sif” and “network.eda”) 




The path where output files will 
be saved. The default is to set a 
new directory MetaNetwork 
under the current working 
directory 
 
aInput from users. bIntermediate argument that can be generated during the MetaNetwork process (can also 
be called output) or specified by users. cThe subfunction in which the arguments are required. dThe 
subfunction will be called to generate values for intermediate arguments if users do not define their values. 
A–HThe corresponding steps in MetaNetwork (Box 1). 
Table 6 | Troubleshooting table 
Problem Possible reason Solution 
Error: marker names 
do not match in 
marker and genotype 
files. Or individual 
names do not match 
in genotypes and 
traits files 
The marker names in 
markers and 
genotypes files and 
the individual names 
in genotypes and 
traits file are not 
identical 
MetaNetwork will first check the order of 
markers and individuals in “markers”, 
“genotypes” and “traits”. This error occurs if 
their names are not consistent among the 
three files. Check the names of markers and 
individuals in those files 
Error: Cannot find 
objects or incorrect 
values 
Argument missing or 
not appropriate for 
analysis 
Occurs when user-defined values are not 
appropriate for analysis 
Warning: A directory 
already exists 
The specified output 
directory already 
exists 
When you want to save results in a specified 
directory, the program will try to create this 
directory. If the directory exists, you will get 
this warning. The result can still be saved in 
this directory, so you can ignore this warning. 
To avoid it, use a new directory name 
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7.4 Anticipated results 
MetaNetwork was used for the genetic study of ~2,000 mass peaks in 162 RILs of 
Arabidopsis generated from a cross between the distant accessions Landsberg erecta (Ler) 
and Cape Verde Islands (Cvi) (Keurentjes, et al., 2006). These individuals have been 
genotyped at 117 markers which are nearly evenly distributed along the genome. The 
network correlations as predicted by the MetaNetwork protocol were verified against 
previous knowledge (Kliebenstein, et al., 2001; Kliebenstein, et al., 2001; Kliebenstein, et 
al., 2001; Kroymann, et al., 2001) for 18 aliphatic glucosinolates and six glycosylated 
flavonols, all products of secondary metabolism. We use this small data set as an example 
of the type of results that can be anticipated. All data are shipped with the package and can 




Alternatively, users can load data and test MetaNetwork simply by command line 
> example(MetaNetwork) 
Mapping genetic determinants 
The QTL likelihood along the genome as stored in “qtlProfiles” is visualized with the 
function “qtlPlot,” loaded by > data(qtlProfiles) and visualized by > qtlPlot(markers, 
qtlProfiles, 4.11). At the empirical -10log P threshold 4.11 (α=0.05, FDR=0.0003), the 
glucosinolate mQTLs map to two major loci, which were confirmed by a previous targeted 
study (Kliebenstein, et al., 2001): gene AOP at 9.0 cM of chromosome 4 is responsible for 
glucosinolate side-chain modification (Kliebenstein, et al., 2001), and gene MAM at 35 cM 
of chromosome 5 is responsible for chain elongation (Kroymann, et al., 2001). The 
observation that all glucosinolates have a QTL at MAM but only some of them have a QTL 
at AOP suggests that AOP acts downstream of MAM (Figure 3a). The mQTL at MAM 
exerts the same sign of effect for all glucosinolates that are in the same branch of the 
network, whereas the mQTL at AOP exerts reversed effects on precursors and their 
successors. Six flavonols showed strong mQTLs at 88.6 cM of chromosome 1, where a not 
previously known glycosyl transferase or regulator was suggested3 (Figure 3b). 
The mQTLs can underlie binary variation of presence/absence of the metabolite, 
quantitative variation of metabolite abundance or both types of variation in the segregants 
(Figure 3c). For the detected 52 mQTLs, 22 mQTLs only underlie quantitative variation; 
seven mQTLs predominantly underlie binary variation and the rest underlies both types of 
variation. For example, two flavonols showed mQTLs 88.6 cM of chromosome 1 that 
underlie only quantitative variation, whereas the four other flavonols showed mQTLs at 
that position that underlie both binary and quantitative variation. Further interpretation of  
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Figure 3 | The visualization of metabolic QTL profiles and networks.  (a) The mQTL profiles 
for ten aliphatic glucosinolates before AOP catalysis (upper part) and eight after AOP catalysis
(lower part). The mQTL at 303.3 cM on chromosome 4 is at the AOP locus. The mQTL at 409.4
cM on chromosome 5 is at the MAM locus. A positive (negative) sign indicates that individuals
carrying the Cvi allele have higher (lower) abundance than individuals carrying the Ler allele. The
different colors represent different carbon chain lengths (black 3C; red 4C; green 5C; blue 6C; 
light blue 7C). (b) The mQTL profiles for six glycosylated flavonols. The mQTL at 88.6 cM on
chromosome 1 is a putative glycosyl transferase, catalyzing the production of
flavonoldihexosides. The different colors represent different aglycone classifications (black: 
quercetin; red: kaempferol; green: isorhamnetin), different line types represent different
glycosylation patterns (solid line: dihexoside; dashed line: hexoside). (c) The detected mQTLs
explain a percentage of the total variation observed between the RILs: the percentage of variance
explained for the binary presence/absence of metabolite is on the x axis; the percentage of
variance for the non-zero quantitative metabolite abundance is on the y axis. The green dots
represent MAM mQTLs for glucosinolates; the red dots represent AOP mQTLs for glucosinolates;
the blue triangles represent mQTLs for flavonols. (d) Visualization of the metabolic network using
Cytoscape. The nodes represent different metabolites and the edges represent significant 
correlations. Glucosinolates are presented in a different color based on their carbon chain
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these mQTLs can be obtained from the QTL summary “qtlSumm,” loaded by > 
data(qtlSumm). 
A combined analysis of mass data and QTL profiles predicted that a single 
glucosinolate can have up to six mass peaks (1.2 on average, 6 glucosinolates had 3–6 mass 
peaks); a single flavonol can have up to four mass peaks. 
Metabolic network (re)-construction 
MetaNetwork computes the zero-order correlation “corrZeroOrder” and second-order 
partial correlation “corrSecondOrder” between pairs of metabolites, loaded by 
>data(corrSecondCorr) and >data(corrZeroOrder), respectively. Thirty-one second order 
correlations were significant at a Bonferroni-corrected a=0.05 level (“corrThres”=0.14 from 
20,000 simulations). These significant correlations are plotted using Cytoscape (Figure 
3d). We can observe that glucosinolates and flavonols are separated into two networks 
because they have different mQTLs. 
The similarities between the reconstructed and known glucosinolate pathway validate 
the approach, and the dissimilarities may suggest (but do not prove) possible previously 
unknown steps in the formation of glucosinolates. In the constructed network for 
glucosinolates (left in Figure 3d), edges for the known transformation between the 
methylthio group and the methylsulfinyl group were always observed. But novel edges 
between metabolites were also observed, for example, the edge linking 2-propenyl to 4-
methylthiobutyl (but the biochemical linkage may be indirect, that is, due to coregulation 
by the same mQTL). The reverse additive effect of the AOP locus for 4-hydroxybutyl, 2-
propenyl and 4-benzoyloxybutyl formation shows that regulation can be completely 
different for different growth stages (Keurentjes, et al., 2006).Except one flavonol, all 
pairwise partial correlations among the other five flavonols remain significant (right in 
Figure 3d). Colocation of mQTLs of these sixflavonols suggests that the biochemical 
linkages are indirect, that is, variation in their abundance is attributable to a single locus 
affecting glycosylation of the basic flavonoid backbone (Keurentjes, et al., 2006). These 
results show how the combined genetic and metabolomic approach allows the 
(re)construction of metabolic pathways. It can provide an independent line of evidence to 
create new knowledge or to validate or modify current knowledge. Even an untargeted 
approach can therefore facilitate the annotation of metabolites and show that they play a 
role in existing or new pathways (Keurentjes, et al., 2006). Although MetaNetwork can 
identify meaningful associations between metabolites, it can obviously not prove causality 
(i.e., that there are true biochemical linkages between highly correlated metabolites). Any 
output should therefore be treated as an independent source of information solely for the 
use of hypothesis formation and be used as guidelines for future experimental confirmation.  
Although MetaNetwork is developed for and has been applied to metabolite data, its 
theoretical basis readily extends to other high-throughput quantitative measurements such 
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as gene and protein expression. We expect that MetaNetwork will prove increasingly useful 
in elucidating systems genetics. 
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Chapter 8 
Discussion and Perspectives 
The advent of a growing range of diverse biomolecular technologies has boosted biological 
and medical research, however, slow production of these infrastructures has become a 
barrier to progress to optimally exploit the data produce. Software infrastructures must 
accommodate the specifics of their biological system, but appropriate mechanisms to 
support variation have been lacking. 
In this thesis we have developed innovative and powerful methods for the production, 
maintenance and evolution of the ‘dynamics’ software infrastructures needed. Leading 
principle was to exploit (mostly informatic) commonalities within a ‘software family’ of 
bioinformatics infrastructures while dealing with (mostly biological) variation in a 
systematic manner. We argued that a strategy that goes ‘beyond standardization’ using a 
minimal computer language to describe what biologists need, and a software tool such as a 
generator or interpreter to automate software implementation, can be used to quickly 
produce customized software infrastructures to suit particular experiments. We made tools 
publicly available to use this strategy in practice, enabling bioinformaticians to generate 
tailored software infrastructures for research efficiently and evaluated the strategy, methods 
and tools in four case studies.  
In this chapter we will first summarize and discuss the benefits for the ‘generative’ 
strategy for local software infrastructures. Then we discuss how use of these strategies will 
(and actually, is) changing the practice of software development in the bioinformatics 
community. Third we will discuss the prospects of using generative tools for the integration 
of data and software resources around the world. Finally we will outline next steps for 
biologists, bioinformaticians and computer scientists towards a future with many more 
benefits for the generation of ‘software biologists want to have’. 
8.1 A suitable software infrastructure for each biologist 
Early 2002 we developed a software infrastructure for a microbial research group 
embarking on microarray experiments. The project aimed to provide researchers with a 
central place on the Internet where all researchers involved, now and in the future, can 
retrieve and understand experiments, download data for analysis and re-analysis, and add 
and manage new experiments. 
The first generation 
The project was challenging in many ways. Understanding the complex world of 
microarray experiments requires much effort, having protocols with many steps and 
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biomaterials, and numerous properties which meaning and function are not obvious (see 
Figure 1 in Chapter 4). Opportunities to reuse standard solutions are limited because 
needs differ between research groups. Also technically the biology domain is demanding 
because of the large datasets and complicated data types (in comparison to application 
domains like ‘finance’). Moreover, insights on how to best organize and execute these 
novel microarray processes were still evolving. We anticipated multiple evolutions of the 
software to sharpen insights of biologists and software developers before we would reach 
the level needed to ‘get it right’.Luckily for this thesis, we had a limited time budget of only 
four months. Using traditional software development methods, we would not make it.  
To keep up with the researchers we developed a ‘stock’ of semi-finished components. 
Each component contained common functionality that we expected to need in each 
evolution, e.g. for database storage, data access, and visualization. In order to produce a 
new software version (better tailored to what biologists needed) we now only had to 
program those parts that were variable. While a big improvement compared to developing 
each software version in isolation, use of this framework still took too much time between 
versions (weeks). For each new/changed biological we would still need to edit many parts 
of the software, e.g., addition of an ‘extraction step’ would require changes in database 
structure, data access tools, and user forms.  
To further speed up the design-implement-evaluate cycle, we created a little ‘domain 
specific language’ (see Figure 2 in Chapter 3, Figure 4 in Chapter 5 and Supplementary 
Information for examples of DSL). Using this DSL, we can much more compactly 
describe the necessary new or changed biological features. We also created a generator that 
automatically translates this language into the various software codes that are necessary to 
tailor and glue the stock of reusable components together. Figure 1 summarizes the 
benefits of the transition to a domain specific language to decimate the ‘implement’ step 
and thus shorten the design-implement-evaluate cycle to a day, with most time spend on 
features to support biology and not on technical issues.  
Using these methods, we delivered the tailored software, called ‘Molecular Genetics 
Information System’ (MOLGENIS) to the microbe research group on time and within 
budget. The system has been in use since then, with some more evolutions, to store 
hundreds of experiments (Chapter 4). In this thesis we asked ourselves the question: can 
other bioinformaticians benefit from this ‘generative’ strategy? 
We did the work, so you do not have to  
We initiated a pilot study to evaluate the potential of the MOLGENIS generator. We 
collaborated with three more research groups/companies also involved in microarrays, but 
then on animal, plant and human samples instead of microbial samples. In a few weeks, we 
described their needs in three new ‘application models’ using MOLGENIS’ domain 
specific language. Thus, we extended the MOLGENIS ‘software family’ with three more 
software variants with appropriate variations to accommodate various species and 
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difference in experimental design, e.g. microbes have no ‘tissue’, or animal samples might 
be ‘pooled’.  
These initial results were promisin but as with the first implementation of any new 
strategy, we found shortcomings in our implementation that limited further progress. 
Improvement of the generator was too complicated. For example, some groups desired a 
‘high performance’ variant of MOLGENIS that could load raw microarray data files into 





















Figure 1 | Efficiently evolving software infrastructures.  
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Development of a software infrastructure requires description (‘implementation’) of what is needed 
in computer executable code. Programming the first computer was much work (big black arrow) 
because all application logic had to be specified directly in such low-level, computer executable 
coden. To reduce the hand-work, higher-level languages have been created, where compilers 
automate the translation into this computer codeo. These languages have a general purpose and 
provided fine-grained commands that in combination can be used to build almost any software. 
Unfortunately, still many of these commands are needed to build a complete software application. 
General and domain specific libraries and frameworks of (semi)finished components written in these 
languages have been created to reduce the work a bit more by easing reusep. Domain specific 
languages are the next level: while they cannot describe ‘any software’, they greatly reduce the 
amount of code that needs to be created/maintained for ‘specific types of software’q. Reducing the 
amount of hand-written code is essential in biology where software is constantly evolving to keep up 




However, to implement these changes the original MOLGENIS generator required changes 
in nearly every program source file, due to a tight coupling of the language parser, the 
reusable components and an monolithic generator. Moreover, each MOLGENIS instance 
required a web server to run making it impossible to use, e.g. as building block for (non-
webbased) data processing tool. 
With these and more lessons learned the hard way, we put in a large effort to rewrite 
the MOLGENIS generator completely (see also Table 2 and Box 2 in Chapter 2, and 
Chapter 3). We separated and modularized the domain specific language parser, reusable 
assets and generators, and rewrote them in a general programming language not requiring a 
web server (Java instead of PHP). For example, each feature now has its own generator, 
which allows addition of a new generation step just by creating a new generator, i.e. one 
program file and one template file (detailed in Chapter 3).  
Benefits 
We have build new MOLGENIS variants for microarrays (Chapter 4), genetical genomics 
(Chapter 6), and clinical trials (Chapter 7), founding up to 40 times efficiency gains 
(Chapter 3). We also translated proven software systems into MOLGENIS, such as the 
microarray database BASE (Chapter 3), the complex traits repository GENENETWORK, 
and the MOUSE PHENOME DATABASE (see below). ‘Molgenisation’ these existing systems 
allowed us to add MOLGENIS functionality for data management, R interfacing (etc.) to 
their rich function sets. We have evolved the function set of MOLGENIS with additional 
tools for biologists to import/export large data sets, and with additional interfaces for 
bioinformaticians in R and Web Services (Chapter 5). After regeneration, each new feature 
is available to all members of the MOLGENIS family, i.e. to each system generated with 
the MOLGENIS generator. 
Besides the obvious reductions of efforts, we learned that there are positive side 
effects of generation. First, there is the uniformity of the generated applications, a feature 
highly appreciated by the users. Next, there is the extreme consistency of the software code, 
which makes it easier to understand and use by programmers, and to integrate and maintain 
the program code into other software. Moreover, generators do not make incidental errors 
as humans do, easing testing and bug fixing. Finally, if a new or improved generator is 
added then all family members benefit by re-generation. This allows much richer features 
than we could have provided if we would have developed each software variant in isolation. 
There are more variation mechanisms 
With the ‘golden hammer’ of code generation in hand, everything might start to look like a 
nail. However, developing a generator obviously takes more effort than writing one to-be-
generated file directly (see Chapter 3). Sometimes another mechanism may be more 
appropriate. 
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For example, sometimes the variation diverges so wildly that building a generator becomes 
too complicated. Therefore, we did not generate the statistical R scripts in Chapter 7 but 
wrote them by hand. Note that however a user interface tool on top of these scripts could be 
generated using tools discussed in section 8.2. Another example: Table 1 summarizes 
mechanisms that we used outside the generator to accommodate variation in the data. In 
Chapter 4 we hid the variation between data files in black boxes such that the software 
only had to deal with variation on a ‘needs to know’ basis (e.g. variation in different 
microarray raw data file formats). In Chapter 5 we treated variation in genetical genomics 
data using a minimal ‘core’ data structure with a uniform extension protocol to add specific 
variants of core data types (e.g. core type ‘Trait’ and specifc type ‘Probe’). This ensured 
that ‘common’ tools could talk to each ‘common’ data variant, while ‘specific’ tools still 
have the details they needed using the ‘specific’ data types. In Chapter 7 we created a  
Table 1 | Data variation mechanisms. Summary of mechanisms to deal with expected variation 
in data. More mechanisms can be found in  (Jones and Paton, 2005). 
Black boxes 
Wrap heterogeneous objects into a standard structure such that it ignores its structural 
differences. For example, use file attachments to store microarray measurement files (Chapter 
4). The advantage is that the infrastructure does not need to be tuned to accommodate each 
new variant of these objects. The disadvantage is that the software infrastructure cannot assist 
in searching/checking/editing the data because it does not know anything about its structure. 
Black boxes are a pragmatic choice the only need is to store the data, while processing is solved 
externally using pre-existing tools (e.g. using microarray tools inside R). 
Uniform extensions 
Create extended variants of a common data types so they provide both the standard and the 
custom behavior. For example, create a specialized variant for each kind of ‘phenotype’ such as 
‘probes is-a phenotype’ (adding sequences) and ‘peaks is-a phenotype’ (adding molecular 
formula) (Chapter 5). The advantage is that probes can both by processed by ‘standard’ tools 
expecting a phenotype and custom tools that expect probes (having a sequence). Furthermore, 
the infrastructure provides maximum support. The disadvantage is that for each new ‘phenotype’ 
a new data structure has to be (re)generated which only the owner of the software can do and 
not the casual scientist passing by. Uniform extension mechanisms are a pragmatic choice 
when variation is not predictable and that no pre-existing tools exist to handle/process the data. 
Generic structures  
Create a flexible data structure that accommodates ‘all’ foreseen types of data. For example, 
model different questionnaires with different questions in a generic data structure that describe 
‘question lists’, ‘questions’ and ‘answers’ (Chapter 6). The advantage of this approach is that the 
structure does not need alterations when unforeseen (combinations) of data types come 
available. The disadvantage is that it typically either supports a small range of variation or that it 
becomes so abstract that it is hard for the user to understand how the structure works. For 
example, it is hard to reconstruct the filled-in questionnaires from a pool of questions and 





generic data structure that is more ‘flexible’ so it can contain all the data variants that we 
could foresee. This removed the need for structural changes when new data types were 
needed (e.g., clinical studies have various questionnaires with each different questions). 
Each mechanism also has costs: one has to put in the initial effort in developing generators, 
one looses the capability to search data inside black boxes, one has to coordinate between 
different users of a standard model, and one lacks structural information in the generic 
option, information that has to be added again by the user. 
Future: an open catalog of software variants 
With all this work in place, it is now timely to push the informatics to the background and 
harvest from these investments. We plan collaborations extend the current catalog of 
MOLGENIS variants where biology most needs it, by de novo development as well as by 
assimilation of proven ‘standard’ structures developed elsewhere. We put these application 
models, but also the reusable assets and generators, in a public repository on 
www.molgenis.org. This will help to keep different research groups on the same track, 
because they can oversee the few changes in a single DSL file much better than they can 
oversee many changes spread throughout many files of software code. From this repository, 
bioinformaticians can pick-and-mix (parts of) existing DSL files to generate a suitable 
variant of MOLGENIS.  
We provide migration tools for groups that already have an infrastructure running. For 
example, GeneNetwork.org can assimilate MOLGENIS to ease evolution of their software 
by describing the data structure of their existing software in the DSL. Figure 2a illustrates 
how this adds the MOLGENIS data management functionality to their existing function set 
so they do not need to reinvent wheels (e.g., to create R or Web Service data access). 
Figure 2b-c illustrates how existing software can benefit even more by replacing parts of 
their hand-written software by generated software, allowing to evolve their software 
infrastructure with less effort. Section 1.4 details more opportunities to ease the evolution 
of biological software. We hope that many bioinformaticians will join our effort so in time 
every biologist may find a MOLGENIS variant that suits their needs on 
www.molgenis.org/variants. 
8.2 A bioinformatics software revolution? 
Some say that domain specific languages are nothing new: computer scientists have created 
increasingly higher-level computer languages since the first digital computer (remember 
Figure 1). Others herald domain specific languages as a major paradigm shift: support a 
specific family of software products with more efficient programming commands then can 
ever be achieved in a general-purpose language (or tools) that aims to support everybody.  
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Revolution or evolution: recent publications in high-impact biological journals were highly 
needed to introduce domain specific and generative methods into life sciences. Around the 
year 2000 interest in domain specific and ‘generative’ methods (model driven, software 
families, product lines) greatly increased as ‘software intensive’ industries reported how 
much they gained when building software product lines for mobile phones (Nokia) and 
tv/videosets (Philips). It brought mass customization into software: use computer aided 
manufacturing systems to produce custom output while retaining the cost efficiency of 
mass production. At the same time, biology was also becoming a software intensive 
‘industry’ with the advent of high-throughput biotechnologies Still, bioinformatics 
literature was only focused on standardization initiatives as the method to reduce duplicated 
efforts by reusing software resources. Recent projects including this thesis have helped to 
change that, and nowadays bioinformatics is at the forefront of generative software 
development/software mass custimization research. 
Beyond standardization 
Well known and important standardization proposals, such as MIAME (Minimum 
Information About a Microarray Experiment), MAGE (MicroArray Gene Expression) and 
PEDRO (Proteome Experimental Data Repository) (Brazma, et al., 2001; Spellman, et al., 
2002; Stoeckert, et al., 2001; Taylor, et al., 2003), are by design of a general and 




Figure 2 | Using generative methods to reduce development effort for existing software.
Owners of existing software, such as GeneNetwork, can gradually adopt generative tools, such as
MOLGENIS, to reduce development time and ease evolution. As start, the owners of
GeneNetwork can generate a MOLGENIS variant, that is separated from the existing software but
connected to their database, so they get MOLGENIS’ tools for data management (a). Our 
‘schema import’ tool (www.molgenis.org/tools) helps to generate a MOLGENIS variant that
exactly suits GeneNetwork’s database. Step by step, GeneNetwork can get rid of the 
programming handwork for new/updated data access and manipulation methods by using
MOLGENIS as building blocks for new/updated parts of GeneNetwork (b). Finally, the owners can 
completely move GeneNetwork into the generative toole.g., by adapting MOLGENIS to generate
screens that exactly look like the original hand-written ones and by putting processing and 










FOR GENENETWORK  
chapter 8 
 122
information requirements. For example, research focusing on a human medicine has 
different annotation requirements compared with research on crop modification. While very 
helpful when used pragmatically (see section 8.3), these ‘one-size-fits-all’ standards largely 
ignore the many minor and major variations in biological needs and the development of 
new/improved biological research methods. Thus, the bioinformatics community needed to 
go ‘beyond standardization’ with mechanisms to support various needs.  
Future: unite domain specific tools 
The current MOLGENIS generator aims to provide tailored software infrastructures to 
manage and search specific experiment data in ‘wet’ and ‘dry’ lab. The plan for future 
versions of MOLGENIS is to support processing, visualization and integration, next to data 
management. Fortunately, we have witnessed a proliferation of more domain specific tools 
since we started. Table 1 in Chapter 2 reviews six example initiatives for the search, 
storage, exchange and editing of biological data (CCPN, caCORE and MOLGENIS); to 
share, and connect to, independently developed analysis components (BioMOBY and 
PISE); to link those components together in processing workflows (Taverna); and provide a 
biologist-friendly user interface (MOLGENIS and PISE). We plan make the most of their 
achievements, in connecting the best parts to MOLGENIS (and vice versa). 
Today, a bioinformatician may want to describe in MOLGENIS’ language what data 
structures should be used for markers, traits, genotypes, and then again in Taverna’s 
language, to build an analysis workflow  (maybe with the help of the biological service 
language of BioMOBY), and yet again in Galaxy’s language, to build a biology friendly 
user interface around these tools. Figure 3 suggests a collaborative project to bring these 
tools together. As first step, we propose to create a common domain specific language that 
combines the best features found in the recently developed domain specific languages, as 




As a second step, we need to ensure that the products of the still separated generators can 
be used in combination. This requires agreement on some common ‘Lego pins’ that can be 
used to assemble a more comprehensive software infrastructure from the parts generated by 
the different generative tools. Some minimal pins are already available today (e.g. web 
services), but more work is needed to optimize the integration. E.g. add a ‘MOLGENIS 
processor’ to Taverna’s language to have full access to MOLGENIS’ data retrieval/update 
capabilities inside Taverna, and vice versa, add a ‘plug-in’ sentence in MOLGENIS’ 
language (similar to Figure 4 in Chapter 4) to embed a Taverna workflows inside 
MOLGENIS. 
Combined DSL Current DSLs Implementations translators generators 
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8.3 Generating a bioinformatics nation 
Integration of local resources with public data is an increasingly important challenge. The 
European Mouse community (EU-CASIMIR) recently invited MOLGENIS (Swertz, et al., 
2004), Taverna (Oinn, et al., 2004) and BioMART  (Kasprzyk, et al., 2004) to outline a 
vision on the sharing and integration of mouse data. Figure 4a summarizes a part of their 
leading ‘use case’: mouse biologists scavenge web sites for information on their favorite 
genes and phenotypes of interest using (i) MGD/MPD databases to find allelic phenotype 
information on their mouse strains, (ii) Ensembl databases to find genome context 
information, (iii) KEGG databases to find pathways the gene is involved in, (iv) 
GeneNetwork.org to find QTL near their genes of interest.  
The problem with the current situation is that biologists need to learn the different user 
interfaces, copy-paste data and identifiers from website to website, convert them to make 
them match, and merge all these partial-results into an Excel or Word document by hand. 
This laborious and error-prone process that has to be repeated for each gene, and again 
when data sources are updated, forms a barrier for large (whole) genome scale experiments. 
Envisioned is a situation where bioinformaticians (i) can easily automate this scavenging 
and integration of data to (ii) provide their biologists with a tailored ‘experiment 

















Data GUI Workflow GUI 
 
Figure 3 | Combining generative bioinformatics tools. We envision combination of data 
management capabilities of MOLGENIS with the processing GUI capabilities of Galaxy and the
processing API/workflow capabilities of Taverna, building on reusable assets such as R and
BioMART. A common domain specific language (or graphical tool therefore) will allow 
bioinformaticists to produce more comprehensive software infrastructures that seamlessly 





the relevant experimental and public data. Below we describe a pilot using MOLGENIS, 
BioMART and Taverna showing possible steps to get there. 
Biology resources don’t speak the same language 
The problem with writing a program to integrate existing databases is that they are 
primarily built for human users. They often don’t have access methods suited for a program 
(for example MGD/MPD), or use very different mechanisms that are hard to master and 
combine inside one program (for example: Ensemble uses its own Perl protocol, 
GeneNetwork uses its own Http protocol, and KEGG uses its own variant of web services). 
Figure 4a illustrates to how this requires much efforts at each step of the integration to 
make their program scripts ‘talk’ to each data source.  
Stein, in his seminal commentary (2002) defined what is needed to create a 
‘bioinformatics nation’: data sources need to provide commonly accepted data formats and 
access methods, and a directory service that allows bioinformaticans/scripts to find them. 
‘Web Services’ is an example technology to build such common access methods (using 
SOAP), formats (using XML), and directories of services (using WSDL). Others prefer 
simpler techniques, such as a simple Internet address to download data (e.g.  
http://server/getdata?type=gene&species=mouse). In any case, creation of programmatic 
access methods requires much additional implementation work, which often does not 
directly benefit local users/database owners. Moreover, much coordination work is 
necessary to make services look-a-like between data sources, essential for ease of learning 
and to allow interoperation. This is much to ask from the limited manpower of most data 
providers. 
Generate standardized access methods 
In theory, use of generators reduces much of the implementation and coordination problems 
because generators automatically produce software in a standard way. In a pilot study, we 
generated two MOLGENIS instances; one for GeneNetwork.org and one for MPD (see 
www.molgenis.org/variants/genenetwork and www.molgenis.org/variants/mpd). For bench 
researchers nothing changes: the online databases still exist with their rich and distinctive 
user interfaces. However, bioinformaticians now also have uniform methods to access the 
data programmatically (Figure 4b, solid boxes). Bioinformaticians can use these methods 
to ‘find’ and ‘add’ data from within their R program or from within their web service tool. 
For example, inside the R-workbench type  
‘source(“http://www.molgenis.org/demo/mpd/api/R”)’ or inside Taverna right-click 
‘Available processors’ and then click ‘Add new WSDL scavenger’ to add the services from 
www.molgenis.org/demo/mpd/api/soap?wsdl. These application programming interfaces 
(APIs) can be used as foundation for new tools, removing the need to build common data 
access methods by hand. More importantly for the pilot, bioinformaticians can use these 
interfaces as sources for integrative protocols, which is the main topic of this section. 
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The generation of MOLGENIS variants for GeneNetwork and MPD required (i) import of 
each data structure into MOLGENIS language files using the schema import tool 
(www.molgenis.org/tools), (ii) optional editing of these files to add cross references, 
integrative queries or hide non-public data, and (iii) generation of a MOLGENIS instance, a 
process we did in a few days. Furthermore, we extended MOLGENIS with a generator 
producing web services, which took two weeks. BioMART provided an alternative (non-
generative) strategy: here source data is transformed by BioMARTs import tool into a 
BioMART database. Subsequently, BioMARTs standard tools can be used to search and 
retrieve this data as a big spreadsheet. In this pilot, we connected to Ensembl as wrapped by 
the BioMART team (Figure 4b, dotted box). In comparison, MOLGENIS works on the 
original data structures resulting in more specific web services, and works on the original 
database which requires no synchronization (obviously one can run it on a copy of the 
database, e.g. to have a mirror in another location). 
Ability to connect programs to the data allows bioinformaticians to take the next step: 
build automated protocols that access each data source and integrate the collected results 
into a suitable form for biologists to explore. In the pilot we used Taverna. First, all web 
services had to be made accessible inside Taverna. For the systems ‘wrapped’ in 
MOLGENIS this was done as follows: right-click ‘Available processors’ and then click 
‘Add new WSDL scavenger’ and paste the link to the WSDL file in the dialogue box (e.g. 
www.molgenis.org/demo/mpd/api/soap?wsdl). BioMART entries and KEGG were already 
 
Figure 4 | Automatically generate ‘wrappers’ to make sources ‘talk to each other’. Before 
integration, bioinformaticists need to put in a lot of work to connect data from different and 
distributed biological data sources. This is due to differences or non-availabiltiy of programmatic 
access methods , i.e. differences in languages and technical protocols (left pane).
Generators can be used to ‘wrap’ these sources (in MOLGENIS, boxes) or to import data into a
standardized tool (in BioMART, dotted box). This makes data programmatically accessible in a
uniform way, in this case, web services (right pane). KEGG already spoke web services and 
needed no wrapping. Wrapping the sources removes technical barriers so bioinformaticists can
focus on the important task: create computational protocols that (automatically) integrate data so 




in the Available Processors list because they the Taverna developers already pre-loaded 
them (tested in v1.6.2.0). Finally, we generated a custom MOLGENIS instance to collect 
and visualize the results in a manner suiting the biologist. From within Taverna, data could 
be uploaded into this ‘experiment compendium’ using the ‘add’ services of MOLGENIS. 
Obviously, bioinformaticians can also use their programming language of choice to build 
such protocols.  
Future: generating a bioinformatics nation 
Much is already gained by having the (mouse) databases speak the same language, and we 
plan to extend the MOLGENIS catalog of variants with more data sources to further 
improve the situation. However, each data source still uses its own conceptual structures 
and naming, e.g. MPD says that Strains have an ‘aname’ while GeneNetwork says ‘name’, 
and MPD Strains also has a ‘fullname’. Moreover, each data source still uses different 
descriptions, e.g. MPD talks about ‘kidney weight’ while GeneNetwork talks about 
‘adjusted kidney weight’ and it has to become clear what are corresponding values.  
Figure 5a serves to demonstrate that individual bioinformaticians will duplicate efforts to 
create numerous small translators between data sources (called ‘shims’ in Taverna). Figure 
5b summarizes how the community can reduce these barriers by (i) a canonical data model 
that defines common data types covering the most important information elements and (ii) 
use of a common ontology to standardize descriptions of these elements. We say ‘most 
important elements’ because it is not pragmatic to cover all data elements of all data 
Figure 5 | Uniform data structures ease integration. During data integration bioinformaticists 
have to overcome many differences. Even when data sources can be made to use the same 
technology for data access (as described in Figure 4), bioinformaticists still have to adapt 
differences in conceptual data structure and semantics (see main text). Without coordination 
initiatives, bioinformaticists will have to implement these adapters on an ad-hoc basis (left pane). 
This results in a worst case scenario of N*(N-1)/2 adapters needed to connect all sources to all 
other sources. A common (‘standard’) structure will vastly reduces the number of adapters 
needed to only N (right pane). Such standard structures can become the ‘integration’ hubs to link 
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sources, especially when many of the data sources are constantly evolving. Much is already 
gained if only the core of information elements is covered so they can be used as 
‘integration highway’ nodes to find related information (conf. knuckles and nodes of Stein, 
2003).  
MOLGENIS can help today by (i) providing a simple language to expose the structure 
of each database (now typically hidden) and by (ii) providing tools to generate standardized 
software that can be used as building blocks to solve integration problems. In Section 1.4 
we describe how MOLGENIS could help even more tomorrow using the envisioned 
‘domain specific language for data integration’. 
8.4 How computer scientists can help 
Below we propose informatics research projects to help bioinformaticians to benefit even 
more by (i) helping with evolution/migration of existing data, (ii) helping the integration of 
heterogeneous data sources, (iii) helping with high performance data management, and (iv) 
helping with better theory on when to use which variation mechanisms. In some cases, new 
knowledge and tools need to be developed from scratch. In other cases, it will ‘just’ require 
the translation from informatics into the biology domain.  
Future: A language for evolution of data state 
Available software generators do a good job in producing new variants of software 
infrastructures. However, they largely ignore the question of what to do with data stored in 
a previous version of the infrastructure (‘state’). In this thesis we largely worked around 
this issue by evolving infrastructure using ‘extension’ instead of ‘modification’, e.g. it is 
easy to add empty database tables to support ‘mass spectrometry’ while it is hard to break-
up a full database tables, e.g. to allow ‘more than one microarray sample to be pooled on 
one array’. In the latter case we had to write complex data migration scripts by hand which 
is much to ask for a bioinformatician.  
We can automate much of these tasks by changing the way that DSL files are edited. 
We envision an extension to the domain specific language that helps bioinformaticians to 
evolve their data structures, i.e. describe concisely what changes are needed (such as 
‘rename a field, ‘split an entity’, replace ‘one-to-many’ with ‘many-to-many’ relationship). 
This language can build on the larger informatics community that researches database 
evolution, see (Ambler and Sadalage, 2006) for a catalog of ‘database refactorings’. Based 
on such an ‘evolution’ file an evolved version of an software infrastructure can be 
(re)generated as well as ‘SQL’ scripts needed to move the data from the previous version to 
the next (e.g. using ‘alter table’ commands). 
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Future: A language for data integration 
Data inside biomolecular experiments typically have many connections to data from 
elsewhere, such as genome information, protein structures, known pathways, functional 
information, etc. Currently we simply make hyperlinks, e.g., to link genes to some of the 
major public databases containing genome/sequence. As we discussed in section 8.3, while 
this is sufficient for human users it does not allow integration on a large scale because a 
computer does not ‘know’ what is on the other end of the hyperlinks. Section 8.3 also 
discussed how software generators help to make software infrastructures share their data in 
a uniform way, e.g., different instances of MOLGENIS can technically already talk to each 
other using the scriptable interface generated by MOLGENIS’ generator. However, there is 
a need for simple tools to model and overcome semantic heterogeneity. We plan to extend 
the MOLGENIS language with syntax to define ‘correspondence assertions’ between the 
data elements of various data sources, e.g. with primitives for ‘conflict resolution’ such as 
rename (a column), merge (two data types), convert (from one id or term to another), 
building on our previous work in database integration (Brock and Balsters, 2001; Swertz, 
2001).  
Future: More reusable assets for large-scale data 
With growing data sizes in an increasingly networked scientific world it is desirable to 
make transparent were data is actually stored. We need algorithms to send data ‘by proxy’ 
so only data items that are really used are send over the network while the bulk of the data 
stays on the remote server, or alternatively, to ship a ‘small’ processing tool to the ‘large’ 
data instead of sending the large data over slow network to the processing tools. Moreover, 
these processes must be able to run in parallel if possible. Is this just a matter of 
incorporating recently developed GRID technology in reusable assets? Until now, the 
projects for GRID computing seem largely disconnected from the bioinformatics projects 
that need it. This seems due to the fact that GRID technologies are very hard to use for un-
initiated users, requiring much configuration/programming. We need to investigate how 
generative bioinformatics projects can benefit from them. Is it just a matter of building new 
generators?  
Moreover, most bioinformatics software stores their data using relational database 
technology or flat files. Relational databases have limitations in the scale of data that can be 
stored (although quite high). Drawback of using flat files is that you then lose the 
sophisticated consistency checks and query capabilities of relational database management 
software. Are there specialized alternatives available/being developed that can be used to 
deal with such data (e.g. as extensions to relational databases)? Moreover, this is also a 
question of resources: smaller bioinformatics groups can only afford freely available open 
source projects and have limited resources to optimize software. 
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Future: Criteria when to use which variation mechanism 
In this thesis we have used many variation mechanisms but hardly discussed when to use 
one or another mechanism. In recent years, other researchers have assembled catalogs of 
variation mechanisms. In Table 2 we summarize some of these mechanisms as well as 
properties influencing when to use them, building on work of (Anastasopoulos and Gacek, 
2001; Czarnecki and Eisenecker, 2000; Svahnberg, et al., 2005): 
• Open endedness – is the range of variation fixed? A variation mechanism can be closed 
(choose from an existing menu of options) or open (add new variant options when they 
are needed). Open-endedness is important when one cannot predict future variants. 
• Binding time – when must the variant be decided? This determines the last moment that 
a variation can be chosen, i.e. at design time, compile time, startup time, or run time. 
For example, runtime binding is important when the biologist end user must be able to 
choose the feature during use of the software (e.g. search filter), startup time binding is 
important for the system administrator (e.g. to set database password), compile time 
binding is important when multiple platforms must be supported (e.g. to compile to a 
standalone or server installation), and design time binding is important when the 
designer of the infrastructure is deciding wat feature to add (e.g. what tools does the 
biologist need). 
• Implementation cost – how much effort is involved in implementing variation points? 
Some variation mechanisms cost much more effort to implement, but may also result in 
much more benefits to the users of the variation point. As a rule of thumb, one chooses 
the variation mechanism that is the easiest to implement, e.g., parameterization is 
preferred over inheritance when open-endedness is ‘closed’. 
• Runtime cost – is there a computational overhead when using the mechanism? Use of a 
variation mechanism can result in significantly slower software, which is typically the 
case of mechanisms with ‘runtime’ binding time. This can become an issue with 
computational demanding functions such as genome scale data processing. 
While useful, we think that current catalogs describing variation mechanisms are still 
insufficient in assisting the developers of generative software. Firstly, they do not take the 
detailed capabilities of programming languages into account. For example, SQL does not 
allow users to parameterize the name of a table, e.g. “SELECT * FROM $table” (where 
$table is a parameter) is not proper SQL, while this sentence can work inside a scripting 
language like PHP. Furthermore, the cost of implementation does  not differentiate between 
‘costs for the software family developers’ (for reusable assets, generator, dsl) and ‘costs for 
the application developers’ (generating software variants). For example, generation has a 
high implementation cost for the family developer but a much lower cost for the application 
developer. Finally, most of these catalogs describe the variation mechanisms in 
implementation terms and provide little theoretical analysis. For example, parameterization 
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(local) and generation (global) differ greatly in the scope of their variation, which is not 
clear when looking at comparisons like shown in Table 2. 
 
Table 2 | Variation mechanisms and criteria on when to use them. Binding time - at which 
timepoint does the variation become constant? Open endedness – is the list of variants fixed or 
open? Implementation cost – how difficult is it to add a variation point? Runtime cost – does it 
slow down the software? (See also main text and Anastasopoulos and Gacek, 2001; Czarnecki 

































Parameterization. Put all variant functionality in 
one component. Variant behavior is determined 
via extra arguments in a function call. For 
example: search filters. 
runtime closed low medium 
Configuration. A kind of parameterization 
where the variables are set in a separate 
configuration file, parsed at startup.  
For example: username for a database. 
startup 
time 
closed medium medium 
Inheritance. A sub class ‘extends’ its super 
class to add variant features or operations, or 
overwrite existing ones.  
For example: Employee extends Person, adding 




open medium low 
Strategy. Put variant functionality (‘strategy’) in 
modules with common interface. These 
modules can then be used interchangeable to 
allow variation.  
For example: Lego has standard pins so allows 
separate modules to be assembled. 
runtime open medium low 
Generation. Define variation in a minimal 
language that is then translated into source 
code of a general programming language. 
For example: MOLGENIS. 
design 
time 
open high low 
Interpretation. Define variation in a minimal 
language that is then interpreted by a program 
that then shows the desired features 
instantaneously. 
For example: Taverna. 
runtime open very high high 
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8.5 Conclusion 
We believe that it is timely to move bioinformatics from expensive, almost one-at-a-time 
‘cottage-industry’, towards twenty-first-century software engineering practice, from which 
biologists obtain the customized software infrastructure they need. Each software 
infrastructure for (systems) biology is a puzzle that consists of many pieces that must work 
seamlessly together. Domain specific tools such as reported in this thesis help to put these 
pieces quickly together using the best pieces, building on an evolving collection of reusable 
assets that assimilates the best practices. This has greatly reduced the ‘time-to-research’ of 
software infrastructures, in comparison with handwriting software. A repository to share 
DSL models, or modules thereof, will help to keep different research groups on the same 
track, because they can oversee the few changes in a single DSL file much better than they 
can oversee many related changes that are spread throughout software code.  
We propose the following steps to optimize the benefits. We need to harvest from the 
investments in the domain specific language and generators by developing many more 
useful software variants there where biology most needs it. We plan to bring these efforts 
together in a public catalog to share application models (in the domain specific language), 
reusable assets, and new generators. We propose to join hands with bioinformatics projects 
like Taverna (Oinn, et al., 2004) and Galaxy (Taylor, 2007) to generate user and 
programming interfaces for analysis workflows and processing tools with the same ease as 
MOLGENIS now generates those interfaces for data retrieval and management. And we 
suggest informatics projects that provide advanced tools for evolution, integration and 
increasing data sets, and theory to support software variation.  
Public catalogs such as www.molgenis.org/variants (sharing MOLGENIS software 
infrastructure variants) and www.myexperiment.org (sharing Taverna processing workflow 
variants) give a glance on a future with much more benefits for biologists and 
bioinformaticians to generate ‘software infrastructures biologists want to have’. 
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Supplementary information 
How to build a MOLGENIS variant in five steps and five minutes 
We provide an online showcase so interested readers can experiences how generative 
development can work in practice. Contact us if you want to routinely generate 
MOLGENISes. We can provide you with a local install of the generator tool, speeding up 
evolution of your software variant.  
See http://gbic.biol.rug.nl/supplementary/2007/molgenis_showcase 
Step 1: what do you want to have? 
Say, for example you are just starting genetical genomics experiments. You start sketching 
and you decide that you want to see on your screen an input box for n experiments, with 
beneat it input boxes to edit your o traits (e.g. probes/genes/markers), p subjects (e.g. 
mice), and qassays (e.g. microarray hybridizations, qtl profiles) with r data (e.g. probe 
intensities, genotypes). Conceptually, that is something as you see below.  
 
 
Step 2: what you want to see? 
At the online showcase, describe the application you just sketched above more precisely. 
The screenshot belows show how you can describe the userinterface, that consists of a 






























showing showing the “Traits” and “Subjects” and “Assay” entities. And underneath 
“Assay” we want to see yet another subform with the related data.  
 
Step 3: be a bit more precise on how your data looks like! 
Below we detail how the data structure can be described in the domain specific language of 
MOLGENIS. Most of it is self-explanatory but we highlight some statements:  
• Implements=”Identifiable” means that the entity has the same properties as 
‘Identifiable’, i.e. each entity has and auto-generated Id and a Name. 
• type=”xref” and xref_field=”Experiment.Id” indicates that the field 
Experiment of Subject should cross reference (x ref) to an existing 
Experiment, using Id to uniquely identify this Experiment.  
• Cross references are used to automatically link forms together, i.e. when 
viewing experiments only the related Subjects are shown using the 








A complete MOLGENIS description. Colored bars relate to colors in schema below. 
Step 4: Generate the variant 
Finally, you only have to push the  button to generate the application you 
just designed. Note: you can choose 
either to create a “standalone” 
MOLGENIS which only needs the 
installation of Java. Alternatively, 
you can connect MOLGENIS to use 
a MySQL database (tick the option 































Step 5: Download and run your own custom-made MOLGENIS 
Double click the hyperlink “MOLGENIS.jar”. The software is downloaded and is then run 




What actually happens, is that a mini web server is started, denoted by the MOLGENIS 
item in the Windows task bar. The browser should be opened automatically. If not, browse 
to it via http://localhost:9080/molgenis.do  
You can stop the MOLGENIS server by clicking the  item in 
the Windows task bar and pushing . 
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Appendix: Complete “blueprint” of the variant. 
We here provide the specification of the variant defined in steps 1-3 for copy-paste. 
 
<molgenis name="example"> 
 <entity name="Identifiable" abstract="true"> 
  <field name="Id" type="autoid"/> 
  <field name="Name" type="varchar"/> 
 </entity> 
 <entity name="Experiment" implements="Identifiable"> 
  <field name="Description" type="text" nillable="true"/> 
  <unique fields="Name"/> 
 </entity> 
 <entity name="Trait" implements="Identifiable"> 
  <field name="Experiment" type="xref" 
xref_field="Experiment.Id"/> 
  <unique fields="Name,Experiment"/> 
 </entity> 
 <entity name="Subject" implements="Identifiable"> 
  <field name="Species" type="varchar"/> 
  <field name="Experiment" type="xref" 
xref_field="Experiment.Id"/> 
  <unique fields="Name,Experiment"/> 
 </entity> 
 <entity name="Assay" implements="Identifiable"> 
  <field name="Experiment" type="xref" 
xref_field="Experiment.Id"/> 
  <unique fields="Name,Experiment"/> 
 </entity> 
 <entity name="Data"> 
  <field name="Assay" type="xref" xref_field="Assay.Id"/> 
  <field name="Row" type="xref" xref_field="Trait.Id"/> 
  <field name="Col" type="xref" xref_field="Subject.Id"/> 
  <field name="Value" type="decimal"/> 
  <unique fields="Assay,Col,Row"/> 
 </entity> 
 <form name="Experiments" entity="Experiment"> 
  <menu name="ExperimentMenu"> 
   <form name="Traits" entity="Trait"/> 
   <form name="Subjects" entity="Subject"/> 
   <form name="Assays" entity="Assay"> 
    <form name="Data" entity="Data"/> 
   </form> 






Online software resources for biology 
References to this online information are indicated in the main text by THIN SMALL CAPS. 
BIOARRAY SOFTWARE ENVIRONMENT (BASE) 
Open source microarray database. http://base.thep.lu.se  
BIOCONDUCTOR  
Open source software for the analysis of genomic data such as microarrays implemented 
upon the →R LANGUAGE. http://www.bioconductor.org  
BIOMART 
Query oriented database system, typically used to import data from elsewhere into and to 
subsequently use as data warehouse. http://www.biomart.org/  
BIOMOBY 
Open source software to help bioinformatics programmers to connect biological data host 
and analytical services together, building on →WEB SERVICES.  http://www.biomoby.org  
BIO* TOOLKITS 
Sequence oriented, open source, software components that can be used as building 
blocks for biological software in Perl (BioPerl), Java (BioJava) and Python (BioPython). 
http://www.open-bio.org/wiki/projects  
CACORE  
Toolkit to generate data management components as a foundation of biological software. 
Is used for cancer research. http://ncicb.nci.nih.gov/infrastructure.  
CCPN 
Open source toolkit to generate data management components as a foundation for 
biological software. Is used by the NMR community to speed up the building and 
integration of analysis tools. http://www.ccpn.ac.uk 
CLINTRAIL 
Commercial software to manage clinical data. 
http://www.phaseforward.com/products/clinical/cdm/cdms/documents/Clintrial.pdf 
CYTOSCAPE: 
Open source software for visualizing molecular interaction networks and integrating these 
with gene expression profiles and other data. Has an extension mechanism to allow 
bioinformaticists to add new methods. http://www.cytoscape.org  
EMBOSS 
Open source analysis package that consist of mainly commandline tools for sequence 
alignments, motif searches, etc. http://emboss.sourceforge.net  
FUGE-OM (FUNCTIONAL GENOMICS EXPERIMENT OBJECT MODEL) 
Standard data structure for the representation of functional genomics experiments. Areas 
this project tries to cover includes gene expression (assimilating the work on →MAGE), 





Website that enables biologists to explore QTL experiments using basic statistics, QTL 
Mapping, Correlation analysis, and linkouts to genomic information. 
http://www.genenetwork.org  
GENERIC MODEL ORGANISM DATABASE TOOLKIT 
Suite of standard software components that can be used by bioinformaticists to build a 
specific database of genome annotations for a specific organism (as used in FlyBase, and 
WormBase). http://www.gmod.org  
INTEGRATED REVIEW 
Commercial system to manage clinical data. http://www.i-
review.com/index.php?option=com_content&task=view&id=25&Itemid=34  
INVENGINE 
A software tool (or generator “engine”) that was previously used to generate 
→MOLGENIS. Newer versions of this tool we simply call the MOLGENIS generator. 
http://www.invengine.nl  
METALIGN 
Commercial software tool for the analysis, alignment and comparison of →MASS 
SPECTROMETRY datasets. http://www.pri.wur.nl/UK/products/MetAlign/  
METANETWORK AND SUPPLEMENTARY MANUAL 
Open source package in R Language to reconstruct metabolic networks. Described in this 
thesis. http://gbic.biol.rug.nl/supplementary  
MAGE-OM (MICROARRAY GENE EXPRESSION  OBJECT MODEL) 
Standard data structure for the representation of microarray expression experiments. 
Builds on the requirements collected in ÆMIAME. 
http://www.mged.org/Workgroups/MAGE/mage.html  
MGED MICROARRAY GENE EXPRESSION DATA SOCIETY 
International organization of biologists, computer scientists and data analysist aiming to 
facilitate the sharing of microarray data, mainly by standardization. http://www.mged.org  
MIAME (MINIMUM INFORMATION ABOUT A MICROARRAY EXPERIMENT)  
Normative description of what information elements are needed to interpret microarray 
experiments. http://www.mged.org/Workgroups/MIAME/miame.html  
MOLGENIS (MOLECULAR GENETICS INFORMATION SYSTEM)  
Software tool to generate data infrastructure that includes database, programmatic tools 
to interact with the data (from other programs) and graphical user interface for biologists. 
Described in this thesis. http://www.molgenis.org  
MOLGENIS ONLINE SHOWCASE 
Showcase website of MOLGENIS with a catalogue of MOLGENIS variants and an online 




MOUSE GENOME INFORMATICS /MGI 
A database of genetic and molecular biology data for the model animal organism Mouse. 
http://www.arabidopsis.org 
MYEXPERIMENT 
Website to share scientific processing workflows that are written in →TAVERNA domain 
specific language. http://www.myexperiment.org  
PEDRO / PSI 
Standard data structure for the representation of proteomics experiments. PEDRo 
(Proteome Experimental Data Repository) was superseded by PSI (Proteomics 
Standards Initiative) and is again superseded by the →FUGE project.  
PISE 
Software tool to generate graphical user interfaces for →EMBOSS processing programs 
such that biologists can then run and link these programs just by clicking on buttons and 
filling in text-boxes. http://www.pasteur.fr/recherche/unites/sis/Pise     
TAIR 
A database of genetic and molecular biology data for the model higher plant organism 
Arabidopsis thaliana. http://www.arabidopsis.org  
TAVERNA 
Graphical software tool to design and execute biological analysis workflows, building to 
analysis services that are made available as →WEB SERVICES. 
http://taverna.sourceforge.net 
TCC (TRIAL COORDINATION CENTER) 
Contract research organization for clinical trials of the University Medical Center 
Groningen. http://www.trialcoordinationcenter.nl 
TRIALDB 
Open source software to manage clinical data. http://ycmi.med.yale.edu/trialdb 
UCSC GENOME BROWSER 
Web site with visual tools that enables biologists to navigate trough the reference 







Online resources for software infrastructure development 
References to this online information are indicated in the main text by THIN SMALL CAPS. 
APACHE TOMCAT 
Web server for java applications. http://tomcat.apache.org  
APACHE WEB SERVER 
Web server to serve →HTML web pages. http://www.apache.org  
CODE GENERATION NETWORK 
Community portal for the code generator. Includes a catalog of open and commercial 
software for code generation. http://www.codegeneration.net  
CSS 
A standard mechanism to style →HTML pages called Cascading Style Sheets.  CSS is a 
Google term. 
DOM 
A standard mechanism for programmatically “talk” to an →XML file. DOM is a Google 
term. 
ECLIPSE 
An open source software for the development of software. Supports many software 
languages and is used as standard editor for Java programming. 
http://www.eclipse.org/emf  
FREEMARKER 
Open source →TEMPLATING LANGUAGE typically used to generate text files such as 
→HTML web pages for a “dynamic” web application. Can also be used for →SOFTWARE 
GENERATION. http://freemarker.sourceforge.net/  
HTML 
Hypertext markup language used to build web pages that can be viewed with browsers 
like FireFox and Internet Explorer. HTML pages can be linked together using hyperlinks. 
HTML is a Google term. 
JAVASCRIPT 
Standard language (also known as ECMA script) that is used to make →HTML web 
pages “interactive”, that is, make the web page response to actions of the user (other 
than clicking hyperlinks). Javascript is a Google term. 
JAVA 
Object oriented programming language, originally developed and distributed for free by 
Sun Microsystems. Java programs and web applications are →PLATFORM INDEPENDENT (as 
long as Java itself is available on the platform). Recently, Java has been made open 
source. http://java.sun.com/  
MYSQL 





Open source →TEMPLATING LANGUAGE typically used to generate text files such as 
→HTML web pages for a “dynamic” web application. Because it is typically embedded 
inside →APACHE WEBSERVER it is not often used for →SOFTWARE GENERATION. 
http://www.php.net  
POSTGRESQL 
Open source database software (→RELATIONAL DATABASE MANAGEMENT SYSTEM). 
http://www.postgresql.org  
SQL AND SQL92 
Standard programming language used to ”talk with” relational database management 
systems to CREATE DATABASES and SELECT, INSERT, UPDATE,  and DELETE data. 
SQL is a Google term. 
SOFTWARE ENGINEERING INSTITUTE (SEI) 
Research institute that studies software engineering principles and practices, including 
those of →SOFTWARE PRODUCT LINES. http://www.sei.cmu.edu/productlines/plp_hof.html  
THE APACHE VELOCITY PROJECT 
Open source →TEMPLATING LANGUAGE typically used to generate text files such as 
→HTML web pages for a “dynamic” web application. Can also be used for →SOFTWARE 
GENERATION. http://velocity.apache.org 
R LANGUAGE / R PROJECT 
Open source programming language for statistical computing and graphics. Widely used 
in biology, see →BIOCONDUCTOR.  
http://www.r-project.org 
W3C SEMANTIC WEB 
Standard framework to describe data in a structured way so its semantics can be 
“understood” by software. http://www.w3.org/2001/sw/ 
WEB SERVICES / W3C WEB SERVICES ACTIVITY 
Standard framework to enable software to software communication over the Internet 
using →XML messenges. http://www.w3.org/2002/ws 
XML (EXTENSIBLE MARKUP LANGUAGE) 
Standard method to describe data in a tree using similar “<>” markup as used in →HTML. 
This allows programmers to define their own markup while still able to reuse tools for 
searching an manipulating such files. http://www.w3.org/XML/  
XSLT (XML STYLESHEET LANGUAGE TRANSFORMATIONS) 
Standard →TEMPLATING LANGUAGE that is used to generated text file from XML files. 
Typically used to generate →HTML web pages for a “dynamic” web application. Can also 
be used for→SOFTWARE GENERATION.  http://www.w3.org/TR/xslt  
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